0000950136-05-007125 10-Q 9 20050930 20051110 20051110 Celanese CORP 0001306830 2820 980420726 DE 1231 10-Q 34 001-32410 051192813 1601 W. LBJ FREEWAY DALLAS TX 75234 972-443-4000 1601 W. LBJ FREEWAY DALLAS TX 75234 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 10-Q 1 file001.htm FORM 10-Q [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] FORM 10-Q [[Image Removed: [X]]] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2005 OR [[Image Removed: [ ]]] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-32410 (Commission File Number) [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] CELANESE CORPORATION (Exact Name of Registrant as Specified in its Charter) [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Delaware [[Image Removed]] 98-0420726 (State or Other Jurisdiction of [[Image Removed]] (I.R.S. Employer Identification No.) Incorporation or Organization) 1601 West LBJ Freeway, [[Image Removed]] 75234-6034 (Address of Principal Executive Offices) [[Image Removed]] (Zip Code) (972) 443-4000 (Registrant's telephone number, including area code) [[Image Removed]] Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [[Image Removed: [X]]] No [[Image Removed: [ ]]] Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes[[Image Removed: [ ]]] No[[Image Removed: [X]]] Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes[[Image Removed: [ ]]] No[[Image Removed: [X]]] The number of outstanding shares of the registrant's Series A Common Stock, $ 0.0001 par value, as of November 2, 2005 was 158,562,161. Exhibit index located on sequential page number 2. [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] -------------------------------------------------------------------------------- CELANESE CORPORATION Form 10-Q For the Quarterly Period Ended September 30, 2005 TABLE OF CONTENTS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Page [[Image Removed]] Basis of Presentation [[Image Removed]] 3 [[Image Removed]] Market Industry and Data Forecasts [[Image Removed]] 5 [[Image Removed]] Special Note Regarding Forward-Looking Statements [[Image Removed]] 5 Part I [[Image Removed]] Financial Information [[Image Removed]] [[Image Removed]] Item 1. [[Image Removed]] Financial Statements [[Image Removed]] 6 [[Image Removed]] Item 2. [[Image Removed]] Management's Discussion and Analysis of Financial Condition [[Image Removed]] and Results of Operations 54 [[Image Removed]] Item 3. [[Image Removed]] Quantitative and Qualitative Disclosures about Market Risk [[Image Removed]] 92 [[Image Removed]] Item 4. [[Image Removed]] Controls and Procedures [[Image Removed]] 92 Part II [[Image Removed]] Other Information [[Image Removed]] [[Image Removed]] Item 1. [[Image Removed]] Legal Proceedings [[Image Removed]] 94 [[Image Removed]] Item 2. [[Image Removed]] Unregistered Sales of Equity Securities and Use of Proceeds [[Image Removed]] 95 [[Image Removed]] Item 3. [[Image Removed]] Defaults Upon Senior Securities [[Image Removed]] 95 [[Image Removed]] Item 4. [[Image Removed]] Submission of Matters to a Vote of Security Holders [[Image Removed]] 95 [[Image Removed]] Item 5. [[Image Removed]] Other Information [[Image Removed]] 95 [[Image Removed]] Item 6. [[Image Removed]] Exhibits [[Image Removed]] 95 [[Image Removed]] Signatures [[Image Removed]] [[Image Removed]] 98 [[Image Removed]] 2 -------------------------------------------------------------------------------- Basis of Presentation In this Quarterly Report on Form 10-Q, the term Celanese refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the Company, we, our and us refer to Celanese and its subsidiaries on a consolidated basis. The term BCP Crystal refers to our subsidiary BCP Crystal US Holdings Corp., and not its subsidiaries. The term Purchaser refers to our subsidiary, Celanese Europe Holding GmbH & Co. KG, formerly known as BCP Crystal Acquisition GmbH & Co. KG, a German limited partnership (Kommanditgesellschaft, KG), and not its subsidiaries, except where otherwise indicated. The term Original Shareholders refers, collectively, to Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone Capital Partners (Cayman) Ltd. 2, Blackstone Capital Partners (Cayman) Ltd. 3 and BA Capital Investors Sidecar Fund, L.P. The terms Sponsor and Advisor refer to certain affiliates of The Blackstone Group. Celanese is a recently-formed company which does not have any independent external operations other than through the indirect ownership of CAG (as defined below) and CAC (as defined below), their consolidated subsidiaries, their non-consolidated subsidiaries, ventures and other investments. For accounting purposes, Celanese and its consolidated subsidiaries are referred to as the Successor. See Note 1 to the Unaudited Interim Consolidated Financial Statements (as defined below) for additional information on the basis of presentation of the Successor. Pursuant to a voluntary tender offer commenced in February 2004 (the Tender Offer), the Purchaser, an indirect wholly-owned subsidiary of Celanese, in April 2004 acquired approximately 84% of the ordinary shares of CAG (the CAG Shares) outstanding. All references in this Quarterly Report to the outstanding ordinary shares of CAG exclude treasury shares, unless expressly provided otherwise. As of September 30, 2005, Celanese's indirect ownership of approximately 96% of the outstanding CAG Shares would equate to approximately 88% of the issued CAG Shares (including treasury shares). Pursuant to a mandatory offer commenced in September 2004 and continuing as of the date of this Quarterly Report, the Purchaser has acquired additional CAG Shares. In addition, in August 2005, the Purchaser acquired approximately 5.9 million, or approximately 12%, of the outstanding CAG Shares from two shareholders. As a result of these acquisitions, partially offset by the issuance of additional CAG Shares as a result of the exercise of options issued under the CAG stock option plan, as of November 2, 2005, we own approximately 98% of the outstanding CAG shares. The mandatory offer expires on December 1, 2005, unless further extended. On November 3, 2005, the Company's Board of Directors approved commencement of the process for effecting a squeeze-out of the remaining shareholders. In October 2004, Celanese and certain of its subsidiaries completed an organizational restructuring (the Restructuring) pursuant to which the Purchaser effected, by giving a corresponding instruction under the Domination Agreement (as defined below), the transfer of all of the shares of Celanese Americas Corporation (CAC) from Celanese Holding GmbH, a wholly owned subsidiary of CAG, to BCP Caylux Holdings Luxembourg S.C.A. (BCP Caylux) resulting in BCP Caylux ownership of 100% of the equity of CAC and indirectly, all of its assets, including subsidiary stock. Thereafter, BCP Caylux transferred certain assets, including its equity ownership interest in CAC, to BCP Crystal. In this Quarterly Report, the term Domination Agreement refers to the domination and profit and loss transfer agreement between CAG and the Purchaser, pursuant to which the Purchaser became obligated on October 1, 2004 to offer to acquire all outstanding CAG Shares from the minority shareholders of CAG in return for payment of fair cash compensation in accordance with German law. Celanese AG is incorporated as a stock corporation (Aktiengesellschaft, AG) organized under the laws of the Federal Republic of Germany. As used in this document, the term CAG refers to (i) prior to the Restructuring, Celanese AG and CAC, their consolidated subsidiaries, their non-consolidated subsidiaries, ventures and other investments, and (ii) following the Restructuring, Celanese AG, its consolidated subsidiaries, its non-consolidated subsidiaries, ventures and other investments, except that with respect to shareholder and similar matters where the context indicates, CAG refers to Celanese AG. For accounting purposes, Predecessor refers to CAG and its subsidiaries. 3 -------------------------------------------------------------------------------- Following the transfer of CAC to BCP Crystal, (1) BCP Crystal Holdings Ltd. 2 contributed substantially all of its assets and liabilities (including all outstanding capital stock of BCP Caylux) to BCP Crystal and (2) BCP Crystal assumed certain obligations of BCP Caylux, including all rights and obligations of BCP Caylux under the senior credit facilities, the floating rate term loan and the notes. BCP Crystal Holdings Ltd. 2 reorganized as a Delaware limited liability company and changed its name to Celanese Holdings LLC. Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. reorganized as a Delaware corporation and changed its name to Celanese Corporation. BCP Crystal, at its discretion, may subsequently cause the liquidation of BCP Caylux. As a result of these transactions, BCP Crystal holds 100% of CAC's equity and, indirectly, all equity owned by CAC in its subsidiaries. In addition, BCP Crystal holds, indirectly, all of the outstanding common stock of CAG held by the Purchaser and all of the wholly owned subsidiaries of Celanese that guarantee BCP Caylux's obligations under the senior credit facilities and guarantee the senior subordinated notes issued on June 8, 2004 and July 1, 2004 on an unsecured senior subordinated basis. See Notes 3 and 9 to the Unaudited Interim Consolidated Financial Statements (as defined below). As of the date of this Quarterly Report, Celanese has two classes of common stock, Series A common stock and Series B common stock, and convertible perpetual preferred stock. In January 2005, Celanese completed an initial public offering of 50,000,000 shares of Series A common stock. The Series A common stock is currently held by public shareholders, the Original Shareholders and certain directors, officers and employees of the Company. No shares of Series B common stock are currently outstanding. All of the shares of Series B common stock outstanding were automatically converted into Series A common stock on April 7, 2005 following the payment on that date of a special Series B common stock cash dividend declared on March 8, 2005 to the then holders of the outstanding shares of Series B common stock. Except for (i) the special Series A common stock dividend which we paid to the holders of outstanding shares of Series B common stock on March 9, 2005 and a special cash dividend which we paid to the holders of outstanding shares of Series B common stock on April 7, 2005, (ii) the convertibility of Series B common stock into Series A common stock and (iii) the right of the Series B common stock to consent to any changes to our governing documents that would adversely affect the Series B common stock, shares of Series A common stock and shares of Series B common stock are identical, including with respect to voting rights. Holders of the common stock are entitled to receive, when, as and if, declared by the Celanese board of directors, out of funds legally available therefor, cash dividends at the rate per annum of 1% of the $16.00 initial public offering price per share of our Series A common stock (or $0.16 per share), payable on a quarterly basis. The initial quarterly dividend payment was made on August 11, 2005. As used in this Quarterly Report, the term common stock means, collectively, the Series A common stock and the Series B common stock, and the term preferred stock means the convertible perpetual preferred stock, in each case unless otherwise specified. Concurrently with the initial public offering of its Series A common stock, Celanese offered 9,600,000 shares of its preferred stock. Holders of the preferred stock are entitled to receive, when, as and if, declared by the Celanese board of directors, out of funds legally available therefor, cash dividends at the rate of 4.25% per annum of liquidation preference, payable quarterly in arrears. The initial quarterly dividend payment was made on May 1, 2005. Dividends on the preferred stock are cumulative from the date of initial issuance. The preferred stock is convertible, at the option of the holder, at any time, into shares of our Series A common stock at a conversion rate of approximately 1.25 shares of Series A common stock for each share of preferred stock, subject to adjustments. The unaudited interim consolidated financial statements of the Successor for the three and nine months ended September 30, 2005 and the three and six months ended September 30, 2004 as well as the unaudited interim consolidated financial statements of the Predecessor for the three months ended March 31, 2004 contained in this Quarterly Report (collectively, the Unaudited Interim Consolidated Financial Statements) were prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for all periods presented. The Unaudited Interim Consolidated Financial Statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations. 4 -------------------------------------------------------------------------------- The results of the Successor are not comparable to the results of the Predecessor due to the differences in the basis of presentation of purchase accounting as compared to historical cost. CAG is a foreign private issuer and previously filed its consolidated financial statements as of December 31, 2003 and 2002 in its Annual Report on Form 20-F. CAG changed its fiscal year end to September 30 and filed its consolidated financial statements as of September 30, 2004 and for the nine months then ended in its 2004 Annual Report on Form 20-F. In accordance with German law, the reporting currency of the CAG consolidated financial statements is the euro. As a result of the Purchaser's acquisition of voting control of CAG, the financial statements of CAG contained in this document are reported in U.S. dollars to be consistent with our reporting requirements. For CAG's reporting requirements, the euro continues to be the reporting currency. In the preparation of other information included in this document, euro amounts have been translated into U.S. dollars at the applicable historical rate in effect on the date of the relevant event or period. For purposes of prospective information, euro amounts have been translated into U.S. dollars using the rate in effect on September 30, 2005. Our inclusion of this information is not meant to suggest that the euro amounts actually represent such dollar amounts or that such amounts could have been converted into U.S. dollars at any particular rate, if at all. Market Industry and Data Forecasts This document includes industry data and forecasts that Celanese has prepared based, in part, upon industry data and forecasts obtained from industry publications and surveys and internal company surveys. Third-party industry publications and surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable. AO Plus, BuyTiconaDirect, CelActiv, Celanex, Celcon, Celstran, Celvolit, Compel, GUR, Hoecat, Hostaform, Impet, Impet-HI, Mowilith, Nutrinova DHA, Riteflex, Sunett, Topas, Vandar, VAntage, Vectra, Vectran, Vinamul, Elite, Duroset and certain other products and services that may be named in this document are registered trademarks and service marks of CAG. Acetex is a registered trademark of Acetex Corporation, an indirect wholly owned subsidiary of Celanese. Fortron is a registered trademark of Fortron Industries, a venture of Celanese. Special Note Regarding Forward-Looking Statements Investors are cautioned that the forward-looking statements contained in this Quarterly Report involve both risk and uncertainty. Many important factors could cause actual results to differ materially from those anticipated by these statements. Many of these factors are macroeconomic in nature and are, therefore, beyond our control. See Management's Discussion and Analysis of Financial Condition and Results of OperationsForward-Looking Statements May Prove Inaccurate. 5 -------------------------------------------------------------------------------- PART I FINANCIAL INFORMATION Item 1. Financial Statements INDEX TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] PAGE CELANESE CORPORATION UNAUDITED INTERIM CONSOLIDATED [[Image Removed]] FINANCIAL STATEMENTS Unaudited Consolidated Statements of Operations for [[Image Removed]] the three months ended September 30, 2005 and 2004 7 Unaudited Consolidated Statements of Operations for the nine months ended September 30, 2005, the six [[Image Removed]] months ended September 30, 2004 and the three months ended March 31, 2004 8 Unaudited Consolidated Balance Sheets as of September [[Image Removed]] 30, 2005 and December 31, 2004 9 Unaudited Consolidated Statements of Shareholders' Equity (Deficit) for the nine months ended September [[Image Removed]] 30, 2005, the six months ended September 30, 2004 and the three months ended March 31, 2004 10 Unaudited Consolidated Statements of Cash Flows for the nine months ended September 30, 2005, the six [[Image Removed]] months ended September 30, 2004 and the three months ended March 31, 2004 11 Notes to the Unaudited Interim Consolidated Financial [[Image Removed]] Statements 13 [[Image Removed]] 6 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended September 30, 2005 September 30, 2004 [[Image Removed]] (in $ millions, except for share and per share data) Net sales [[Image Removed]] 1,536 [[Image Removed]] 1,265 Cost of sales [[Image Removed]] (1,253 ) [[Image Removed]] (1,005 ) Selling, general and administrative expenses [[Image Removed]] (144 ) [[Image Removed]] (153 ) Research and development expenses [[Image Removed]] (22 ) [[Image Removed]] (23 ) Special charges: [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] (1 ) Restructuring, impairment and other special charges [[Image Removed]] (24 ) [[Image Removed]] (58 ) Foreign exchange gain (loss), net [[Image Removed]] (2 ) [[Image Removed]] (2 ) Gain (loss) on disposition of assets, net [[Image Removed]] 1 [[Image Removed]] 2 Operating profit [[Image Removed]] 92 [[Image Removed]] 25 Equity in net earnings of affiliates [[Image Removed]] 21 [[Image Removed]] 17 Interest expense [[Image Removed]] (72 ) [[Image Removed]] (98 ) Interest income [[Image Removed]] 7 [[Image Removed]] 8 Other income (expense), net [[Image Removed]] 26 [[Image Removed]] 17 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] and minority interests 74 (31 ) Income tax provision [[Image Removed]] (26 ) [[Image Removed]] (48 ) Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] minority interests 48 (79 ) Minority interests [[Image Removed]] (3 ) [[Image Removed]] 8 Earnings (loss) from continuing operations [[Image Removed]] 45 [[Image Removed]] (71 ) Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] 45 [[Image Removed]] (71 ) Cumulative undeclared preferred stock dividend [[Image Removed]] (3 ) [[Image Removed]] Net earnings (loss) available to common shareholders [[Image Removed]] 42 [[Image Removed]] (71 ) Earnings (loss) per common share basic: [[Image Removed]] [[Image Removed]] Continuing operations [[Image Removed]] 0.26 [[Image Removed]] (0.71 ) Discontinued operations [[Image Removed]] [[Image Removed]] Net earnings (loss) available to common shareholders [[Image Removed]] 0.26 [[Image Removed]] (0.71 ) Earnings (loss) per common share diluted: [[Image Removed]] [[Image Removed]] Continuing operations [[Image Removed]] 0.26 [[Image Removed]] (0.71 ) Discontinued operations [[Image Removed]] [[Image Removed]] Net earnings (loss) available to common shareholders [[Image Removed]] 0.26 [[Image Removed]] (0.71 ) Weighted average shares basic: [[Image Removed]] 158,546,594 [[Image Removed]] 99,377,884 Weighted average shares diluted: [[Image Removed]] 171,930,270 [[Image Removed]] 99,377,884 [[Image Removed]] See the accompanying notes to the unaudited interim consolidated financial statements. 7 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Nine Months Ended [[Image Removed]] Six Months Ended [[Image Removed]] Three Months Ended September 30, 2005 September 30, 2004 March 31, 2004 [[Image Removed]] (in $ millions, except for share and per share data) Net sales [[Image Removed]] 4,562 [[Image Removed]] 2,494 [[Image Removed]] 1,243 Cost of sales [[Image Removed]] (3,553 ) [[Image Removed]] (2,063 ) [[Image Removed]] (1,002 ) Selling, general and administrative expenses [[Image Removed]] (441 ) [[Image Removed]] (278 ) [[Image Removed]] (137 ) Research and development expenses [[Image Removed]] (68 ) [[Image Removed]] (45 ) [[Image Removed]] (23 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] 4 [[Image Removed]] 1 [[Image Removed]] Restructuring, impairment and other special charges [[Image Removed]] (93 ) [[Image Removed]] (59 ) [[Image Removed]] (28 ) Foreign exchange gain (loss), net [[Image Removed]] [[Image Removed]] (2 ) [[Image Removed]] Gain (loss) on disposition of assets, net [[Image Removed]] (1 ) [[Image Removed]] 2 [[Image Removed]] (1 ) Operating profit [[Image Removed]] 410 [[Image Removed]] 50 [[Image Removed]] 52 Equity in net earnings of affiliates [[Image Removed]] 48 [[Image Removed]] 35 [[Image Removed]] 12 Interest expense [[Image Removed]] (316 ) [[Image Removed]] (228 ) [[Image Removed]] (6 ) Interest income [[Image Removed]] 31 [[Image Removed]] 15 [[Image Removed]] 5 Other income (expense), net [[Image Removed]] 47 [[Image Removed]] (7 ) [[Image Removed]] 9 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 220 (135 ) 72 Income tax provision [[Image Removed]] (77 ) [[Image Removed]] (58 ) [[Image Removed]] (17 ) Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 143 (193 ) 55 Minority interests [[Image Removed]] (41 ) [[Image Removed]] (2 ) [[Image Removed]] Earnings (loss) from continuing operations [[Image Removed]] 102 [[Image Removed]] (195 ) [[Image Removed]] 55 Earnings (loss) from discontinued operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] Gain (loss) from operation of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] (5 ) Gain (loss) on disposal of discontinued operations [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] 14 Income tax benefit (expense) [[Image Removed]] [[Image Removed]] [[Image Removed]] 14 Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] 23 Net earnings (loss) [[Image Removed]] 102 [[Image Removed]] (196 ) [[Image Removed]] 78 Cumulative declared and undeclared preferred stock [[Image Removed]] [[Image Removed]] [[Image Removed]] dividend (7 ) Net earnings (loss) available to common shareholders [[Image Removed]] 95 [[Image Removed]] (196 ) [[Image Removed]] 78 Earnings (loss) per common share basic: [[Image Removed]] [[Image Removed]] [[Image Removed]] Continuing operations [[Image Removed]] 0.62 [[Image Removed]] (1.96 ) [[Image Removed]] 1.12 Discontinued operations [[Image Removed]] [[Image Removed]] (0.01 ) [[Image Removed]] 0.46 Net earnings (loss) available to common shareholders [[Image Removed]] 0.62 [[Image Removed]] (1.97 ) [[Image Removed]] 1.58 Earnings (loss) per common share diluted: [[Image Removed]] [[Image Removed]] [[Image Removed]] Continuing operations [[Image Removed]] 0.62 [[Image Removed]] (1.96 ) [[Image Removed]] 1.11 Discontinued operations [[Image Removed]] [[Image Removed]] (0.01 ) [[Image Removed]] 0.46 Net earnings (loss) available to common shareholders [[Image Removed]] 0.62 [[Image Removed]] (1.97 ) [[Image Removed]] 1.57 Weighted average shares basic: [[Image Removed]] 153,001,360 [[Image Removed]] 99,377,884 [[Image Removed]] 49,321,468 Weighted average shares diluted: [[Image Removed]] 153,536,802 [[Image Removed]] 99,377,884 [[Image Removed]] 49,712,421 [[Image Removed]] See the accompanying notes to the unaudited interim consolidated financial statements. 8 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] As of [[Image Removed]] As of September 30, 2005 December 31, 2004 [[Image Removed]] (in $ millions) ASSETS [[Image Removed]] [[Image Removed]] Current assets: [[Image Removed]] [[Image Removed]] Cash and cash equivalents [[Image Removed]] 401 [[Image Removed]] 838 Receivables [[Image Removed]] [[Image Removed]] Trade receivables, net third party and affiliates, net of allowance for doubtful accounts of $23 million [[Image Removed]] [[Image Removed]] and $22 million as of September 30, 2005 and December 31, 2004, respectively 947 866 Other receivables [[Image Removed]] 519 [[Image Removed]] 670 Inventories [[Image Removed]] 625 [[Image Removed]] 618 Deferred income taxes [[Image Removed]] 69 [[Image Removed]] 71 Other assets [[Image Removed]] 47 [[Image Removed]] 86 Assets of discontinued operations [[Image Removed]] 2 [[Image Removed]] 2 Total current assets [[Image Removed]] 2,610 [[Image Removed]] 3,151 Investments [[Image Removed]] 551 [[Image Removed]] 600 Property, plant and equipment, net of accumulated depreciation of $857 million and $446 million as of [[Image Removed]] [[Image Removed]] September 30, 2005 and December 31, 2004, respectively 1,982 1,702 Deferred income taxes [[Image Removed]] 35 [[Image Removed]] 54 Other assets [[Image Removed]] 727 [[Image Removed]] 756 Goodwill [[Image Removed]] 1,042 [[Image Removed]] 747 Intangible assets, net [[Image Removed]] 393 [[Image Removed]] 400 Total assets [[Image Removed]] 7,340 [[Image Removed]] 7,410 LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) [[Image Removed]] [[Image Removed]] Current liabilities: [[Image Removed]] [[Image Removed]] Short-term borrowings and current installments of [[Image Removed]] [[Image Removed]] long-term debt third party and affiliates 181 144 Accounts payable and accrued liabilities: [[Image Removed]] [[Image Removed]] Trade payables third party and affiliates [[Image Removed]] 698 [[Image Removed]] 722 Other current liabilities [[Image Removed]] 813 [[Image Removed]] 888 Deferred income taxes [[Image Removed]] 13 [[Image Removed]] 20 Income taxes payable [[Image Removed]] 224 [[Image Removed]] 214 Liabilities of discontinued operations [[Image Removed]] 3 [[Image Removed]] 7 Total current liabilities [[Image Removed]] 1,932 [[Image Removed]] 1,995 Long-term debt [[Image Removed]] 3,315 [[Image Removed]] 3,243 Deferred income taxes [[Image Removed]] 225 [[Image Removed]] 256 Benefit obligations [[Image Removed]] 1,154 [[Image Removed]] 1,000 Other liabilities [[Image Removed]] 506 [[Image Removed]] 510 Minority interests [[Image Removed]] 149 [[Image Removed]] 518 Commitments and contingencies [[Image Removed]] [[Image Removed]] Shareholders' equity (deficit): [[Image Removed]] [[Image Removed]] Preferred stock, $0.01 par value, 100,000,000 shares authorized and 9,600,000 issued and outstanding as of [[Image Removed]] [[Image Removed]] September 30, 2005 Series A common stock, $0.0001 par value, 400,000,000 shares authorized and 158,562,161 and 0 issued and [[Image Removed]] [[Image Removed]] outstanding as of September 30, 2005 and December 31, 2004, respectively Series B common stock, $0.0001 par value, 100,000,000 shares authorized and 0 and 99,377,884 issued and [[Image Removed]] [[Image Removed]] outstanding as of September 30, 2005 and December 31, 2004, respectively Additional paid-in capital [[Image Removed]] 344 [[Image Removed]] 158 Retained earnings (accumulated deficit) [[Image Removed]] (151 ) [[Image Removed]] (253 ) Accumulated other comprehensive income (loss), net [[Image Removed]] (134 ) [[Image Removed]] (17 ) Total shareholders' equity (deficit) [[Image Removed]] 59 [[Image Removed]] (112 ) Total liabilities and shareholders' equity (deficit) [[Image Removed]] 7,340 [[Image Removed]] 7,410 [[Image Removed]] See the accompanying notes to the unaudited interim consolidated financial statements. 9 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Accumulated Retained Other Total [[Image Removed]] [[Image Removed]] [[Image Removed]] Additional [[Image Removed]] Earnings [[Image Removed]] Comprehensive [[Image Removed]] [[Image Removed]] Shareholders' Preferred Common Paid-in (Accumulated Income (Loss), Treasury Equity Stock Stock Capital Deficit) Net Stock (Deficit) [[Image Removed]] (in $ millions) Predecessor [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Balance at December 31, 2003 [[Image Removed]] [[Image Removed]] 150 [[Image Removed]] 2,714 [[Image Removed]] 25 [[Image Removed]] (198 ) [[Image Removed]] (109 ) [[Image Removed]] 2,582 Comprehensive income (loss), net of tax: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 78 [[Image Removed]] [[Image Removed]] [[Image Removed]] 78 Other comprehensive income (loss): [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Unrealized gain (loss) on securities [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 7 [[Image Removed]] [[Image Removed]] 7 Foreign currency translation [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (46 ) [[Image Removed]] [[Image Removed]] (46 ) Other comprehensive income (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (39 ) [[Image Removed]] [[Image Removed]] (39 ) Comprehensive income (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 39 Amortization of deferred compensation [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 Balance at March 31, 2004 [[Image Removed]] [[Image Removed]] 150 [[Image Removed]] 2,715 [[Image Removed]] 103 [[Image Removed]] (237 ) [[Image Removed]] (109 ) [[Image Removed]] 2,622 Successor [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Contributed capital [[Image Removed]] [[Image Removed]] [[Image Removed]] 641 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 641 Comprehensive income (loss), net of tax: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (196 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] (196 ) Other comprehensive income (loss): [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Unrealized gain (loss) on securities [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Foreign currency translation [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Unrealized gain (loss) on derivative contracts [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Other comprehensive income (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Comprehensive income (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (196 ) Distribution to stockholders [[Image Removed]] [[Image Removed]] [[Image Removed]] (500 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (500 ) Indemnification of demerger liability [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 Balance at September 30, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] 143 [[Image Removed]] (196 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] (53 ) Successor [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Balance at December 31, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] 158 [[Image Removed]] (253 ) [[Image Removed]] (17 ) [[Image Removed]] [[Image Removed]] (112 ) Comprehensive income (loss), net of tax: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 102 [[Image Removed]] [[Image Removed]] [[Image Removed]] 102 Other comprehensive income (loss): [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Unrealized gain (loss) on securities [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 6 [[Image Removed]] [[Image Removed]] 6 Minimum pension liability [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (109 ) [[Image Removed]] [[Image Removed]] (109 ) Foreign currency translation [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (11 ) [[Image Removed]] [[Image Removed]] (11 ) Unrealized gain (loss) on derivative contracts [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (3 ) [[Image Removed]] [[Image Removed]] (3 ) Other comprehensive income (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (117 ) [[Image Removed]] [[Image Removed]] (117 ) Comprehensive income (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (15 ) Indemnification of demerger liability [[Image Removed]] [[Image Removed]] [[Image Removed]] 3 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 3 Common stock dividends [[Image Removed]] [[Image Removed]] [[Image Removed]] (6 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (6 ) Preferred stock dividends [[Image Removed]] [[Image Removed]] [[Image Removed]] (5 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (5 ) Net proceeds from issuance of common stock [[Image Removed]] [[Image Removed]] [[Image Removed]] 752 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 752 Net proceeds from issuance of preferred stock [[Image Removed]] [[Image Removed]] [[Image Removed]] 233 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 233 Net proceeds from issuance of discounted common stock [[Image Removed]] [[Image Removed]] [[Image Removed]] 12 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 12 Stock based compensation [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 Distribution to Series B shareholders [[Image Removed]] [[Image Removed]] [[Image Removed]] (804 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (804 ) Balance at September 30, 2005 [[Image Removed]] [[Image Removed]] [[Image Removed]] 344 [[Image Removed]] (151 ) [[Image Removed]] (134 ) [[Image Removed]] [[Image Removed]] 59 [[Image Removed]] See the accompanying notes to the unaudited interim consolidated financial statements. 10 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor Nine Months Six Months Three Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended September 30, 2005 September 30, 2004 March 31, 2004 [[Image Removed]] [[Image Removed]] (in $ millions) [[Image Removed]] Operating activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] 102 [[Image Removed]] (196 ) [[Image Removed]] 78 (Earnings) loss from discontinued operations, net [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] (23 ) Adjustments to reconcile net earnings (loss) to net [[Image Removed]] [[Image Removed]] [[Image Removed]] cash provided by (used in) operating activities: Special charges, net of amounts used [[Image Removed]] 10 [[Image Removed]] 22 [[Image Removed]] 20 Stock based compensation [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] 2 Depreciation [[Image Removed]] 153 [[Image Removed]] 147 [[Image Removed]] 69 Amortization of intangibles and other assets [[Image Removed]] 47 [[Image Removed]] 3 [[Image Removed]] 3 Amortization of deferred financing fees [[Image Removed]] 38 [[Image Removed]] 95 [[Image Removed]] Premiums paid on early redemption of debt [[Image Removed]] 74 [[Image Removed]] 21 [[Image Removed]] Change in equity of affiliates [[Image Removed]] 12 [[Image Removed]] (14 ) [[Image Removed]] 3 Deferred income taxes [[Image Removed]] (15 ) [[Image Removed]] 84 [[Image Removed]] (12 ) (Gain) loss on disposition of assets, net [[Image Removed]] 1 [[Image Removed]] (2 ) [[Image Removed]] (Gain) loss on foreign currency, net [[Image Removed]] 45 [[Image Removed]] 26 [[Image Removed]] (26 ) Minority interest [[Image Removed]] 41 [[Image Removed]] 2 [[Image Removed]] Changes in operating assets and liabilities: [[Image Removed]] [[Image Removed]] [[Image Removed]] Trade receivables, net third party and affiliates [[Image Removed]] (13 ) [[Image Removed]] (22 ) [[Image Removed]] (89 ) Other receivables [[Image Removed]] 56 [[Image Removed]] [[Image Removed]] (42 ) Prepaid expenses [[Image Removed]] (20 ) [[Image Removed]] 15 [[Image Removed]] 14 Inventories [[Image Removed]] 58 [[Image Removed]] 2 [[Image Removed]] (11 ) Trade payables third party and affiliates [[Image Removed]] (70 ) [[Image Removed]] 4 [[Image Removed]] (6 ) Benefit obligations and other liabilities [[Image Removed]] (46 ) [[Image Removed]] (107 ) [[Image Removed]] (118 ) Income taxes payable [[Image Removed]] 25 [[Image Removed]] 21 [[Image Removed]] 38 Other, net [[Image Removed]] 18 [[Image Removed]] 6 [[Image Removed]] (7 ) Net cash provided by (used in) operating activities [[Image Removed]] 516 [[Image Removed]] 109 [[Image Removed]] (107 ) Investing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] Capital expenditures on property, plant and equipment [[Image Removed]] (132 ) [[Image Removed]] (106 ) [[Image Removed]] (44 ) Acquisition of CAG shares, net of cash acquired [[Image Removed]] (397 ) [[Image Removed]] (1,531 ) [[Image Removed]] Fees associated with acquisitions [[Image Removed]] (27 ) [[Image Removed]] (69 ) [[Image Removed]] Acquisition of Vinamul [[Image Removed]] (208 ) [[Image Removed]] [[Image Removed]] Acquisition of Acetex, net of cash acquired [[Image Removed]] (216 ) [[Image Removed]] [[Image Removed]] Proceeds from sale of businesses and assets [[Image Removed]] 40 [[Image Removed]] 5 [[Image Removed]] Net proceeds from disposal of discontinued operations [[Image Removed]] 75 [[Image Removed]] [[Image Removed]] 139 Proceeds from sale of marketable securities [[Image Removed]] 175 [[Image Removed]] 85 [[Image Removed]] 42 Purchases of marketable securities [[Image Removed]] (96 ) [[Image Removed]] (107 ) [[Image Removed]] (42 ) Other, net [[Image Removed]] 5 [[Image Removed]] (1 ) [[Image Removed]] 1 Net cash provided by (used in) investing activities [[Image Removed]] (781 ) [[Image Removed]] (1,724 ) [[Image Removed]] 96 [[Image Removed]] See the accompanying notes to the unaudited interim consolidated financial statements. 11 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor Nine Months Six Months Three Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended September 30, 2005 September 30, 2004 March 31, 2004 [[Image Removed]] [[Image Removed]] (in $ millions) [[Image Removed]] Financing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] Initial capitalization [[Image Removed]] [[Image Removed]] 641 [[Image Removed]] Issuance of mandatorily redeemable preferred stock [[Image Removed]] [[Image Removed]] 200 [[Image Removed]] Repayment of mandatorily redeemable preferred stock [[Image Removed]] [[Image Removed]] (221 ) [[Image Removed]] Borrowings under bridge loans [[Image Removed]] [[Image Removed]] 1,565 [[Image Removed]] Repayment of bridge loans [[Image Removed]] [[Image Removed]] (1,565 ) [[Image Removed]] Proceeds from issuance of senior subordinated notes [[Image Removed]] [[Image Removed]] 1,475 [[Image Removed]] Proceeds from issuance of senior discount notes [[Image Removed]] [[Image Removed]] 513 [[Image Removed]] Redemption of senior subordinated notes, including related premium [[Image Removed]] (572 ) [[Image Removed]] [[Image Removed]] Proceeds from floating rate term loan [[Image Removed]] [[Image Removed]] 350 [[Image Removed]] Repayment of floating rate term loan, including related premium [[Image Removed]] (354 ) [[Image Removed]] [[Image Removed]] Borrowings under term loan facility [[Image Removed]] 1,135 [[Image Removed]] 389 [[Image Removed]] Proceeds from issuance of common stock, net [[Image Removed]] 752 [[Image Removed]] [[Image Removed]] Proceeds from issuance of preferred stock, net [[Image Removed]] 233 [[Image Removed]] [[Image Removed]] Proceeds from issuance of discounted common stock [[Image Removed]] 12 [[Image Removed]] [[Image Removed]] Redemption of senior discount notes, including related premium [[Image Removed]] (207 ) [[Image Removed]] [[Image Removed]] Redemption of Acetex bonds [[Image Removed]] (280 ) [[Image Removed]] [[Image Removed]] Distribution to stockholders [[Image Removed]] [[Image Removed]] (500 ) [[Image Removed]] Distribution to Series B shareholders [[Image Removed]] (804 ) [[Image Removed]] [[Image Removed]] Short-term borrowings (repayments), net [[Image Removed]] 18 [[Image Removed]] 17 [[Image Removed]] (16 ) Proceeds (payments) from other long term debt, net [[Image Removed]] 8 [[Image Removed]] (235 ) [[Image Removed]] (27 ) Issuance of preferred stock by consolidated subsidiary [[Image Removed]] [[Image Removed]] 17 [[Image Removed]] Fees associated with financings [[Image Removed]] (8 ) [[Image Removed]] (197 ) [[Image Removed]] Dividend payments on preferred stock [[Image Removed]] (5 ) [[Image Removed]] [[Image Removed]] Dividend payments on common shares [[Image Removed]] (6 ) [[Image Removed]] (1 ) [[Image Removed]] Net cash provided by (used in) financing activities [[Image Removed]] (78 ) [[Image Removed]] 2,448 [[Image Removed]] (43 ) Exchange rate effects on cash [[Image Removed]] (94 ) [[Image Removed]] (14 ) [[Image Removed]] (1 ) Net increase (decrease) in cash and cash equivalents . [[Image Removed]] (437 ) [[Image Removed]] 819 [[Image Removed]] (55 ) Cash and cash equivalents at beginning of period [[Image Removed]] 838 [[Image Removed]] [[Image Removed]] 148 Cash and cash equivalents at end of period [[Image Removed]] 401 [[Image Removed]] 819 [[Image Removed]] 93 Net cash provided by (used in) discontinued operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] Operating activities [[Image Removed]] (75 ) [[Image Removed]] 1 [[Image Removed]] (139 ) Investing activities [[Image Removed]] 75 [[Image Removed]] (1 ) [[Image Removed]] 139 Financing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] Net cash provided by (used in) discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] See the accompanying notes to the unaudited interim consolidated financial statements. 12 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. Description of the Company and Basis of Presentation Description of the Company Celanese Corporation and its subsidiaries (collectively the Company or the Successor) is a global industrial chemicals company, primarily comprising the former business of Celanese AG and its subsidiaries (CAG or the Predecessor). The Company's business involves processing chemical raw materials, such as ethylene and propylene, and natural products, including natural gas and wood pulp, into value-added chemicals and chemical-based products. Basis of Presentation The results of operations and cash flows and related disclosures for periods prior to April 1, 2004 (a convenience date for the April 6, 2004 acquisition date), the effective date of the acquisition of CAG (the Effective Date), are presented as those of the Predecessor. The financial position, results of operations and cash flows and related disclosures subsequent to the Effective Date, are presented as those of the Successor. The unaudited interim consolidated financial statements of the Successor as of and for the three and nine months ended September 30, 2005, for the three and six months ended September 30, 2004 and as of December 31, 2004 reflect the acquisition of CAG under the purchase method of accounting in accordance with Financial Accounting Standards Board (FASB) Statement of Financial Accounting Standards (SFAS) No. 141, Business Combinations. In the opinion of management, the unaudited interim consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the financial position, results of operations, and cash flows of the Company and the Predecessor. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission (SEC). These unaudited interim consolidated financial statements should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the nine months ended December 31, 2004, as filed with the SEC on Form 10-K. Operating results for the three and nine months ended September 30, 2005, for the three and six months ended September 30, 2004 and for the three months ended March 31, 2004 are not necessarily indicative of the results to be expected for the entire year. The results of the Successor are not comparable to the results of the Predecessor due to the difference in the basis of presentation of purchase accounting as compared to historical cost. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues, expenses and allocated charges during the reporting period. The more significant estimates pertain to purchase accounting, allowance for doubtful accounts, inventory allowances, impairments of intangible assets and other long-lived assets, restructuring costs and other special charges, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates. The Company has reclassified certain prior period amounts to conform to the current period's presentation. 13 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) 2. Acquisition of Celanese AG (the Acquisition) On April 6, 2004, Celanese Europe Holding GmbH & Co. KG (the Purchaser), an indirect wholly owned subsidiary of the Successor, acquired approximately 84% of the Celanese AG ordinary shares, excluding treasury shares (CAG Shares), pursuant to a voluntary tender offer commenced in February 2004. The CAG Shares were acquired at a price of 32.50 per share or an aggregate purchase price of $1,693 million, including direct acquisition costs of approximately $69 million. During the nine months ended September 30, 2005 and December 31, 2004, the Purchaser acquired additional CAG Shares for a purchase price of $397 million and $33 million, respectively. As of September 30, 2005 and December 31, 2004, the Purchaser's ownership percentage was approximately 96% and 84%, respectively. The additional CAG Shares were acquired pursuant to either i) the mandatory offer (See Note 3) commenced in September 2004 that will expire on December 1, 2005, unless further extended or ii) the recent purchase of CAG shares as described below. On November 3, 2005, the Company's Board of Directors approved commencement of the process for effecting a squeeze-out of the remaining shareholders. Recent Purchases of CAG Shares In August 2005, the Company acquired approximately 5.9 million, or approximately 12%, of the outstanding CAG Shares from two shareholders of CAG for the aggregate consideration of approximately 302 million ($369 million). In addition, the Company also paid to such shareholders an additional purchase price of approximately 12 million ($15 million) in consideration for the settlement of certain claims and for such shareholders agreeing to, among other things, (1) accept the shareholders' resolutions passed at the extraordinary general meeting of CAG held on July 30 and 31, 2004 and the annual general meeting of CAG held on May 19 and 20, 2005, (2) acknowledge the legal effectiveness of the domination and profit and loss transfer agreement, (3) irrevocably withdraw and abandon all actions, applications and appeals each brought or joined in legal proceedings related to, among other things, challenging the effectiveness of the Domination Agreement and amount of fair cash compensation offered by Purchaser in the mandatory offer required by Section 305(1) of the German Stock Corporation Act, (4) refrain from acquiring any CAG Shares or any other investment in CAG, and (5) refrain from taking any future legal action with respect to shareholder resolutions or corporate actions of CAG. The Company paid the aggregate consideration of 314 million ($384 million) for the additional CAG Shares that were acquired from such shareholders and for the agreements described above using available cash. The Company also announced that it would increase its offer to purchase any remaining outstanding CAG Shares to 51 per share (plus interest on 41.92 per share) for all minority shareholders that would accept the increased offer on or prior to September 29, 2005 and waive their rights to participate in an increase of the offer consideration as a result of the pending award proceedings. In addition, all shareholders who tendered their shares pursuant to the mandatory offer of 41.92 per share commenced in September 2004 and continuing as of the date of this filing, were entitled to claim the difference between the increased offer of 51 per share and the mandatory offer of 41.92 per share. Any shareholder who accepted the increased offer of 51 per share, or claimed the difference between the mandatory offer and the increased offer, was obligated to agree to waive its rights to participate in any possible future increase of the offer consideration as a result of the pending award proceedings. For minority shareholders who did not accept the increased offer on or prior to the September 29, 2005 expiration date, the terms of the original 41.92 per share mandatory offer will continue to apply. The mandatory offer will expire on December 1, 2005 unless further extended. As of November 2, 2005, the Company increased its ownership interest in CAG to approximately 98% as a result of additional shares tendered under the mandatory offer. 14 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) Pro forma information The following pro forma information for the nine months ended September 30, 2004 was prepared as if the Acquisition had occurred as of the beginning of such period: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Nine Months Ended September 30, 2004 [[Image Removed]] (in $ millions) Net sales [[Image Removed]] 3,737 Operating profit [[Image Removed]] 149 Net earnings (loss) [[Image Removed]] (55 ) [[Image Removed]] Pro forma adjustments include adjustments for (1) purchase accounting, including (i) the application of purchase accounting to pension and other postretirement obligations (ii) the application of purchase accounting to property, plant and equipment and intangible assets, (2) adjustments for items directly related to the transaction, including (i) the impact of the additional pension contribution, (ii) fees incurred by the Company related to the Acquisition, and (iii) adjustments to interest expense to reflect the Company's new capital structure, and (3) corresponding adjustments to income tax expense. The pro forma information is not necessarily indicative of the results that would have occurred had the Acquisition occurred as of the beginning of the period presented, nor is it necessarily indicative of future results. 3. Domination Agreement and Organizational Restructuring Domination Agreement On October 1, 2004, a domination and profit and loss transfer agreement (the Domination Agreement) between Celanese AG and the Purchaser became operative. When the Domination Agreement became operative, the Purchaser became obligated to offer to acquire all outstanding CAG Shares from the minority shareholders of Celanese AG in return for payment of fair cash compensation. The amount of this fair cash compensation has been determined to be 41.92 per share, plus interest, in accordance with applicable German law. The Purchaser may elect, or be required, to pay a purchase price in excess of 41.92 to acquire the remaining outstanding CAG Shares. Any minority shareholder who elects not to sell its shares to the Purchaser will be entitled to remain a shareholder of CAG and to receive from the Purchaser a gross guaranteed fixed annual payment on its shares of 3.27 per CAG Share less certain corporate taxes in lieu of any future dividend. Beginning October 1, 2004, taking into account the circumstances and the tax rates at the time of entering into the Domination Agreement, the net guaranteed fixed annual payment would be 2.89 per share for a full fiscal year. As indicated in Note 2, pursuant to an agreement with two shareholders of CAG to acquire 5.9 million additional shares, the Company, subject to certain conditions, increased its offer to acquire all remaining outstanding CAG Shares from all minority shareholders that accepted the Mandatory Offer on or prior to September 29, 2005. This increased offer expired on September 29, 2005. The net guaranteed fixed annual payment may, depending on applicable corporate tax rates, in the future be higher, lower or the same as 2.89 per share. For the three and nine months ended September 30, 2005, a charge of $5 million and $20 million, respectively, was recorded in Other income (expense), net for the anticipated guaranteed payment. Beginning October 1, 2004, under the terms of the Domination Agreement, the Purchaser, as the dominating entity, among other things, is required to compensate Celanese AG for any statutory annual loss incurred by Celanese AG, the dominated entity, on a non-consolidated basis, at the end of the fiscal year when the loss was incurred. This obligation to compensate Celanese AG for annual losses will apply during the entire term of the Domination Agreement. 15 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) There is no assurance that the Domination Agreement will remain operative in its current form. If the Domination Agreement ceases to be operative, the Company will not be able to directly give instructions to the Celanese AG board of management. The Domination Agreement cannot be terminated by the Purchaser in the ordinary course until September 30, 2009. However, irrespective of whether a domination agreement is in place between the Company and Celanese AG, under German law Celanese AG is effectively controlled by the Company because of the Company's approximate 98% ownership of the outstanding CAG Shares. The Company does have the ability, through a variety of means, to utilize its controlling rights to, among other things, (1) cause a domination agreement to become operative; (2) use its ability, through its approximately 98% voting power at any shareholders' meetings of Celanese AG, to elect the shareholder representatives on the supervisory board and to thereby effectively control the appointment and removal of the members of the Celanese AG board of management; and (3) effect all decisions that an approximately 98% majority shareholder is permitted to make under German law. The controlling rights of the Company constitute a controlling financial interest for accounting purposes and result in the Company being required to consolidate CAG as of the date of acquisition. Organizational Restructuring In October 2004, Celanese Corporation and certain of its subsidiaries completed an organizational restructuring (the Organizational Restructuring) pursuant to which the Purchaser effected, by giving a corresponding instruction under the Domination Agreement, the transfer of all of the shares of Celanese Americas Corporation (CAC) from Celanese Holding GmbH, a wholly owned subsidiary of Celanese AG, to BCP Caylux Holdings Luxembourg S.C.A (BCP Caylux), which resulted in BCP Caylux owning 100% of the equity of CAC and, indirectly, all of its assets, including subsidiary stock. This transfer was affected by CAG selling all outstanding shares in CAC for a 291 million note. This note eliminates in consolidation. Following the transfer of CAC to BCP Caylux, (1) Celanese Holdings contributed substantially all of its assets and liabilities (including all outstanding capital stock of BCP Caylux) to BCP Crystal US Holdings Corp. (BCP Crystal) in exchange for all outstanding capital stock of BCP Crystal and (2) BCP Crystal assumed certain obligations of BCP Caylux, including all rights and obligations of BCP Caylux under the senior credit facilities, the floating rate term loan and the senior subordinated notes. BCP Crystal, at its discretion, may subsequently cause the liquidation of BCP Caylux. As a result of these transactions, BCP Crystal holds 100% of CAC's equity and, indirectly, all equity owned by CAC in its subsidiaries. In addition, BCP Crystal holds, indirectly, all of the outstanding common stock of Celanese AG held by the Purchaser and all of the wholly owned subsidiaries of the Company that guarantee BCP Caylux's obligations under the senior credit facilities to guarantee the senior subordinated notes issued on June 8, 2004 and July 1, 2004 (see Note 9) on an unsecured senior subordinated basis. 4. Initial Public Offering and Concurrent Financings In January 2005, the Company completed an initial public offering of 50,000,000 shares of Series A common stock and received net proceeds of $752 million after deducting underwriters discounts and offering expenses of $48 million. Concurrently, the Company received net proceeds of $233 million from the offering of 9,600,000 shares of convertible perpetual preferred stock after deducting underwriters discounts and offering expenses of $7 million. A portion of the proceeds of the share offerings were used to redeem $188 million of senior discount notes and $521 million of senior subordinated notes, excluding early redemption premiums of $19 million and $51 million, respectively. Subsequent to the closing of the initial public offering, the Company borrowed an additional $1,135 million under the amended and restated senior credit facilities, a portion of which was used to 16 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) repay a $350 million floating rate term loan, which excludes a $4 million early redemption premium, and $200 million of which was used as the primary financing for the February 2005 acquisition of the Vinamul business (see Notes 6 and 9). Additionally, the amended and restated senior credit facilities included a $242 million delayed draw term loan. The delayed draw facility expired unutilized in July 2005. On April 7, 2005, the Company used the remaining proceeds of the initial public offering and concurrent financings to pay a special cash dividend to holders of the Company's Series B common stock of $804 million, which was declared March 8, 2005. In addition, on March 9, 2005, the Company issued a 7,500,000 Series A common stock dividend to the Original Shareholders of its Series B common stock which was declared on March 8, 2005. Upon payment of the $804 million dividend, all of the outstanding shares of Series B common stock converted automatically to shares of Series A common stock. 5. Accounting Changes and New Accounting Pronouncements Accounting Changes In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary Assets, an amendment of APB Opinion No. 29, Accounting for Nonmonetary Transactions. The amendments made by SFAS No. 153 are based on the principle that exchanges of nonmonetary assets should be measured based on the fair value of the assets exchanged. Further, the amendments eliminate the narrow exception for nonmonetary exchanges of similar productive assets and replace it with a broader exception for exchanges of nonmonetary assets that do not have commercial substance. The statement is effective for nonmonetary asset exchanges occurring in fiscal periods beginning after June 15, 2005. Earlier application is permitted for nonmonetary asset exchanges occurring in fiscal periods beginning after the date of issuance. The provisions of this statement were applied prospectively. The adoption of SFAS No. 153 did not have a material impact on the results of operations and financial position as of and for the three months ended September 30, 2005. During 2004, the Predecessor changed its inventory valuation method of accounting for its US subsidiaries from the LIFO method to the FIFO method to conform to the Successor's accounting policy. The Predecessor's financial statements have been restated to reflect this change. On November 3, 2005, the FASB issued FASB Staff Position ("FSP") No. FAS 115-1 and FAS 124-1, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments. The guidance in this FSP addresses the determination as to when an investment is considered impaired, whether that impairment is other than temporary, and the measurement of an impairment loss. The guidance is to be applied prospectively in periods beginning after December 15, 2005. The Company is in the process of determining the impact that this FSP will have on its results of operations and financial position. On December 8, 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Medicare Act) was signed into law. The Medicare Act introduces a prescription drug benefit under Medicare (Medicare Part D) as well as a federal subsidy to sponsors of retiree health care benefit plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. As of March 31, 2004, as permitted by FASB Staff Position (FSP) 106-1, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, the Company deferred accounting for the effects of the Medicare Act in the measurement of its Accumulated Postretirement Benefit Obligation (APBO) and the effect to net periodic postretirement benefit costs. Specific guidance with respect to accounting for the effects of the Medicare Act was issued in FSP No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, and the Company has adopted the provisions of FSP No. 106-2 as of the Effective Date, and included any impact in the overall measurement of the liabilities of the U.S. postretirement medical plans in purchase accounting. 17 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) In March 2005, the FASB issued FSP No. FIN 46(R)-5, Implicit Variable Interests under FASB Interpretation No. 46 (revised December 2003). FSP FIN 46(R)-5 addresses whether a reporting enterprise should consider whether it holds an implicit interest in a variable interest entity or potential variable interest entity when specific conditions exist. The provisions of FSP FIN 46(R)-5 are applicable for reporting periods beginning after March 3, 2005 (the Company's fiscal quarter ending June 30, 2005). FSP FIN 46(R)-5 did not have a material impact on the Companys consolidated financial statements for the three months ended September 30, 2005. Recent Accounting Pronouncements In May 2005, the FASB issued Statement of Financial Accounting Standards No. 154, Accounting Changes and Error Corrections-A Replacement of APB Opinion No. 20 and FASB Statement No. 3 (SFAS No. 154). SFAS No. 154 requires retrospective application to prior period financial statements for changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. SFAS No. 154 also requires that retrospective application of a change in accounting principle be limited to the direct effects of the change. Indirect effects of a change in accounting principle, such as a change in non-discretionary profit-sharing payments resulting from an accounting change, should be recognized in the period of the accounting change. SFAS No. 154 also requires that a change in depreciation, amortization, or depletion method for long-lived non-financial assets be accounted for as a change in accounting estimate affected by a change in accounting principle. SFAS No. 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. Early adoption is permitted for accounting changes and corrections of errors made in fiscal years beginning after the date this Statement is issued. The Company is required to adopt the provision of SFAS No. 154, as applicable, beginning in the fiscal year ended December 31, 2006. In September 2005, the FASB's Emerging Issues Task Force ("EITF") reached a consensus on Issue No. 04-13, Accounting for Purchases and Sales of Inventory with the Same Counterparty. This consensus outlines the treatment of sales and purchases of inventory between an entity and the same counterparty as one transaction for purposes of applying Accounting Principles Board Opinion 29. The guidance is to be applied prospectively in periods beginning after March 15, 2006. The Company is evaluating the impact of EITF 04-13 on its financial statements. In June 2005, the FASB's Emerging Issues Task Force reached a consensus on Issue No. 05-6, Determining the Amortization Period for Leasehold Improvements (EITF Issue No. 05-6). The guidance requires that leasehold improvements acquired in a business combination or purchased subsequent to the inception of a lease be amortized over the lesser of the useful life of the assets or a term that includes renewals that are reasonably assured at the date of the business combination or purchase. The guidance is effective prospectively for leasehold improvements acquired in periods beginning after June 29, 2005. As the Company has not completed its purchase accounting related to the acquisition of Acetex Corporation (see Note 6), the Company is still evaluating the impact of EITF Issue No. 05-6 on its results of operations and financial position. In March 2005, FASB issued Interpretation No. 47, Accounting for Conditional Asset Retirement Obligations an interpretation of FASB Statement No. 143 (FIN No. 47). FIN No. 47 provides guidelines as to when a company is required to record a conditional asset retirement obligation. In general, an entity is required to recognize a liability for the fair value of a conditional asset retirement obligation if the fair value of the liability can be reasonably estimated. The fair value of a liability for the conditional asset retirement obligation should be recognized when incurred generally upon acquisition, construction, or development and (or) through the normal operation of the asset. FIN No. 47 is effective no later than the end of fiscal years ending after December 15, 2005 (December 31, 2005, for calendar-year enterprises). The Company is still assessing the impact of FIN No. 47 on its future results of operations and financial position. 18 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) In December 2004, the FASB revised SFAS No. 123, Accounting for Stock Based Compensation (SFAS No. 123R), which requires that the cost from all share-based payment transactions be recognized in the financial statements. In March 2005, the SEC issued Staff Accounting Bulletin No. 107 (SAB 107) regarding the SECs interpretation of SFAS 123R and the valuation of share-based payments for public companies. The SEC has deferred SFAS No. 123R until the first annual period beginning after June 15, 2005. Accordingly, the Company intends to comply with SFAS No. 123R beginning with the fiscal year commencing January 1, 2006. The Company is currently evaluating the potential impact of SFAS No. 123R, although it is anticipated that the adoption will have a negative impact on its results of operations. In November 2004, the FASB issued SFAS No. 151, Inventory Costs, amendment to ARB No. 43 Chapter 4 (SFAS No. 151), which clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). SFAS No. 151 is effective for fiscal years beginning after June 15, 2005. The Company is in the process of assessing the impact of SFAS No. 151 on its future results of operations and financial position. In October 2004, the American Jobs Creation Act of 2004 (the Act) was signed into law. Three of the more significant provisions of the Act relate to a one-time opportunity to repatriate foreign earnings at a reduced rate, manufacturing benefits for qualified production activity income and new requirements with respect to deferred compensation plans. The Company has not yet determined the impact, if any, of this Act on its future results of operations or cash flows. Additionally, under new Section 409A of the Internal Revenue Code, created in connection with the Act, the U.S. Treasury Department is directed to issue regulations providing guidance and provide a limited period during which deferred compensation plans may be amended to comply with the requirements of Section 409A. When the regulations are issued, the Company may be required to make modifications to certain compensation plans to comply with Section 409A. 6. Acquisitions, Divestitures and Ventures Acquisitions: On April 6, 2004, the Company acquired CAG (See Notes 1 and 2). In February 2005, the Company acquired Vinamul, the North American and European emulsion polymer business of Imperial Chemical Industries PLC (ICI) for $208 million. The Vinamul product line includes vinyl acetate-ethylene copolymers, vinyl acetate homopolymers and copolymers, and acrylic and vinyl acrylic emulsions. Vinamul operates manufacturing facilities in the United States, Canada, the United Kingdom, and The Netherlands. As part of the agreement, ICI will continue to supply Vinamul with starch, dextrin and other specialty ingredients following the acquisition. The Company will supply ICI with vinyl acetate monomer and polyvinyl alcohols. The supply agreements are for 15 years, and the pricing is based on market and other negotiated terms. The Company primarily financed this acquisition through borrowings of $200 million under the amended and restated senior credit facilities (See Note 9). The Company has allocated the purchase price on the basis of its preliminary estimate of the fair value of the assets acquired and the liabilities assumed. The estimated fair value of the total assets acquired was approximately $280 million. The net sales and operating profit (loss) of the Vinamul business included in the Company's results of operations were $279 million and ($4) million, respectively, for the nine months ended September 30, 2005. In July 2005, the Company acquired Acetex Corporation (Acetex) for $270 million and assumed Acetexs $247 million of debt, which is net of cash acquired of $54 million. Acetexs operations include an acetyls business with plants in Europe and a North-American specialty polymers and film business. The Company acquired Acetex using existing cash. The Company caused Acetex to exercise its option to redeem its 10 7/8% senior notes due 2009 totaling approximately $265 million. The 19 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) redemption was funded primarily with cash on hand and occurred on August 19, 2005. The redemption price was approximately $280 million, which represents 105.438% of the outstanding principal amount, plus accrued and unpaid interest to August 19, 2005. On August 25, 2005, the Company repaid the remaining $36 million of assumed debt with available cash. Pro forma financial information has not been provided as the acquisition did not have a material impact on the Companys results of operations. The estimated fair value of the total assets acquired was approximately $495 million. The net sales and operating profit (loss) of the Acetex business included in the Company's results of operations were $115 million and ($1) million, respectively, for the nine months ended September 30, 2005. Divestitures: In July 2005, in connection with the Vinamul transaction, the Company agreed to sell its emulsion powders business to ICI for approximately $25 million. This transaction includes a supply agreement whereby the Company will supply product to ICI for a period of up to fifteen years. Closing of the transaction occurred in September 2005. Net sales for the emulsion powders business for the nine months ended September 30, 2005 were approximately $30 million and net earnings for the same period was approximately $1 million. In February 2004, the Predecessor sold its acrylates business to The Dow Chemical Company (Dow) for a sales price of approximately $149 million, which resulted in a pre-tax gain of approximately $14 million in the three months ended March 31, 2004. Dow acquired the Predecessor's acrylates business line, including inventory, intellectual property and technology for crude acrylic acid, glacial acrylic acid, ethyl acrylate, butyl acrylate, methyl acrylate and 2-ethylhexyl acrylate, as well as acrylates production assets at the Clear Lake, Texas facility. In related agreements, the Company provides certain contract manufacturing services to Dow, and Dow supplies acrylates to the Company for use in its emulsions production. Simultaneous with the sale, the Predecessor repaid an unrelated obligation of $95 million to Dow. The acrylates business was part of the Predecessor's Chemical business. As a result of this transaction, the assets, liabilities, revenues and expenses related to the acrylates product lines at the Clear Lake, Texas facility as well as the gain recorded on the sale are reflected as a component of discontinued operations in the consolidated financial statements in accordance with SFAS No. 144. Discontinued operations of Chemical Products for the three months ended March 31, 2004 had net sales of $21 million and an operating loss of $5 million. Ventures: In April 2004, the Company and a group of investors led by Conduit Ventures Ltd. entered into a venture, Pemeas GmbH, which was formed to advance the commercialization of the Company's fuel cell technology. Pemeas GmbH is considered a variable interest entity as defined under FIN No. 46. The Company is deemed the primary beneficiary of this variable interest entity and, accordingly, consolidates this entity in its consolidated financial statements. In December 2004, the Company approved a plan to dispose of the Company's ownership interest in Pemeas GmbH. In August 2005, the Company and Hatco Corporation agreed to wind up Estech GmbH, its venture for neopropyl esters. The Company recorded an impairment charge of $10 million related to this matter in the second quarter of 2005. 20 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) 7. Inventories [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] As of [[Image Removed]] As of September 30, 2005 December 31, 2004 [[Image Removed]] (in $ millions) Finished goods [[Image Removed]] 461 [[Image Removed]] 470 Work-in-process [[Image Removed]] 24 [[Image Removed]] 26 Raw materials and supplies [[Image Removed]] 140 [[Image Removed]] 122 Total Inventories [[Image Removed]] 625 [[Image Removed]] 618 [[Image Removed]] As a result of the acquisition of Vinamul (see Note 6), the Company acquired inventory with a fair value of $24 million, which included $1 million in capitalized manufacturing profit in inventory. The inventory was sold prior to July 1, 2005. As a result of the acquisition of Acetex (see Note 6), the Company acquired inventory with a fair value of $74 million, which included $9 million in capitalized manufacturing profit in inventory, of which $9 million was sold prior to October 1, 2005. As a result of the acquisition of the additional CAG shares (see Note 2), the Company recorded preliminary purchase accounting adjustments which included a $6 million inventory step-up related to capitalized manufacturing profit in inventory. The inventory was sold prior to October 1, 2005. 8. Intangible Assets Goodwill [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical [[Image Removed]] Acetate [[Image Removed]] [[Image Removed]] Performance [[Image Removed]] Products Products Ticona Products Total [[Image Removed]] (in $ millions) Successor [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Carrying value of goodwill as of December 31, 2004 [[Image Removed]] 193 [[Image Removed]] 180 [[Image Removed]] 290 [[Image Removed]] 84 [[Image Removed]] 747 Acquisition of Vinamul Polymers [[Image Removed]] 27 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 27 Acquisition of Acetex [[Image Removed]] 244 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 244 Acquisition of CAG [[Image Removed]] 6 [[Image Removed]] 7 [[Image Removed]] 1 [[Image Removed]] 1 [[Image Removed]] 15 Exchange rate changes [[Image Removed]] 4 [[Image Removed]] 4 [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 9 Carrying value of goodwill as of September 30, 2005 [[Image Removed]] 474 [[Image Removed]] 191 [[Image Removed]] 292 [[Image Removed]] 85 [[Image Removed]] 1,042 [[Image Removed]] In connection with the acquisition of Vinamul (See Note 6), the Company has preliminarily allocated the purchase price to assets acquired and liabilities assumed based on the preliminary estimate of their fair value. The excess of the purchase price over the amounts allocated to assets and liabilities is included in goodwill, and is preliminarily estimated to be $27 million at September 30, 2005. The Company is in the process of determining the fair value of all assets acquired and liabilities assumed. The Company expects to finalize the purchase accounting for this transaction in the fourth quarter of 2005. In connection with the acquisition of Acetex (See Note 6), the Company has preliminarily allocated the purchase price to assets acquired and liabilities assumed primarily based on the historical cost of the business acquired. The excess of the purchase price over the amounts allocated to assets and liabilities is included in goodwill, and is preliminarily estimated to be $244 million at September 30, 2005. The Company is in the process of determining the fair value of all assets acquired and liabilities assumed. The Company expects to finalize the purchase accounting for this transaction as soon as practical, but no later than June 30, 2006. In connection with the acquisitions of Vinamul Polymers and Acetex, at the acquisition dates, the Company began formulating a plan to exit or restructure certain activities. The Company has not completed this analysis, and as of September 30, 2005, has not recorded any liabilities associated with 21 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) these activities. As the Company finalizes any plans to exit or restructure activities, it may record additional liabilities, for among other things, severance and severance related costs, and such amounts could be material. In the nine months ended September 30, 2005, the Company increased goodwill by $15 million as a result of purchase accounting adjustments related to the Acquisition and acquisition of additional CAG shares. Included in this adjustment is a $23 million increase to goodwill, and a corresponding increase to the Companys minority interest liability primarily associated with the organizational restructuring that occurred in October 2004 (See Note 2). As this represented an immaterial adjustment, prior periods have not been restated. Other Intangible Assets [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] As of [[Image Removed]] As of September 30, 2005 December 31, 2004 [[Image Removed]] (in $ millions) Trademarks and tradenames [[Image Removed]] 86 [[Image Removed]] 68 Customer related intangible assets [[Image Removed]] 365 [[Image Removed]] 365 Developed technology [[Image Removed]] 9 [[Image Removed]] 9 Other intangible assets [[Image Removed]] 10 [[Image Removed]] Total intangible assets, gross [[Image Removed]] 470 [[Image Removed]] 442 Less: accumulated amortization [[Image Removed]] (77 ) [[Image Removed]] (42 ) Total intangible assets, net [[Image Removed]] 393 [[Image Removed]] 400 [[Image Removed]] Aggregate amortization expense charged against earnings for intangible assets with finite lives during the three months ended September 30, 2005 and 2004 totaled $14 million and $12 million, respectively. Aggregate amortization expense charged against earnings for intangible assets with finite lives during the nine months ended September 30, 2005 and the six months ended September 30, 2004 and the three months ended March 31, 2004 totaled $38 million, $13 million and $2 million, respectively. In connection with the acquisition of Vinamul, the Company entered into a five-year non-compete agreement with ICI. The contract has a preliminary fair value of $10 million. In addition, the Company has identified other intangible assets with an estimated value of $11 million. As the Company has not finalized its purchase price allocation, these amounts could change based on final valuations. In addition, other intangible assets may be identified. 22 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) 9. Debt [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] As of [[Image Removed]] As of September 30, 2005 December 31, 2004 [[Image Removed]] (in $ millions) Short-term borrowings and current installments of [[Image Removed]] [[Image Removed]] long-term debt Current installments of long-term debt [[Image Removed]] 48 [[Image Removed]] 15 Short-term borrowings from Affiliates [[Image Removed]] 133 [[Image Removed]] 128 Other [[Image Removed]] [[Image Removed]] 1 Total short-term borrowings and current installments [[Image Removed]] [[Image Removed]] of long-term debt 181 144 Long-term debt [[Image Removed]] [[Image Removed]] Senior Credit Facilities: [[Image Removed]] [[Image Removed]] Term loan facility [[Image Removed]] 1,719 [[Image Removed]] 624 Revolving credit facility [[Image Removed]] 35 [[Image Removed]] Floating Rate Term Loan, due 2011 [[Image Removed]] [[Image Removed]] 350 Senior Subordinated Notes 9.625%, due 2014 [[Image Removed]] 800 [[Image Removed]] 1,231 Senior Subordinated Notes 10.375%, due 2014 [[Image Removed]] 157 [[Image Removed]] 272 Senior Discount Notes 10.5%, due 2014 [[Image Removed]] 298 [[Image Removed]] 424 Senior Discount Notes 10%, due 2014 [[Image Removed]] 72 [[Image Removed]] 103 Term notes 7.125%, due 2009 [[Image Removed]] 14 [[Image Removed]] 14 Pollution control and industrial revenue bonds, interest rates ranging from 5.2% to 6.7%, due at [[Image Removed]] [[Image Removed]] various dates through 2030 191 191 Obligations under capital leases and other secured [[Image Removed]] [[Image Removed]] borrowings due at various dates through 2018 56 49 Other borrowings [[Image Removed]] 21 [[Image Removed]] Subtotal [[Image Removed]] 3,363 [[Image Removed]] 3,258 Less: Current installments of long-term debt [[Image Removed]] 48 [[Image Removed]] 15 Total long-term debt [[Image Removed]] 3,315 [[Image Removed]] 3,243 [[Image Removed]] In the first quarter of 2005, the Company borrowed an additional $1,135 million under the amended and restated senior credit facilities. A portion of these proceeds, coupled with the proceeds from the initial public offering, were used to repay a $350 million floating rate term loan and redeem $188 million of senior discount notes and $521 million of senior subordinated notes, excluding early redemption premiums of $4 million, $19 million and $51 million, respectively. In addition, $200 million was used to finance the February 2005 acquisition of the Vinamul business. Under the amended and restated facilities, the term loan facility increased to $1,750 million (including 275 million), which matures in 2011. There was also a $242 million delayed draw facility which expired unutilized in July 2005. The revolving credit facility, through a syndication of banks, provides for borrowings of up to $600 million, including the availability of letters of credit in U.S. dollars and euros and for borrowings on same-day notice. In the first quarter of 2005, the revolving credit facility was increased from $380 million to $600 million under the amended and restated senior credit facilities. As of September 30, 2005, $507 million remained available for borrowing under the revolving credit facility, taking into account letters of 23 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) credit issued under the revolving credit facility. As of September 30, 2005, there was $35 million borrowed under the revolving credit facility and $58 million of letters of credit had been issued under the revolving credit facility. In addition, the Company has a $228 million credit-linked revolving facility, which matures in 2009. The credit-linked revolving facility includes borrowing capacity available for letters of credit. As of September 30, 2005, there were $226 million of letters of credit issued under the credit-linked revolving facility and an additional $2 million was available for borrowing. As detailed in Note 6, in July 2005, the Company acquired Acetex for $270 million and assumed Acetexs $247 million of net debt, which is net of cash acquired of $54 million. The Company caused Acetex to exercise its option to redeem its 10 7/8% senior notes due 2009 totaling approximately $265 million. The redemption was funded primarily with cash on hand and occurred on August 19, 2005. The redemption price was approximately $280 million, which represents 105.438% of the outstanding principal amount, plus accrued and unpaid interest to August 19, 2005. On August 25, 2005, the Company repaid the remaining $36 million of assumed debt with available cash. The Company was in compliance with all of the financial covenants related to its debt agreements as of September 30, 2005. Interest expense The components of interest expense are as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor Three Months Three Months Nine Months Six Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Three Months September 30, September 30, September 30, September 30, Ended 2005 2004 2005 2004 March 31, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] (in $ millions) [[Image Removed]] [[Image Removed]] Accelerated amortization of deferred financing costs [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] on early redemption and prepayment of debt 18 28 89 Premium paid on early redemption of debt [[Image Removed]] [[Image Removed]] 21 [[Image Removed]] 74 [[Image Removed]] 21 [[Image Removed]] Other interest expense [[Image Removed]] 72 [[Image Removed]] 59 [[Image Removed]] 214 [[Image Removed]] 118 [[Image Removed]] 6 Total interest expense [[Image Removed]] 72 [[Image Removed]] 98 [[Image Removed]] 316 [[Image Removed]] 228 [[Image Removed]] 6 [[Image Removed]] 24 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) 10. Benefit Obligations The components of net periodic benefit costs recognized and contributions made to the pension plans and benefit payments made to other postretirement obligations participants are as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Defined Benefit Obligations [[Image Removed]] Other Postretirement Obligations [[Image Removed]] Successor [[Image Removed]] Successor Three Months Three Months Three Months Three Months [[Image Removed]] Ended September [[Image Removed]] Ended September [[Image Removed]] Ended September [[Image Removed]] Ended September 30, 2005 30, 2004 30, 2005 30, 2004 [[Image Removed]] [[Image Removed]] (in $ millions) [[Image Removed]] Components of net periodic benefit cost [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Service cost [[Image Removed]] 11 [[Image Removed]] 10 [[Image Removed]] 1 [[Image Removed]] 1 Interest cost [[Image Removed]] 46 [[Image Removed]] 44 [[Image Removed]] 6 [[Image Removed]] 6 Expected return on plan assets [[Image Removed]] (51 ) [[Image Removed]] (43 ) [[Image Removed]] [[Image Removed]] Recognized actuarial loss [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] Settlement loss [[Image Removed]] [[Image Removed]] 4 [[Image Removed]] [[Image Removed]] Special termination (benefit)/charge [[Image Removed]] 1 [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] Curtailment loss [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] [[Image Removed]] Net periodic benefit cost [[Image Removed]] 9 [[Image Removed]] 15 [[Image Removed]] 7 [[Image Removed]] 7 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Defined Benefit Obligations [[Image Removed]] Other Postretirement Obligations [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Successor [[Image Removed]] Predecessor Nine Months Six Months Three Months Nine Months Six Months Three Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended September 30, September 30, March 31, September 30, September 30, March 31, 2005 2004 2004 2005 2004 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] (in $ millions) [[Image Removed]] [[Image Removed]] Components of net periodic benefit cost [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Service cost [[Image Removed]] 31 [[Image Removed]] 20 [[Image Removed]] 9 [[Image Removed]] 2 [[Image Removed]] 2 [[Image Removed]] 1 Interest cost [[Image Removed]] 136 [[Image Removed]] 88 [[Image Removed]] 40 [[Image Removed]] 18 [[Image Removed]] 12 [[Image Removed]] 6 Expected return on plan assets [[Image Removed]] (149 ) [[Image Removed]] (86 ) [[Image Removed]] (40 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] Amortization of prior service cost [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) Recognized actuarial loss [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] 6 [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 Settlement loss [[Image Removed]] [[Image Removed]] 4 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Special termination (benefit)/charge [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Curtailment (gain)/loss [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] Net periodic benefit cost [[Image Removed]] 21 [[Image Removed]] 28 [[Image Removed]] 16 [[Image Removed]] 19 [[Image Removed]] 14 [[Image Removed]] 8 [[Image Removed]] The Company previously disclosed in its financial statements for the year ended December 31, 2004 that it expected to contribute $7 million to its Canadian defined benefit pension plans in 2005. As of September 30, 2005, $6 million of contributions have been made. The Company presently anticipates contributing an additional $2 million to fund its defined benefit pension plans in 2005, bringing the full year contributions to $8 million. The Company previously disclosed in its financial statements for the year ended December 31, 2004 that it expected to make benefit payments of $47 million under the provisions of its other postretirement benefit plans. As of September 30, 2005, $35 million of benefit payments have been 25 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) made. The Company presently anticipates paying an additional $12 million in other postretirement benefits during the fourth quarter of 2005. Contributions to the defined contribution plans are based on specified percentages of employee contributions and aggregated $9 million, $5 million and $3 million for the nine months ended September 30, 2005, the six months ended September 30, 2004 and the three months ended March 31, 2004, respectively. In connection with the acquisition of CAG, the Purchaser agreed to pre-fund $463 million of certain pension obligations. During the nine months ended December 31, 2004, $409 million was pre-funded to the Company's pension plans. The Company contributed the remaining $54 million that the Purchaser agreed to pre-fund, as well as an additional $9 million to the non-qualified pension plan's rabbi trusts during the nine months ended September 30, 2005. In connection with the Company's acquisition of Vinamul and Acetex, it assumed certain obligations related to the acquired pension and postretirement benefit plans. The Company is in the process of evaluating the effects of purchase accounting regarding these obligations. As part of a restructuring program announced in October 2004, the Company closed certain plants related to its acetate filament production and has consolidated its acetate flake and tow operations from five locations to three. This resulted in the reduction of nearly 600 United States employees triggering a curtailment. The curtailment resulted in an increase in the Projected Benefit Obligation (PBO) and a corresponding curtailment loss of $2 million for the pension plan during the three months ended September 30, 2005. 11. Shareholders' Equity (Deficit) See table below for share activity: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Preferred [[Image Removed]] Series A [[Image Removed]] Series B Stock Common Stock Common Stock [[Image Removed]] (number of shares) Balance as of December 31, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] 99,377,884 Issuance of preferred stock [[Image Removed]] 9,600,000 [[Image Removed]] [[Image Removed]] Issuance of common stock [[Image Removed]] [[Image Removed]] 51,684,277 [[Image Removed]] Stock dividend [[Image Removed]] [[Image Removed]] 7,500,000 [[Image Removed]] Conversion of Series B common stock to Series A common stock [[Image Removed]] [[Image Removed]] 99,377,884 [[Image Removed]] (99,377,884 ) Balance as of September 30, 2005 [[Image Removed]] 9,600,000 [[Image Removed]] 158,562,161 [[Image Removed]] [[Image Removed]] Funding for the Acquisition included equity investments from Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone Capital Partners (Cayman) Ltd. 2, and Blackstone Capital Partners (Cayman) Ltd. 3 (collectively, Blackstone) and BA Capital Investors Sidecar Fund, L.P. (and together with Blackstone, the Original Shareholders). On December 31, 2004, the capital structure of the Company consisted of 650,494 shares of Series B common stock, par value $0.01 per share. In January 2005, the Company amended its certificate of incorporation and increased its authorized common stock to 500,000,000 shares and the Company effected a 152.772947 for 1 stock split for the outstanding shares of the Series B common stock. Accordingly, all Successor share information is effected for such stock split effective December 31, 2004. As a result of the offering in January 2005, the Company now has $240 million aggregate liquidation preference of outstanding preferred stock. Holders of the preferred stock are entitled to receive, when, as and if, declared by the Company's board of directors, out of funds legally available 26 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) therefore, cash dividends at the rate of 4.25% per annum of liquidation preference, payable quarterly in arrears, commencing on May 1, 2005. Dividends on the preferred stock are cumulative from the date of initial issuance. Accumulated but unpaid dividends accumulate at an annual rate of 4.25%. The preferred stock is convertible, at the option of the holder, at any time into approximately 1.25 shares of Series A common stock, subject to adjustments, per $25.00 liquidation preference of preferred stock and upon conversion will be recorded in shareholders' equity (deficit). As of September 30, 2005, the Company had $3 million of accumulated but unpaid dividends, which have not been declared. On March 8, 2005, the Company declared a special cash dividend to holders of the Company's Series B common stock of $804 million, which was paid on April 7, 2005. Upon payment of the $804 million dividend, all of the outstanding shares of Series B common stock converted automatically to shares of Series A common stock. In addition, on March 9, 2005, the Company issued a 7,500,000 Series A common stock dividend to the Original Shareholders of its Series B common stock. Other Comprehensive Income (Loss) Other comprehensive income (loss) totaled $(117) million, $0 million and $(39) million, for the nine months ended September 30, 2005, the six months ended September 30, 2004 and the three months ended March 31, 2004, respectively. These amounts were net of tax expense (benefit) of $(13) million, $1 million and $2 million, for the nine months ended September 30, 2005, the six months ended September 30, 2004 and the three months ended March 31, 2004, respectively. As part of the curtailment charge discussed in Note 10, the Company's U.S. qualified pension benefit plan and the postretirement benefit plan obligations were remeasured to reflect the discount rate and market value of plan assets as of September 30, 2005. This remeasurement resulted in additional minimum liability of approximately $92 million with an offsetting charge to accumulated other comprehensive income (loss). In addition, the Company performed its annual remeasurement of its German pension benefit plans as of September 30, 2005. This remeasurement resulted in a pretax additional minimum liability of $29 million (taxes of $12 million), with an offsetting charge to accumulated other comprehensive income (loss). 12. Commitments and Contingencies The Company is involved in a number of legal proceedings, lawsuits and claims incidental to the normal conduct of our business, relating to such matters as product liability, antitrust, past waste disposal practices and release of chemicals into the environment. While it is impossible at this time to determine with certainty the ultimate outcome of these proceedings, lawsuits and claims, management believes that adequate provisions have been made and that the ultimate outcomes will not have a material adverse effect on our financial position, but may have a material adverse effect on the results of operations or cash flows in any given accounting period. The following disclosure should be read in conjunction with the Companys Annual Report on Form 10-K for the year ended December 31, 2004. Plumbing Actions CNA Holdings, Inc. (CNA Holdings), a U.S. subsidiary of Celanese, which included the U.S. business now conducted by the Ticona segment, along with Shell Oil Company (Shell), E.I. DuPont de Nemours and Company (DuPont) and others, has been a defendant in a series of lawsuits, including a number of class actions, alleging that plastics manufactured by these companies that were utilized in the production of plumbing systems for residential property were defective or caused such plumbing systems to fail. Based on, among other things, the findings of outside experts and the successful use of Ticona's acetal copolymer in similar applications, CNA Holdings does not believe 27 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) Ticona's acetal copolymer was defective or caused the plumbing systems to fail. In many cases CNA Holdings' exposure may be limited by invocation of the statute of limitations since CNA Holdings ceased selling the resin for use in the plumbing systems in site built homes during 1986 and in manufactured homes during 1990. CNA Holdings has been named a defendant in ten putative class actions, as well as a defendant in other non-class actions filed in ten states, the U.S. Virgin Islands, and Canada. In these actions, the plaintiffs typically have sought recovery for alleged property damages and, in some cases, additional damages under the Texas Deceptive Trade Practices Act or similar type statutes. Damage amounts have not been specified. In order to reduce litigation expenses and to provide relief to qualifying homeowners, in November 1995, CNA Holdings, DuPont and Shell Oil Company entered into national class action settlements, which have been approved by the courts. The settlements call for the replacement of plumbing systems of claimants who have had qualifying leaks, as well as reimbursements for certain leak damage. Furthermore, the three companies have agreed to fund these replacements and reimbursements up to $950 million. As of September 30, 2005, the aggregate funding is $1,073 million due to additional contributions and funding commitments made primarily by other parties. There are approximately ten additional pending lawsuits not discussed herein; however, these cases do not involve (either individually or in the aggregate) a large number of homes, and management does not expect the obligations arising from these lawsuits to have a material adverse effect on the Company. In 1995, CNA Holdings and Shell Oil Company settled the claims relating to individuals in Texas owning a total of 110,000 property units, who are represented by a Texas law firm, for an amount that will not exceed $170 million. These claimants are also eligible for a replumb of their homes in accordance with terms similar to those of the national class action settlement. CNA Holdings' and Shell Oil Company's contributions under this settlement were subject to allocation as determined by binding arbitration. In addition, a lawsuit filed in November 1989 in Delaware Chancery Court, between CNA Holdings and various of its insurance companies relating to all claims incurred and to be incurred for the product liability exposure led to a partial declaratory judgment in CNA Holdings' favor. As a result, settlements have been reached with a majority of CNA Holdings' insurers specifying their responsibility for these claims. In February 2005, CNA Holdings reached a settlement agreement through mediation with another insurer, pursuant to which the insurer paid CNA Holdings $44 million in exchange for the release of certain claims against the policy with the insurer. This amount was recorded as a reduction of goodwill as of December 31, 2004 and was received during the nine months ended September 30, 2005. CNA Holdings has accrued its best estimate of its share of the plumbing actions. At September 30, 2005, the Company has remaining accruals of $68 million for this matter. Management believes that the plumbing actions are adequately provided for in the Company's financial statements and that they will not have a material adverse effect on our financial position. However, if the Company were to incur an additional charge for this matter, such a charge would not be expected to have a material adverse effect on our financial position, but may have a material adverse effect on our results of operations or cash flows in any given accounting period. No assurance can be given that the Company's litigation reserves will be adequate or that these reserves will fully recover claims under the Company's insurance policies. The Company has reached settlements with CNA Holdings' insurers specifying their responsibility for these claims; as a result, the Company has recorded receivables relating to the anticipated recoveries from certain third party insurance carriers. These receivables are based on the probability 28 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) of collection, an opinion of external counsel, the settlement agreements with the Company's insurance carriers whose coverage level exceeds the receivables and the status of current discussions with other insurance carriers. As of September 30, 2005, the Company has $31 million of receivables related to a settlement with an insurance carrier. This receivable is discounted and recorded within other assets as it will be collected over the next three years. Sorbates Antitrust Actions In May 2002, the European Commission informed Hoechst of its intent to investigate officially the sorbates industry. In early January 2003, the European Commission served Hoechst, Nutrinova, Inc., a U.S. subsidiary of Nutrinova Nutrition Specialties & Food Ingredients GmbH, previously a wholly owned subsidiary of Hoechst, and a number of competitors with a statement of objections alleging unlawful, anticompetitive behavior affecting the European sorbates market. In October 2003, the European Commission ruled that Hoechst, Chisso Corporation, Daicel Chemical Industries Ltd., The Nippon Synthetic Chemical Industry Co. Ltd. and Ueno Fine Chemicals Industry Ltd. operated a cartel in the European sorbates market between 1979 and 1996. The European Commission imposed a total fine of 138 million, of which 99 million was assessed against Hoechst. The case against Nutrinova was closed. The fine against Hoechst is based on the European Commission's finding that Hoechst does not qualify under the leniency policy, is a repeat violator and, together with Daicel, was a co-conspirator. In Hoechst's favor, the European Commission gave a discount for cooperating in the investigation. Hoechst appealed the European Commission's decision in December 2003, and that appeal is still pending. In addition, several civil antitrust actions by sorbates customers, seeking monetary damages and other relief for alleged conduct involving the sorbates industry, have been filed in U.S. state and federal courts naming Hoechst, Nutrinova, and our other subsidiaries, as well as other sorbates manufacturers, as defendants. Many of these actions have been settled and dismissed by the court. One private action, Kerr v. Eastman Chemical Co. et al., previously pending in the Superior Court of New Jersey, Law Division, Gloucester County, was dismissed in October 2005 for failure to prosecute. The plaintiff alleged violations of the New Jersey Antitrust Act and the New Jersey Consumer Fraud Act and sought unspecified damages. The only other private action previously pending, Freeman v. Daicel et al., had been dismissed. The plaintiffs lost their appeal to the Supreme Court of Tennessee in August 2005 and have since filed a motion for leave. In July 2001, Hoechst and Nutrinova entered into an agreement with the Attorneys General of 33 states, pursuant to which the statutes of limitations were tolled pending the states' investigations. This agreement expired in July 2003. Since October 2002, the Attorneys General for several states filed suit on behalf of indirect purchasers in their respective states, all of which have been either settled or dismissed, except as noted below. The Nevada action has been dismissed as to Hoechst, Nutrinova and CAG; however, a motion for reconsideration is still pending. The New York action, New York v. Daicel Chemical Industries Ltd., et al. which was pending in the New York State Supreme Court, New York County was dismissed in August 2005; however, it is still subject to appeal. In January 2005, Hoechst, Nutrinova, and other subsidiaries, as well as other sorbates manufacturers, entered into a settlement agreement with the Attorneys General of Connecticut, Florida, Hawaii, Maryland, South Carolina, Oregon and Washington before these states filed suit. Pursuant to the terms of the settlement agreement, the defendants agreed to refrain from engaging in anticompetitive conduct with respect to the sale or distribution of sorbates and pay approximately $1 million to the states in satisfaction of all released claims. Based on the advice of external counsel and a review of the existing facts and circumstances relating to the sorbates matter, including the status of government investigations, as well as civil claims filed and settled, the Company has remaining accruals of $130 million. This amount is included in current liabilities at September 30, 2005 for the estimated loss related to this matter. Although the 29 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) outcome of the remaining foregoing proceedings and claims of this matter cannot be predicted with certainty, management's best estimate of the range of possible additional future losses and fines (in excess of amounts already accrued), including any that may result from the above noted governmental proceedings, as of September 30, 2005 is between $0 and $9 million. The estimated range of such possible future losses is management's best estimate based on the advice of external counsel taking into consideration potential fines and claims, both civil and criminal, that may be imposed or made in other jurisdictions. Pursuant to the Demerger Agreement with Hoechst, Celanese AG was assigned the obligation related to the sorbates matter. However, Hoechst agreed to indemnify Celanese AG for 80 percent of any costs Celanese may incur relative to this matter. Accordingly, Celanese AG has recognized a receivable from Hoechst and a corresponding contribution of capital, net of tax, from this indemnification. As of September 30, 2005, the Company has receivables, recorded within other current assets, relating to the sorbates indemnification from Hoechst totaling $104 million. Although the outcome of the foregoing proceedings and claims cannot be predicted with certainty, the Company believes that any resulting liabilities, net of amounts recoverable from Hoechst, will not, in the aggregate, have a material adverse effect on its financial position, but may have a material adverse effect on the results of operations or cash flows in any given period. Acetic Acid Patent Infringement Matters Celanese International Corporation v. China Petrochemical Development Corporation Taiwan Kaohsiung District Court.On February 7, 2001, Celanese International Corporation filed a private criminal action for patent infringement against China Petrochemical Development Corporation, or CPDC, alleging that CPDC infringed Celanese International Corporation's patent covering the manufacture of acetic acid. Celanese International Corporation also filed a supplementary civil brief which, in view of changes in Taiwanese patent laws, was subsequently converted to a civil action alleging damages against CPDC based on a period of infringement of ten years, 1991-2000, and based on CPDC's own data and as reported to the Taiwanese securities and exchange commission. Celanese International Corporation's patent was held valid by the Taiwanese patent office. On August 31, 2005 a Taiwanese court held that CPDC infringed Celanese International Corporations acetic acid patent and awarded Celanese International Corporation approximately $28 million for the period of 1995 through 1999. The judgment has been appealed. The Company will not record income associated with this favorable judgment until cash is received. Shareholder Litigation During August 2004, nine actions were brought by minority shareholders against CAG in the Frankfurt District Court (Landgericht), all of which were consolidated in September 2004. Several minority shareholders joined these proceedings via a third party intervention in support of the plaintiffs. The Purchaser joined the proceedings via a third party intervention in support of CAG. Among other things, these actions request the court to set aside shareholder resolutions passed at the extraordinary general meeting held on July 30 and 31, 2004 based on allegations that include the alleged violation of procedural requirements and information rights of the shareholders. In a related matter, twenty-seven minority shareholders filed lawsuits in May and June of 2005 in the Frankfurt District Court (Landgericht) contesting the shareholder resolutions passed at the annual general meeting held May 19-20, 2005, which confirmed the resolutions passed at the July 30-31, 2004 extraordinary general meeting. In conjunction with the acquisition of 5.9 million CAG shares from two shareholders in August 2005, two of those lawsuits were withdrawn in August 2005. In June and September 2005, Celanese AG was served in three actions filed in the Frankfurt District Court (Landgericht) requesting that the court declare some or all of the shareholder resolutions passed at the extraordinary general meeting on July 30 and 31, 2004 null and void (Nichtigkeitsklage), based on 30 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) allegations that certain formal requirements necessary in connection with the invitation to the extraordinary general meeting had been violated. The Frankfurt District Court (Landgericht) has suspended the proceedings regarding the resolutions passed at the July 30-31, 2004 extraordinary general meeting described above as long as the lawsuits contesting the confirmatory resolutions are pending. Further, on August 2, 2004, two minority shareholders instituted public register proceedings with each of the Knigstein Local Court (Amtsgericht) and the Frankfurt District Court (Landgericht), both with a view to have the registration of the Domination Agreement in the Commercial Register deleted (Amtslschungsverfahren). These actions are based on an alleged violation of procedural requirements at the extraordinary general meeting, an alleged undercapitalization of the Purchaser and Blackstone and an alleged misuse of discretion by the competent court with respect to the registration of the Domination Agreement in the Commercial Register. In April 2005, the court of appeals rejected the demand by one shareholder for injunctive relief, and in June 2005 the Frankfurt District Court (Landgericht) ruled that it does not have jurisdiction over this matter. The claims in the Knigstein Local Court (Amtsgericht) are still pending. Based upon information available as of September 30, 2005, the outcome of the foregoing proceedings cannot be predicted with certainty. Except for certain challenges on limited grounds, the time period to bring forward challenges (Anfechtungsklagen) has expired. The amounts of the fair cash compensation (Abfindung) and of the guaranteed fixed annual payment (Ausgleich) offered under the Domination Agreement may be increased in special award proceedings (Spruchverfahren) initiated by minority shareholders, which may further reduce the funds the Purchaser can otherwise make available to the Company. Several minority shareholders of CAG had initiated special award proceedings seeking the court's review of the amounts of the fair cash compensation (Abfindung) and of the guaranteed fixed annual payment (Ausgleich) offered under the Domination Agreement. As a result of these proceedings, the amount of the fair cash consideration and the guaranteed fixed annual payment offered under the Domination Agreement could be increased by the court so that all minority shareholders, including those who have already tendered their shares into the Mandatory Offer and have received the fair cash compensation could claim the respective higher amounts. This could reduce the funds the Purchaser can make available to the Company and its subsidiaries and, accordingly, diminish our ability to make payments on our indebtedness. However, the court dismissed all of these proceedings in March 2005 on the grounds of inadmissibility. The dismissal has been appealed. In February 2005, a minority shareholder also brought a lawsuit against the Purchaser, as well as a former member of CAG's board of management and a former member of CAG's supervisory board, in the Frankfurt District Court (Landgericht). Among other things, this action seeks to unwind the tender of the plaintiff's shares in the Acquisition and seeks compensation for damages suffered as a consequence of tendering such shares. The court ruled against the plaintiff in this matter in June 2005. The plaintiff appealed this decision with respect to the Purchaser and the former member of the CAG board of management; however, with respect to the former member of the CAG supervisory board, the plaintiff has withdrawn his appeal. Based upon the information available as of September 30, 2005, the outcome of the foregoing proceedings cannot be predicted with certainty. Guarantees The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements, and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations. 31 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims that have been brought to its attention. These known obligations include the following: Demerger Obligations The Company has obligations to indemnify Hoechst for various liabilities under the Demerger Agreement as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] The Company agreed to indemnify Hoechst for environmental liabilities associated with contamination arising under 19 divestiture agreements entered into by Hoechst prior to the demerger. The Company's obligation to indemnify Hoechst is subject to the following thresholds: [[Image Removed]] [[Image Removed]] [[Image Removed]] The Company will indemnify Hoechst against those liabilities up to 250 million; [[Image Removed]] [[Image Removed]] [[Image Removed]] Hoechst will bear those liabilities exceeding 250 million, however the Company will reimburse Hoechst for one-third of those liabilities for amounts that exceed 750 million in the aggregate. The Company's obligation regarding two agreements has been settled. The aggregate maximum amount of environmental indemnifications under the remaining divestiture agreements that provide for monetary limits is 750 million. Three of the divested agreements do not provide for monetary limits. Based on the estimate of the probability of loss under this indemnification, the Company has reserves of $34 million as of September 30, 2005, for this contingency. Where the Company is unable reasonably to determine the probability of loss or estimate such loss under an indemnification, the Company has not recognized any related liabilities. The Company has also undertaken in the Demerger Agreement to indemnify Hoechst to the extent that Hoechst is required to discharge liabilities, including tax liabilities, associated with businesses that were included in the demerger where such liabilities were not demerged, due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not provided for any reserves associated with this indemnification. Neither the Company nor the Predecessor made any payments to Hoechst in the nine months ended September 30, 2005 or at any point during 2004, in connection with this indemnification. Divestiture Obligations The Company and its predecessor companies agreed to indemnify third party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to any significant risk. The Company and the Predecessor have divested in the aggregate over 20 businesses, investments and facilities, through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, ranging from one year to 30 years.The aggregate amount of guarantees provided for under these agreements is approximately $2.9 billion as of September 30, 2005. Other agreements do not provide for any monetary or time limitations. Based on historical claims experience and its knowledge of the sites and businesses involved, the Company believes that it is adequately reserved for these matters. As of September 30, 2005, the Company has reserves in the aggregate of $55 million for all such environmental matters. 32 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) Plumbing Insurance Indemnifications CAG entered into agreements with insurance companies related to product liability settlements associated with Celcon plumbing claims. These agreements, except those with insolvent insurance companies, require the Company to indemnify and/or defend these insurance companies in the event that third parties seek additional monies for matters released in these agreements. The indemnifications in these agreements do not provide for time limitations. In certain of the agreements, CAG received a fixed settlement amount. The indemnities under these agreements generally are limited to, but in some cases are greater than, the amount received in settlement from the insurance company. The maximum exposure under these indemnifications is $95 million. Other settlement agreements have no stated limits. There are other agreements whereby the settling insurer agreed to pay a fixed percentage of claims that relate to that insurer's policies. The Company has provided indemnifications to the insurers for amounts paid in excess of the settlement percentage. These indemnifications do not provide for monetary or time limitations. The Company has reserves associated with these product liability claims. See Plumbing Actionsabove. Other Obligations [[Image Removed]] [[Image Removed]] [[Image Removed]] The Company is secondarily liable under a lease agreement pursuant to which the Company has assigned a direct obligation to a third party. The lease assumed by the third party expires on April 30, 2012. The lease liability for the period from October 1, 2005 to April 30, 2012 is estimated to be approximately $50 million. [[Image Removed]] [[Image Removed]] [[Image Removed]] The Company has agreed to indemnify various insurance carriers, for amounts not in excess of the settlements received, from claims made against these carriers subsequent to the settlement. The aggregate amount of guarantees under these settlements is approximately $10 million, which is unlimited in term. As indemnification obligations often depend on the occurrence of unpredictable future events, the future costs associated with them cannot be determined at this time. However, if the Company were to incur additional charges for these matters, such charges may have a material adverse effect on the financial position, results of operations or cash flows of the Company in any given accounting period. Other Matters As of September 30, 2005, Celanese Ltd. and/or CNA Holdings, Inc., both U.S. subsidiaries of the Company, are defendants in approximately 650 asbestos cases. Because many of these cases involve numerous plaintiffs, the Company is subject to claims significantly in excess of the number of actual cases. The Company has reserves for defense costs related to claims arising from these matters. The Company believes that there is not significant exposure related to these matters. Under the transaction and monitoring fee agreement/sponsor services agreement, the Company has agreed to indemnify the Advisor and its affiliates and their respective partners, members, directors, officers, employees, agents and representatives for any and all losses relating to services contemplated by these agreements and the engagement of the Advisor pursuant to, and the performance by the Advisor or the services contemplated by, these agreements. The Company has also agreed under the transaction and monitoring fee agreement/sponsor services agreement to reimburse the Advisor and its affiliates for their expenses incurred in connection with the services provided under these agreements or in connection with their ownership or subsequent sale of Celanese Corporation stock (See Note 17). On July 31, 2003, a federal district court ruled that the formula used in International Business Machine Corporation's (IBM) cash balance pension plan violated the age discrimination provisions 33 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) of the Employee Retirement Income Security Act of 1974. The IBM decision, however, conflicts with the decisions from two other federal district courts and with the proposed regulations for cash balance plans issued by the Internal Revenue Service in December 2002. IBM has announced that it will appeal the decision to the United States Court of Appeals for the Seventh Circuit. The effect of the IBM decision on the Company's cash balance plan cannot be determined at this time. From time to time, certain of our foreign subsidiaries have made sales of acetate, sweeteners and polymer products to countries that are or have previously been subject to sanctions and embargoes imposed by the US government and the United Nations. These countries include Iran, Sudan and Syria, three countries currently identified by the U.S. State Department as terrorist-sponsoring states and other countries that previously have been identified by the U.S. State Department as terrorist-sponsoring states, or countries to which sales have been regulated in connnection with other foreign policy concerns. Approximately $10 million of these sales by the Company's foreign subsidiaries may be in violation of regulations of the United States Treasury Departments Office of Foreign Assets Control, or OFAC, or the United States Department of Commerces Bureau of Industry and Security. In addition, the Company has recently discovered that two of its foreign subsidiaries made approximately $180,000 of sales of emulsions to Cuba which were apparently in violation of OFAC regulations. Cuba is also currently identified by the U.S. State Department as a terrorist-sponsoring state. The Company has informed the U.S. Treasury Department and the U.S. Department of Commerce of both of these matters and is currently engaged in preliminary discussions with the Departments. Our inquiry into these transactions is continuing and the Departments review of this matter is in a very preliminary stage. To the extent the Company violated any regulations with respect to the above or other transactions, the Company may be subject to fines or other sanctions, including possible criminal penalties, which may result in adverse business consequences. The Company does not expect these matters to have a material adverse effect on its financial position, results of operations and cash flows. 13. Special Charges The components of special charges are as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended September 30, 2005 September 30, 2004 [[Image Removed]] (in $ millions) Employee termination benefits [[Image Removed]] (9 ) [[Image Removed]] (6 ) Plant/office closures [[Image Removed]] (1 ) [[Image Removed]] (52 ) Restructuring adjustments [[Image Removed]] [[Image Removed]] 1 Total Restructuring [[Image Removed]] (10 ) [[Image Removed]] (57 ) Environmental related plant closures [[Image Removed]] (12 ) [[Image Removed]] Asset impairments [[Image Removed]] (1 ) [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] (1 ) Other [[Image Removed]] (1 ) [[Image Removed]] (1 ) Total Special Charges [[Image Removed]] (24 ) [[Image Removed]] (59 ) [[Image Removed]] Special charges decreased to $24 million compared to $59 million for the same period last year primarily due to including impairment charges associated with the Acetate products segment restructuring recorded in the third quarter of 2004. The third quarter of 2005 includes charges related to a change in environmental remediation strategy related to the closure of the Edmonton Methanol plant, severance associated with the same closure and severance related to the relocation of corporate offices of $12 million, $6 million and $3 million respectively. 34 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Nine Months Ended [[Image Removed]] Six Months Ended [[Image Removed]] Three Months Ended September 30, 2005 September 30, 2004 March 31, 2004 [[Image Removed]] [[Image Removed]] (in $ millions) [[Image Removed]] Employee termination benefits [[Image Removed]] (18 ) [[Image Removed]] (7 ) [[Image Removed]] (2 ) Plant/office closures [[Image Removed]] (2 ) [[Image Removed]] (52 ) [[Image Removed]] Restructuring adjustments [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] Total Restructuring [[Image Removed]] (20 ) [[Image Removed]] (58 ) [[Image Removed]] (2 ) Termination of advisor monitoring services [[Image Removed]] (35 ) [[Image Removed]] [[Image Removed]] Environmental related plant closures [[Image Removed]] (12 ) [[Image Removed]] [[Image Removed]] Asset impairments [[Image Removed]] (25 ) [[Image Removed]] [[Image Removed]] Advisory services [[Image Removed]] [[Image Removed]] [[Image Removed]] (25 ) Insurance recoveries associated with plumbing cases [[Image Removed]] 4 [[Image Removed]] 1 [[Image Removed]] Other [[Image Removed]] (1 ) [[Image Removed]] (1 ) [[Image Removed]] (1 ) Total Special Charges [[Image Removed]] (89 ) [[Image Removed]] (58 ) [[Image Removed]] (28 ) [[Image Removed]] Asset impairments primarily consists of revised estimates related to the Companys decision to divest its Cyclo-olefin Copolymer (COC) business. The components of the restructuring reserves are as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Employee [[Image Removed]] Termination [[Image Removed]] Plant/Office [[Image Removed]] Benefits Closures Total [[Image Removed]] (in $ millions) Predecessor [[Image Removed]] [[Image Removed]] [[Image Removed]] Restructuring reserve at December 31, 2003 [[Image Removed]] 28 [[Image Removed]] 21 [[Image Removed]] 49 Restructuring additions [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Cash and noncash uses [[Image Removed]] (5 ) [[Image Removed]] (2 ) [[Image Removed]] (7 ) Restructuring reserve at March 31, 2004 [[Image Removed]] 25 [[Image Removed]] 19 [[Image Removed]] 44 [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] [[Image Removed]] [[Image Removed]] Restructuring reserve at April 1, 2004 [[Image Removed]] 25 [[Image Removed]] 19 [[Image Removed]] 44 Purchase accounting adjustments [[Image Removed]] 10 [[Image Removed]] [[Image Removed]] 10 Restructuring additions [[Image Removed]] 6 [[Image Removed]] 52 [[Image Removed]] 58 Cash and noncash uses [[Image Removed]] (10 ) [[Image Removed]] (54 ) [[Image Removed]] (64 ) Restructuring reserve at September 30, 2004 [[Image Removed]] 31 [[Image Removed]] 17 [[Image Removed]] 48 Restructuring reserve at December 31, 2004 [[Image Removed]] 72 [[Image Removed]] 14 [[Image Removed]] 86 Purchase accounting adjustments [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 1 Restructuring additions [[Image Removed]] 18 [[Image Removed]] 14 [[Image Removed]] 32 Cash and noncash uses [[Image Removed]] (26 ) [[Image Removed]] (20 ) [[Image Removed]] (46 ) Currency translation adjustments [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] (2 ) Other charges [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] (2 ) Restructuring reserve at September 30, 2005 [[Image Removed]] 61 [[Image Removed]] 8 [[Image Removed]] 69 [[Image Removed]] 14. Stock-based and Other Management Compensation Plans In December 2004, the Company approved a stock incentive plan, which included executive officers, key employees and directors, a deferred compensation plan, which included executive officers and key employees, as well as other management incentive programs. 35 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) These stock incentive plans allows for the issuance or delivery of up to 16.25 million shares of the Company's Series A common stock through stock options and a discounted share program. In January 2005, options were initially granted at an exercise price equal to the initial public offering price. The options have a ten-year term with vesting terms pursuant to a schedule, with no vesting to occur later than the 8th anniversary of the date of the grant. Accelerated vesting depends on meeting specified performance targets. Of the 11.8 million stock options outstanding, 11.3 million are non-compensatory. The remaining 0.5 million options are subject to variable plan accounting. Compensation expense related to these options was approximately $1 million for the three and nine months ended September 30, 2005. No options were exercised during the nine months ended September 30, 2005. In December 2004, the Company granted rights to executive officers and key employees to purchase up to 1,797,386 shares of Series A common stock at a discount of $8.80 per share. During the nine months ended September 30, 2005, 1,684,277 shares have been purchased. As a result of this discounted share offering, the Company recorded a pre-tax non-cash charge of $14 million, with a corresponding adjustment to additional paid-in capital within shareholders' equity (deficit) in the fourth quarter 2004. Compensation expense associated with the discounted shares was immaterial for the nine months ended September 30, 2005. The deferred compensation plan has an aggregate maximum amount payable of $192 million. The initial component of the deferred compensation plan, totaling an aggregate of approximately $27 million, vested in 2004 and was paid in the first quarter of 2005. Stock-based compensation As permitted by SFAS No. 123, Accounting for Stock-Based Compensation (SFAS No. 123), the Successor accounts for employee stock-based compensation in accordance with APB Opinion No. 25, Accounting for Stock Issued to Employees (APB No. 25), using an intrinsic value approach to measure compensation expense, if any. For the three months ended March 31, 2004, the Predecessor accounted for stock options and similar equity instruments under the fair value method, which requires compensation cost to be measured at the grant date based on the value of the award. The fair value of options granted in the three and nine month period ended September 30, 2005 under the Companys stock incentive plan was estimated at the date of grant using the Black Scholes option pricing model. The following weighted average assumptions were used: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Three Months Nine Months [[Image Removed]] Ended [[Image Removed]] Ended September 30, 2005 September 30, 2005 Risk free interest rate [[Image Removed]] 4.0 % [[Image Removed]] 4.0 % Estimated life in years [[Image Removed]] 7.8 [[Image Removed]] 7.5 Dividend yield [[Image Removed]] 0.96 % [[Image Removed]] 0.77 % Volatility [[Image Removed]] 27.4 % [[Image Removed]] 26.2 % [[Image Removed]] 36 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) The following table illustrates the effect on net earnings (loss) and related per share amounts if the Successor had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] For the Three Months Ended September 30, 2005 [[Image Removed]] For the Nine Months Ended September 30, 2005 Basic Diluted Basic Diluted [[Image Removed]] [[Image Removed]] Earnings [[Image Removed]] Earnings [[Image Removed]] [[Image Removed]] Earnings [[Image Removed]] Earnings Earnings Per Common Per Common Earnings Per Common Per Common (Loss) Share Share (Loss) Share Share [[Image Removed]] (in $ millions, except per share information) Net earnings, available to common shareholders, as [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] reported 42.0 0.26 0.26 95.0 0.62 0.62 Add: stock-based employee compensation expense included in reported net earnings, net of the related [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] tax effects 0.5 0.5 Less: stock-based compensation under SFAS No. 123, [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] net of the related tax effects (2.0) (0.01 ) (0.01 ) (6.0) (0.04 ) (0.04 ) Pro forma net earnings available to common [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] shareholders 40.5 0.25 0.25 89.5 0.58 0.58 [[Image Removed]] 15. Income Taxes Income taxes for the three and nine months ended September 30, 2005, the three and six months ended September 30, 2004 and the three month period ended March 31, 2004, are recorded based on the estimated annual effective tax rate. As of September 30, 2005, the estimated annualized tax rate for 2005 is 35%, which is slightly less than the combination of the statutory rate and state income tax rates in the U.S. The estimated annual effective tax rate for 2005 reflects earnings in low tax jurisdictions, a valuation allowance for the tax benefit associated with projected U.S. losses (which includes the expenses associated with the early redemption of debt), and tax expense in certain non-U.S. jurisdictions. For the three and nine months ended September 30, 2005, the Company recorded tax expenses of $26 million and $77 million, respectively. For the three and six months ended September 30, 2004, tax expenses of $48 million and $58 million were recorded which resulted in a tax rate of negative 155% and negative 43%, respectively. The effective tax rates were significantly affected by the non-recognition of tax benefits associated with acquisition related expenses. The Predecessor had tax expenses of $17 million, which resulted in an effective tax rate of 24%, for the three months ended March 31, 2004, compared to the German statutory rate of 40%, which was primarily affected by earnings in low tax jurisdictions. 37 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) 16. Business Segments [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Chemical [[Image Removed]] [[Image Removed]] Acetate [[Image Removed]] Performance [[Image Removed]] Total [[Image Removed]] Other [[Image Removed]] [[Image Removed]] Products Ticona Products Products Segments Activities Reconciliation Consolidated [[Image Removed]] (in $ millions) [[Image Removed]] For the three months ended September 30, 2005 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Sales to external customers [[Image Removed]] 1,060 [[Image Removed]] 212 [[Image Removed]] 163 [[Image Removed]] 46 [[Image Removed]] 1,481 [[Image Removed]] 55 [[Image Removed]] [[Image Removed]] 1,536 Inter-segment revenues [[Image Removed]] 40 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 40 [[Image Removed]] [[Image Removed]] (40 ) [[Image Removed]] Operating profit [[Image Removed]] 98 [[Image Removed]] 18 [[Image Removed]] 4 [[Image Removed]] 13 [[Image Removed]] 133 [[Image Removed]] (41 ) [[Image Removed]] [[Image Removed]] 92 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 134 34 4 10 182 (108 ) 74 Depreciation and amortization [[Image Removed]] 45 [[Image Removed]] 13 [[Image Removed]] 3 [[Image Removed]] 4 [[Image Removed]] 65 [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 70 Capital expenditures [[Image Removed]] 22 [[Image Removed]] 12 [[Image Removed]] 8 [[Image Removed]] [[Image Removed]] 42 [[Image Removed]] 4 [[Image Removed]] [[Image Removed]] 46 For the three months ended [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] September 30, 2004 Sales to external customers [[Image Removed]] 809 [[Image Removed]] 213 [[Image Removed]] 176 [[Image Removed]] 47 [[Image Removed]] 1,245 [[Image Removed]] 20 [[Image Removed]] [[Image Removed]] 1,265 Inter-segment revenues [[Image Removed]] 31 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 31 [[Image Removed]] [[Image Removed]] (31 ) [[Image Removed]] Operating profit [[Image Removed]] 83 [[Image Removed]] 15 [[Image Removed]] (39 ) [[Image Removed]] 12 [[Image Removed]] 71 [[Image Removed]] (46 ) [[Image Removed]] [[Image Removed]] 25 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 100 29 (39 ) 11 101 (132 ) (31 ) Depreciation and amortization [[Image Removed]] 39 [[Image Removed]] 19 [[Image Removed]] 16 [[Image Removed]] 3 [[Image Removed]] 77 [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 79 Capital expenditures [[Image Removed]] 20 [[Image Removed]] 22 [[Image Removed]] 11 [[Image Removed]] 1 [[Image Removed]] 54 [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 56 For the nine months ended [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] September 30, 2005 Sales to external customers [[Image Removed]] 3,131 [[Image Removed]] 674 [[Image Removed]] 542 [[Image Removed]] 140 [[Image Removed]] 4,487 [[Image Removed]] 75 [[Image Removed]] [[Image Removed]] 4,562 Inter-segment revenues [[Image Removed]] 98 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 98 [[Image Removed]] [[Image Removed]] (98 ) [[Image Removed]] Operating profit [[Image Removed]] 430 [[Image Removed]] 62 [[Image Removed]] 34 [[Image Removed]] 41 [[Image Removed]] 567 [[Image Removed]] (157 ) [[Image Removed]] [[Image Removed]] 410 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 476 107 36 36 655 (435 ) 220 Depreciation and amortization [[Image Removed]] 118 [[Image Removed]] 42 [[Image Removed]] 21 [[Image Removed]] 10 [[Image Removed]] 191 [[Image Removed]] 9 [[Image Removed]] [[Image Removed]] 200 Capital expenditures [[Image Removed]] 66 [[Image Removed]] 35 [[Image Removed]] 22 [[Image Removed]] 3 [[Image Removed]] 126 [[Image Removed]] 6 [[Image Removed]] [[Image Removed]] 132 For the six months ended [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] September 30, 2004 Sales to external customers [[Image Removed]] 1,589 [[Image Removed]] 433 [[Image Removed]] 349 [[Image Removed]] 92 [[Image Removed]] 2,463 [[Image Removed]] 31 [[Image Removed]] [[Image Removed]] 2,494 Inter-segment revenues [[Image Removed]] 59 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 59 [[Image Removed]] [[Image Removed]] (59 ) [[Image Removed]] Operating profit [[Image Removed]] 119 [[Image Removed]] 26 [[Image Removed]] (29 ) [[Image Removed]] 14 [[Image Removed]] 130 [[Image Removed]] (80 ) [[Image Removed]] [[Image Removed]] 50 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 134 55 (25 ) 12 176 (311 ) (135 ) Depreciation and amortization [[Image Removed]] 77 [[Image Removed]] 34 [[Image Removed]] 30 [[Image Removed]] 5 [[Image Removed]] 146 [[Image Removed]] 4 [[Image Removed]] [[Image Removed]] 150 Capital expenditures [[Image Removed]] 37 [[Image Removed]] 41 [[Image Removed]] 24 [[Image Removed]] 2 [[Image Removed]] 104 [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 106 [[Image Removed]] 38 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Predecessor [[Image Removed]] Chemical [[Image Removed]] [[Image Removed]] Acetate [[Image Removed]] Performance [[Image Removed]] Total [[Image Removed]] Other [[Image Removed]] [[Image Removed]] Products Ticona Products Products Segments Activities Reconciliation Consolidated [[Image Removed]] (in $ millions) [[Image Removed]] For the three months ended [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] March 31, 2004 Sales to external customers [[Image Removed]] 789 [[Image Removed]] 227 [[Image Removed]] 172 [[Image Removed]] 44 [[Image Removed]] 1,232 [[Image Removed]] 11 [[Image Removed]] [[Image Removed]] 1,243 Inter-segment revenues [[Image Removed]] 29 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 29 [[Image Removed]] [[Image Removed]] (29 ) [[Image Removed]] Operating profit [[Image Removed]] 65 [[Image Removed]] 31 [[Image Removed]] 9 [[Image Removed]] 11 [[Image Removed]] 116 [[Image Removed]] (64 ) [[Image Removed]] [[Image Removed]] 52 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 64 45 9 11 129 (57 ) 72 Depreciation and amortization [[Image Removed]] 39 [[Image Removed]] 16 [[Image Removed]] 13 [[Image Removed]] 2 [[Image Removed]] 70 [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 72 Capital expenditures [[Image Removed]] 15 [[Image Removed]] 20 [[Image Removed]] 8 [[Image Removed]] [[Image Removed]] 43 [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 44 [[Image Removed]] 17. Related Party Transactions Upon closing of the Acquisition, the Company entered into a transaction and monitoring fee agreement with Blackstone Management Partners (the Advisor), an affiliate of the Blackstone Group (the Sponsor). Under the agreement, the Advisor agreed to provide monitoring services to the Company for a 12 year period. Also, the Advisor may receive additional compensation for providing investment banking or other advisory services provided to the Company by the Advisor or any of its affiliates, and may be reimbursed for certain expenses, in connection with any specific acquisition, divestiture, refinancing, recapitalization, or similar transaction. In connection with the completion of the initial public offering, the parties amended and restated the transaction and monitoring fee agreement to terminate the monitoring services and all obligations to pay future monitoring fees and paid the Advisor $35 million. The Company also paid $10 million to the Advisor for the 2005 monitoring fee. The transaction based agreement remains in effect. In connection with the acquisition of Vinamul, the Company paid the Advisor a fee of $2 million, which was included in the computation of the purchase price for the acquisition. In connection with the acquisition of Acetex, the Company paid the Advisor an initial fee of $1 million. Additional fees of $3 million were paid in August 2005 to the Advisor upon the successful completion of this acquisition. In addition, the Company has paid the Advisor aggregate fees of approximately 3 million (approximately $4 million) in connection with the Companys acquisition of 5.9 million additional CAG shares in August 2005 (See Note 2). During the nine months ended September 30, 2005, the Company reimbursed the Advisor approximately $2 million for other costs. Commencing in September 2005, the Company filed a Registration Statement on Form S-1 and amendments to that Registration Statement with the SEC on behalf of the Original Shareholders (the Resale Offering") pursuant to the terms of the Amended and Restated Registration Rights Agreement (Registration Rights Agreement) dated as of January 26, 2005, between the Company and the Original Shareholders. Pursuant to the terms of the Registration Rights Agreement, the Company will pay certain fees and expenses incurred in connection with the Resale Offering, which the Company anticipates will be approximately $1 million. 18. Consolidating Guarantor Financial Information The following unaudited consolidating financial statement information is presented in the provided form because (i) the Issuers are wholly owned subsidiaries of the Parent Guarantor; (ii) the 39 -------------------------------------------------------------------------------- CELANESE CORPORATION AND SUBSIDIARIES NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued) guarantee is considered to be full and unconditional, that is, if the Issuers fail to make a scheduled payment, the Parent Guarantor is obligated to make the scheduled payment immediately and, if they do not, any holder of notes may immediately bring suit directly against the Parent Guarantor for payment of all amounts due and payable. Separate financial statements and other disclosures concerning the Parent Guarantor are not presented because management does not believe that such information is material to investors. 40 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING STATEMENT OF OPERATIONS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] For the Three Months Ended September 30, 2005 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Guarantor Issuer Non-Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net sales [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,536 [[Image Removed]] [[Image Removed]] 1,536 Cost of sales [[Image Removed]] [[Image Removed]] [[Image Removed]] (1,253 ) [[Image Removed]] [[Image Removed]] (1,253 ) Selling, general and administrative expenses [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (143 ) [[Image Removed]] [[Image Removed]] (144 ) Research and development expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (22 ) [[Image Removed]] [[Image Removed]] (22 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Restructuring, impairment and other special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] (24 ) [[Image Removed]] [[Image Removed]] (24 ) Foreign exchange gain (loss), net [[Image Removed]] [[Image Removed]] [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] (2 ) Gain (loss) on disposition of assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 1 Operating profit (loss) [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] 93 [[Image Removed]] [[Image Removed]] 92 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Equity in net earnings of affiliates [[Image Removed]] 47 [[Image Removed]] 57 [[Image Removed]] 21 [[Image Removed]] (104 ) [[Image Removed]] 21 Interest expense [[Image Removed]] [[Image Removed]] (10 ) [[Image Removed]] (62 ) [[Image Removed]] [[Image Removed]] (72 ) Interest income [[Image Removed]] [[Image Removed]] [[Image Removed]] 7 [[Image Removed]] [[Image Removed]] 7 Other income (expense), net [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] 27 [[Image Removed]] [[Image Removed]] 26 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 45 47 86 (104 ) 74 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Income tax provision [[Image Removed]] [[Image Removed]] [[Image Removed]] (26 ) [[Image Removed]] [[Image Removed]] (26 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 45 47 60 (104 ) 48 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] (3 ) [[Image Removed]] [[Image Removed]] (3 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations [[Image Removed]] 45 [[Image Removed]] 47 [[Image Removed]] 57 [[Image Removed]] (104 ) [[Image Removed]] 45 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] 45 [[Image Removed]] 47 [[Image Removed]] 57 [[Image Removed]] (104 ) [[Image Removed]] 45 [[Image Removed]] 41 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING STATEMENT OF OPERATIONS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] For the Three Months Ended September 30, 2004 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Guarantor Issuer Non-Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net sales [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,265 [[Image Removed]] [[Image Removed]] 1,265 Cost of sales [[Image Removed]] [[Image Removed]] [[Image Removed]] (1,005 ) [[Image Removed]] [[Image Removed]] (1,005 ) Selling, general and administrative expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (153 ) [[Image Removed]] [[Image Removed]] (153 ) Research and development expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (23 ) [[Image Removed]] [[Image Removed]] (23 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Restructuring, impairment and other special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] (58 ) [[Image Removed]] [[Image Removed]] (58 ) Foreign exchange gain (loss), net [[Image Removed]] [[Image Removed]] [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] (2 ) Gain (loss) on disposition of assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Operating profit [[Image Removed]] [[Image Removed]] [[Image Removed]] 25 [[Image Removed]] [[Image Removed]] 25 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Equity in net earnings of affiliates [[Image Removed]] (31 ) [[Image Removed]] (29 ) [[Image Removed]] 17 [[Image Removed]] 60 [[Image Removed]] 17 Interest expense [[Image Removed]] (40 ) [[Image Removed]] (2 ) [[Image Removed]] (57 ) [[Image Removed]] 1 [[Image Removed]] (98 ) Interest income [[Image Removed]] [[Image Removed]] [[Image Removed]] 9 [[Image Removed]] (1 ) [[Image Removed]] 8 Other income (expense), net [[Image Removed]] [[Image Removed]] [[Image Removed]] 17 [[Image Removed]] [[Image Removed]] 17 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests (71 ) (31 ) 11 60 (31 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Income tax provision [[Image Removed]] [[Image Removed]] [[Image Removed]] (48 ) [[Image Removed]] [[Image Removed]] (48 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests (71 ) (31 ) (37 ) 60 (79 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] 8 [[Image Removed]] [[Image Removed]] 8 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earning (loss) from continuing operations [[Image Removed]] (71 ) [[Image Removed]] (31 ) [[Image Removed]] (29 ) [[Image Removed]] 60 [[Image Removed]] (71 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] (71 ) [[Image Removed]] (31 ) [[Image Removed]] (29 ) [[Image Removed]] 60 [[Image Removed]] (71 ) [[Image Removed]] 42 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING STATEMENT OF OPERATIONS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] For the Nine Months Ended September 30, 2005 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Guarantor Issuer Non-Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net sales [[Image Removed]] [[Image Removed]] [[Image Removed]] 4,562 [[Image Removed]] [[Image Removed]] 4,562 Cost of sales [[Image Removed]] [[Image Removed]] [[Image Removed]] (3,553 ) [[Image Removed]] [[Image Removed]] (3,553 ) Selling, general and administrative expenses [[Image Removed]] (6 ) [[Image Removed]] [[Image Removed]] (435 ) [[Image Removed]] [[Image Removed]] (441 ) Research and development expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (68 ) [[Image Removed]] [[Image Removed]] (68 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] [[Image Removed]] 4 [[Image Removed]] [[Image Removed]] 4 Restructuring, impairment and other special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] (93 ) [[Image Removed]] [[Image Removed]] (93 ) Gain (loss) on disposition of assets, net [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Operating profit [[Image Removed]] (6 ) [[Image Removed]] [[Image Removed]] 416 [[Image Removed]] [[Image Removed]] 410 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Equity in net earnings of affiliates [[Image Removed]] 103 [[Image Removed]] 152 [[Image Removed]] 48 [[Image Removed]] (255 ) [[Image Removed]] 48 Interest expense [[Image Removed]] [[Image Removed]] (55 ) [[Image Removed]] (261 ) [[Image Removed]] [[Image Removed]] (316 ) Interest income [[Image Removed]] 6 [[Image Removed]] [[Image Removed]] 25 [[Image Removed]] [[Image Removed]] 31 Other income (expense), net [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] 48 [[Image Removed]] [[Image Removed]] 47 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 102 97 276 (255 ) 220 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Income tax provision [[Image Removed]] [[Image Removed]] 6 [[Image Removed]] (83 ) [[Image Removed]] [[Image Removed]] (77 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 102 103 193 (255 ) 143 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] (41 ) [[Image Removed]] [[Image Removed]] (41 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations [[Image Removed]] 102 [[Image Removed]] 103 [[Image Removed]] 152 [[Image Removed]] (255 ) [[Image Removed]] 102 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] 102 [[Image Removed]] 103 [[Image Removed]] 152 [[Image Removed]] (255 ) [[Image Removed]] 102 [[Image Removed]] 43 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING STATEMENT OF OPERATIONS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] For the Six Months Ended September 30, 2004 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Guarantor Issuer Non-Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net sales [[Image Removed]] [[Image Removed]] [[Image Removed]] 2,494 [[Image Removed]] [[Image Removed]] 2,494 Cost of sales [[Image Removed]] [[Image Removed]] [[Image Removed]] (2,063 ) [[Image Removed]] [[Image Removed]] (2,063 ) Selling, general and administrative expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (278 ) [[Image Removed]] [[Image Removed]] (278 ) Research and development expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (45 ) [[Image Removed]] [[Image Removed]] (45 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 1 Restructuring, impairment and other special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] (59 ) [[Image Removed]] [[Image Removed]] (59 ) Foreign exchange gain (loss), net [[Image Removed]] [[Image Removed]] [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] (2 ) Gain (loss) on disposition of assets, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Operating profit [[Image Removed]] [[Image Removed]] [[Image Removed]] 50 [[Image Removed]] [[Image Removed]] 50 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Equity in net earnings of affiliates [[Image Removed]] (147 ) [[Image Removed]] (29 ) [[Image Removed]] 35 [[Image Removed]] 176 [[Image Removed]] 35 Interest expense [[Image Removed]] (46 ) [[Image Removed]] (2 ) [[Image Removed]] (181 ) [[Image Removed]] 1 [[Image Removed]] (228 ) Interest income [[Image Removed]] [[Image Removed]] [[Image Removed]] 16 [[Image Removed]] (1 ) [[Image Removed]] 15 Other income (expense), net [[Image Removed]] (3 ) [[Image Removed]] [[Image Removed]] (4 ) [[Image Removed]] [[Image Removed]] (7 ) Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests (196 ) (31 ) (84 ) 176 (135 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Income tax provision [[Image Removed]] [[Image Removed]] [[Image Removed]] (58 ) [[Image Removed]] [[Image Removed]] (58 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests (196 ) (31 ) (142 ) 176 (193 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations [[Image Removed]] (196 ) [[Image Removed]] (31 ) [[Image Removed]] (144 ) [[Image Removed]] 176 [[Image Removed]] (195 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] (196 ) [[Image Removed]] (31 ) [[Image Removed]] (145 ) [[Image Removed]] 176 [[Image Removed]] (196 ) [[Image Removed]] 44 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING STATEMENT OF OPERATIONS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Predecessor [[Image Removed]] For the Three Months Ended, March 31, 2004 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Guarantor Issuer Non-Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net sales [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,243 [[Image Removed]] [[Image Removed]] 1,243 Cost of sales [[Image Removed]] [[Image Removed]] [[Image Removed]] (1,002 ) [[Image Removed]] [[Image Removed]] (1,002 ) Selling, general and administrative expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (137 ) [[Image Removed]] [[Image Removed]] (137 ) Research and development expenses [[Image Removed]] [[Image Removed]] [[Image Removed]] (23 ) [[Image Removed]] [[Image Removed]] (23 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Restructuring, impairment and other special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] (28 ) [[Image Removed]] [[Image Removed]] (28 ) Gain (loss) on disposition of assets [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Operating profit [[Image Removed]] [[Image Removed]] [[Image Removed]] 52 [[Image Removed]] [[Image Removed]] 52 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Equity in net earnings of affiliates [[Image Removed]] [[Image Removed]] [[Image Removed]] 12 [[Image Removed]] [[Image Removed]] 12 Interest expense [[Image Removed]] [[Image Removed]] [[Image Removed]] (6 ) [[Image Removed]] [[Image Removed]] (6 ) Interest income [[Image Removed]] [[Image Removed]] [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 5 Other income (expense), net [[Image Removed]] [[Image Removed]] [[Image Removed]] 9 [[Image Removed]] [[Image Removed]] 9 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] 72 [[Image Removed]] [[Image Removed]] 72 and minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Income tax provision [[Image Removed]] [[Image Removed]] [[Image Removed]] (17 ) [[Image Removed]] [[Image Removed]] (17 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] 55 [[Image Removed]] [[Image Removed]] 55 minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 55 [[Image Removed]] [[Image Removed]] 55 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 23 [[Image Removed]] [[Image Removed]] 23 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] 78 [[Image Removed]] [[Image Removed]] 78 [[Image Removed]] 45 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING BALANCE SHEET INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] As of September 30, 2005 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] Non- [[Image Removed]] [[Image Removed]] Guarantor Issuer Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) ASSETS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Current assets: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Cash and cash equivalents [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 400 [[Image Removed]] [[Image Removed]] 401 Receivables, net: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Trade receivables, net third party and affiliates [[Image Removed]] [[Image Removed]] [[Image Removed]] 947 [[Image Removed]] [[Image Removed]] 947 Other receivables [[Image Removed]] [[Image Removed]] [[Image Removed]] 522 [[Image Removed]] (3 ) [[Image Removed]] 519 Inventories [[Image Removed]] [[Image Removed]] [[Image Removed]] 625 [[Image Removed]] [[Image Removed]] 625 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 69 [[Image Removed]] [[Image Removed]] 69 Other assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 47 [[Image Removed]] [[Image Removed]] 47 Assets of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Total current assets [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 2,612 [[Image Removed]] (3 ) [[Image Removed]] 2,610 Investments [[Image Removed]] 63 [[Image Removed]] 418 [[Image Removed]] 551 [[Image Removed]] (481 ) [[Image Removed]] 551 Property, plant and equipment, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,982 [[Image Removed]] [[Image Removed]] 1,982 Deferred income taxes [[Image Removed]] [[Image Removed]] 6 [[Image Removed]] 29 [[Image Removed]] [[Image Removed]] 35 Other assets [[Image Removed]] [[Image Removed]] 9 [[Image Removed]] 718 [[Image Removed]] [[Image Removed]] 727 Goodwill [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,042 [[Image Removed]] [[Image Removed]] 1,042 Intangible assets, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 393 [[Image Removed]] [[Image Removed]] 393 Total assets [[Image Removed]] 64 [[Image Removed]] 433 [[Image Removed]] 7,327 [[Image Removed]] (484 ) [[Image Removed]] 7,340 LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Current liabilities: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Short-term borrowings and current installments of [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] long-term debt third party and affiliates 181 181 Accounts payable and accrued liabilities: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Trade payables third party and affiliates [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 696 [[Image Removed]] [[Image Removed]] 698 Other current liabilities [[Image Removed]] 3 [[Image Removed]] [[Image Removed]] 813 [[Image Removed]] (3 ) [[Image Removed]] 813 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 13 [[Image Removed]] [[Image Removed]] 13 Income taxes payable [[Image Removed]] [[Image Removed]] [[Image Removed]] 224 [[Image Removed]] [[Image Removed]] 224 Liabilities of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 3 [[Image Removed]] [[Image Removed]] 3 Total current liabilities [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 1,930 [[Image Removed]] (3 ) [[Image Removed]] 1,932 Long-term debt [[Image Removed]] [[Image Removed]] 370 [[Image Removed]] 2,945 [[Image Removed]] [[Image Removed]] 3,315 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 225 [[Image Removed]] [[Image Removed]] 225 Benefit obligations [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,154 [[Image Removed]] [[Image Removed]] 1,154 Other liabilities [[Image Removed]] [[Image Removed]] [[Image Removed]] 506 [[Image Removed]] [[Image Removed]] 506 Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] 149 [[Image Removed]] [[Image Removed]] 149 Commitments and contingencies [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Shareholders equity (deficit) [[Image Removed]] 59 [[Image Removed]] 63 [[Image Removed]] 418 [[Image Removed]] (481 ) [[Image Removed]] 59 Total liabilities and shareholders' equity (deficit) [[Image Removed]] 64 [[Image Removed]] 433 [[Image Removed]] 7,327 [[Image Removed]] (484 ) [[Image Removed]] 7,340 [[Image Removed]] 46 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING BALANCE SHEET INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] As of December 31, 2004 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] Non- [[Image Removed]] [[Image Removed]] Guarantor Issuer Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) ASSETS [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Current assets: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Cash and cash equivalents [[Image Removed]] [[Image Removed]] [[Image Removed]] 838 [[Image Removed]] [[Image Removed]] 838 Receivables, net: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Trade receivables, net third party and affiliates [[Image Removed]] [[Image Removed]] [[Image Removed]] 866 [[Image Removed]] [[Image Removed]] 866 Other receivables [[Image Removed]] [[Image Removed]] [[Image Removed]] 678 [[Image Removed]] (8 ) [[Image Removed]] 670 Inventories [[Image Removed]] [[Image Removed]] [[Image Removed]] 618 [[Image Removed]] [[Image Removed]] 618 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 71 [[Image Removed]] [[Image Removed]] 71 Other assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 86 [[Image Removed]] [[Image Removed]] 86 Assets of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Total current assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 3,159 [[Image Removed]] (8 ) [[Image Removed]] 3,151 Investments [[Image Removed]] [[Image Removed]] 406 [[Image Removed]] 600 [[Image Removed]] (406 ) [[Image Removed]] 600 Property, plant and equipment, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,702 [[Image Removed]] [[Image Removed]] 1,702 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 54 [[Image Removed]] [[Image Removed]] 54 Other assets [[Image Removed]] 7 [[Image Removed]] 12 [[Image Removed]] 739 [[Image Removed]] (2 ) [[Image Removed]] 756 Goodwill [[Image Removed]] [[Image Removed]] [[Image Removed]] 747 [[Image Removed]] [[Image Removed]] 747 Intangible assets, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 400 [[Image Removed]] [[Image Removed]] 400 Total assets [[Image Removed]] 7 [[Image Removed]] 418 [[Image Removed]] 7,401 [[Image Removed]] (416 ) [[Image Removed]] 7,410 LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Current liabilities: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Short-term borrowings and current installments of [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] long-term debt third party and affiliates 1 144 (1 ) 144 Accounts payable and accrued liabilities: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Trade payables third party and affiliates [[Image Removed]] [[Image Removed]] [[Image Removed]] 722 [[Image Removed]] [[Image Removed]] 722 Other current liabilities [[Image Removed]] 7 [[Image Removed]] [[Image Removed]] 888 [[Image Removed]] (7 ) [[Image Removed]] 888 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 20 [[Image Removed]] [[Image Removed]] 20 Income taxes payable [[Image Removed]] [[Image Removed]] [[Image Removed]] 214 [[Image Removed]] [[Image Removed]] 214 Liabilities of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 7 [[Image Removed]] [[Image Removed]] 7 Total current liabilities [[Image Removed]] 8 [[Image Removed]] [[Image Removed]] 1,995 [[Image Removed]] (8 ) [[Image Removed]] 1,995 Long-term debt [[Image Removed]] [[Image Removed]] 527 [[Image Removed]] 2,716 [[Image Removed]] [[Image Removed]] 3,243 Deferred income taxes [[Image Removed]] [[Image Removed]] [[Image Removed]] 256 [[Image Removed]] [[Image Removed]] 256 Benefit obligations [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,000 [[Image Removed]] [[Image Removed]] 1,000 Other liabilities [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 510 [[Image Removed]] (2 ) [[Image Removed]] 510 Share of subsidiary losses [[Image Removed]] 109 [[Image Removed]] [[Image Removed]] [[Image Removed]] (109 ) [[Image Removed]] Minority interests [[Image Removed]] [[Image Removed]] [[Image Removed]] 518 [[Image Removed]] [[Image Removed]] 518 Commitments and contingencies [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Shareholders equity (deficit) [[Image Removed]] (112 ) [[Image Removed]] (109 ) [[Image Removed]] 406 [[Image Removed]] (297 ) [[Image Removed]] (112 ) Total liabilities and shareholders' equity (deficit) [[Image Removed]] 7 [[Image Removed]] 418 [[Image Removed]] 7,401 [[Image Removed]] (416 ) [[Image Removed]] 7,410 [[Image Removed]] 47 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] For the Nine Months Ended September 30, 2005 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] Non- [[Image Removed]] [[Image Removed]] Guarantor Issuer Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net cash provided by (used in) operating activities [[Image Removed]] 8 [[Image Removed]] 1 [[Image Removed]] 507 [[Image Removed]] [[Image Removed]] 516 Investing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Capital expenditures on property, plant and equipment [[Image Removed]] [[Image Removed]] [[Image Removed]] (132 ) [[Image Removed]] [[Image Removed]] (132 ) Investments in Subsidiaries, net [[Image Removed]] (189 ) [[Image Removed]] 18 [[Image Removed]] [[Image Removed]] 171 [[Image Removed]] Acquisition of CAG shares [[Image Removed]] [[Image Removed]] [[Image Removed]] (397 ) [[Image Removed]] [[Image Removed]] (397 ) Fees associated with the acquisitions [[Image Removed]] [[Image Removed]] [[Image Removed]] (27 ) [[Image Removed]] [[Image Removed]] (27 ) Acquisition of Vinamul [[Image Removed]] [[Image Removed]] [[Image Removed]] (208 ) [[Image Removed]] [[Image Removed]] (208 ) Acquisition of Acetex, net of cash acquired [[Image Removed]] [[Image Removed]] [[Image Removed]] (216 ) [[Image Removed]] [[Image Removed]] (216 ) Proceeds from sale of assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 40 [[Image Removed]] [[Image Removed]] 40 Net proceeds from disposal of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 75 [[Image Removed]] [[Image Removed]] 75 Proceeds from sale of marketable securities [[Image Removed]] [[Image Removed]] [[Image Removed]] 175 [[Image Removed]] [[Image Removed]] 175 Purchases of marketable securities [[Image Removed]] [[Image Removed]] [[Image Removed]] (96 ) [[Image Removed]] [[Image Removed]] (96 ) Other, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 5 Net cash provided by (used in) investing activities [[Image Removed]] (189 ) [[Image Removed]] 18 [[Image Removed]] (781 ) [[Image Removed]] 171 [[Image Removed]] (781 ) Financing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Redemption of senior subordinated notes, including related [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] premium (572 ) (572 ) Repayment of floating rate term loan, including related [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] premium (354 ) (354 ) Borrowings under term loan facility [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,135 [[Image Removed]] [[Image Removed]] 1,135 Proceeds from issuance of common stock, net [[Image Removed]] 752 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 752 Proceeds from issuance of preferred stock, net [[Image Removed]] 233 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 233 Proceeds from issuance of discounted common stock [[Image Removed]] 12 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 12 Contribution from parent [[Image Removed]] [[Image Removed]] 779 [[Image Removed]] 572 [[Image Removed]] (1,351 ) [[Image Removed]] Redemption of senior discount notes, including related [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] premium (207 ) (207 ) Redemption of Acetex bonds [[Image Removed]] [[Image Removed]] [[Image Removed]] (280 ) [[Image Removed]] [[Image Removed]] (280 ) Distribution to Series B Shareholders/parent [[Image Removed]] (804 ) [[Image Removed]] (590 ) [[Image Removed]] (590 ) [[Image Removed]] 1,180 [[Image Removed]] (804 ) Short-term borrowing (repayments), net [[Image Removed]] [[Image Removed]] [[Image Removed]] 18 [[Image Removed]] [[Image Removed]] 18 Proceeds (payments) from other long-term debt, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 8 [[Image Removed]] [[Image Removed]] 8 Fees associated with financings [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] (7 ) [[Image Removed]] [[Image Removed]] (8 ) Preferred dividends [[Image Removed]] (5 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (5 ) Common dividends [[Image Removed]] (6 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (6 ) Net cash provided by (used in) financing activities [[Image Removed]] 182 [[Image Removed]] (19 ) [[Image Removed]] (70 ) [[Image Removed]] (171 ) [[Image Removed]] (78 ) Exchange rate effects on cash [[Image Removed]] [[Image Removed]] [[Image Removed]] (94 ) [[Image Removed]] [[Image Removed]] (94 ) Net increase in cash and cash equivalents [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] (438 ) [[Image Removed]] [[Image Removed]] (437 ) Cash and cash equivalents at beginning of period [[Image Removed]] [[Image Removed]] [[Image Removed]] 838 [[Image Removed]] [[Image Removed]] 838 Cash and cash equivalents at end of period [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 400 [[Image Removed]] [[Image Removed]] 401 Net cash provided by (used in) discontinued operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Operating activities [[Image Removed]] [[Image Removed]] [[Image Removed]] (75 ) [[Image Removed]] [[Image Removed]] (75 ) Investing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] 75 [[Image Removed]] [[Image Removed]] 75 Net cash provided by (used in) discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 48 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] For the Six Months Ended September 30, 2004 [[Image Removed]] Parent [[Image Removed]] [[Image Removed]] Non- [[Image Removed]] [[Image Removed]] Guarantor Issuer Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net cash provided by (used in) operating activities [[Image Removed]] (9 ) [[Image Removed]] [[Image Removed]] 118 [[Image Removed]] [[Image Removed]] 109 Investing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Capital expenditures on property, plant and equipment [[Image Removed]] [[Image Removed]] [[Image Removed]] (106 ) [[Image Removed]] [[Image Removed]] (106 ) Acquisition of CAG, net of cash acquired [[Image Removed]] [[Image Removed]] [[Image Removed]] (1,531 ) [[Image Removed]] [[Image Removed]] (1,531 ) Fees associated with acquisitions [[Image Removed]] [[Image Removed]] [[Image Removed]] (69 ) [[Image Removed]] [[Image Removed]] (69 ) Proceeds on sale of assets [[Image Removed]] [[Image Removed]] [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 5 Proceeds from sale of marketable securities [[Image Removed]] [[Image Removed]] [[Image Removed]] 85 [[Image Removed]] [[Image Removed]] 85 Purchases of marketable securities [[Image Removed]] [[Image Removed]] [[Image Removed]] (107 ) [[Image Removed]] [[Image Removed]] (107 ) Other, net [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Net cash provided by (used in) investing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] (1,724 ) [[Image Removed]] [[Image Removed]] (1,724 ) Financing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Initial capitalization [[Image Removed]] [[Image Removed]] [[Image Removed]] 641 * [[Image Removed]] [[Image Removed]] 641 Issuance of mandatory redeemable preferred stock [[Image Removed]] [[Image Removed]] [[Image Removed]] 200 * [[Image Removed]] [[Image Removed]] 200 Repayment of manditorily redeemable preferred stock [[Image Removed]] (221 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (221 ) Borrowings under bridge loans [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,565 [[Image Removed]] [[Image Removed]] 1,565 Repayments under bridge loans [[Image Removed]] [[Image Removed]] [[Image Removed]] (1,565 ) [[Image Removed]] [[Image Removed]] (1,565 ) Proceeds from issuance of senior subordinated notes [[Image Removed]] [[Image Removed]] [[Image Removed]] 1,475 [[Image Removed]] [[Image Removed]] 1,475 Proceeds from issuance of Senior discount notes [[Image Removed]] [[Image Removed]] 513 [[Image Removed]] [[Image Removed]] [[Image Removed]] 513 Proceeds from floating rate term loan [[Image Removed]] [[Image Removed]] [[Image Removed]] 350 [[Image Removed]] [[Image Removed]] 350 Borrowings under term loan facility [[Image Removed]] [[Image Removed]] [[Image Removed]] 389 [[Image Removed]] [[Image Removed]] 389 Distribution to stockholders [[Image Removed]] (500 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (500 ) Short term borrowings (repayments), net [[Image Removed]] [[Image Removed]] [[Image Removed]] 17 [[Image Removed]] [[Image Removed]] 17 Proceeds (payments) from other long term debt, net [[Image Removed]] [[Image Removed]] [[Image Removed]] (235 ) [[Image Removed]] [[Image Removed]] (235 ) Distribution from subsidiary [[Image Removed]] 521 [[Image Removed]] (500 ) [[Image Removed]] (21 ) [[Image Removed]] [[Image Removed]] Issuance of preferred stock by consolidated subsidiary [[Image Removed]] [[Image Removed]] [[Image Removed]] 17 [[Image Removed]] [[Image Removed]] 17 Fees associated with financings [[Image Removed]] (18 ) [[Image Removed]] (13 ) [[Image Removed]] (166 ) [[Image Removed]] [[Image Removed]] (197 ) Loan to Shareholder [[Image Removed]] 227 [[Image Removed]] [[Image Removed]] (227 ) [[Image Removed]] [[Image Removed]] Dividend payments [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Net cash provided by (used in) financing activities [[Image Removed]] 9 [[Image Removed]] [[Image Removed]] 2,439 [[Image Removed]] [[Image Removed]] 2,448 Exchange rate effects on cash [[Image Removed]] [[Image Removed]] [[Image Removed]] (14 ) [[Image Removed]] [[Image Removed]] (14 ) Net increase in cash and cash equivalents [[Image Removed]] [[Image Removed]] [[Image Removed]] 819 [[Image Removed]] [[Image Removed]] 819 Cash and cash equivalents at beginning of period [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Cash and cash equivalents at end of period [[Image Removed]] [[Image Removed]] [[Image Removed]] 819 [[Image Removed]] [[Image Removed]] 819 Net cash provided by (used in) discontinued operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Operating activities [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 1 Investing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Net cash provided by (used in) discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] * Amounts included in Non-Guarantors column represent proceeds received directly by the Non-Guarantors, on behalf of the Parent Guarantor. The legal issuer of the mandatorily redeemable preferred stock is the Parent Guarantor. 49 -------------------------------------------------------------------------------- UNAUDITED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Predecessor [[Image Removed]] For the Three Months Ended March 31, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] Non- [[Image Removed]] [[Image Removed]] Parent Issuer Guarantors Eliminations Consolidated [[Image Removed]] (in $ millions) Net cash provided by (used in) operating activities [[Image Removed]] [[Image Removed]] [[Image Removed]] (107 ) [[Image Removed]] [[Image Removed]] (107 ) Investing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Capital expenditures on property, plant and equipment [[Image Removed]] [[Image Removed]] [[Image Removed]] (44 ) [[Image Removed]] [[Image Removed]] (44 ) Net proceeds from disposal of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 139 [[Image Removed]] [[Image Removed]] 139 Proceeds from sale of marketable securities [[Image Removed]] [[Image Removed]] [[Image Removed]] 42 [[Image Removed]] [[Image Removed]] 42 Purchases of marketable securities [[Image Removed]] [[Image Removed]] [[Image Removed]] (42 ) [[Image Removed]] [[Image Removed]] (42 ) Other, net [[Image Removed]] [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] [[Image Removed]] 1 Net cash provided by investing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] 96 [[Image Removed]] [[Image Removed]] 96 Financing activities from continuing operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Short-term borrowings (repayments), net [[Image Removed]] [[Image Removed]] [[Image Removed]] (16 ) [[Image Removed]] [[Image Removed]] (16 ) Proceeds (payments) of other long-term debt, net [[Image Removed]] [[Image Removed]] [[Image Removed]] (27 ) [[Image Removed]] [[Image Removed]] (27 ) Net cash provided by (used in) financing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] (43 ) [[Image Removed]] [[Image Removed]] (43 ) Exchange rate effects on cash [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Net decrease in cash and cash equivalents [[Image Removed]] [[Image Removed]] [[Image Removed]] (55 ) [[Image Removed]] [[Image Removed]] (55 ) Cash and cash equivalents at beginning of period [[Image Removed]] [[Image Removed]] [[Image Removed]] 148 [[Image Removed]] [[Image Removed]] 148 Cash and cash equivalents at end of period [[Image Removed]] [[Image Removed]] [[Image Removed]] 93 [[Image Removed]] [[Image Removed]] 93 Net cash provided by (used in) discontinued operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Operating activities [[Image Removed]] [[Image Removed]] [[Image Removed]] (139 ) [[Image Removed]] [[Image Removed]] (139 ) Investing activities [[Image Removed]] [[Image Removed]] [[Image Removed]] 139 [[Image Removed]] [[Image Removed]] 139 Net cash provided by (used in) discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 50 -------------------------------------------------------------------------------- 19. Earnings (Loss) Per Share [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Three Months Ended September 30, 2005 [[Image Removed]] Three Months Ended September 30, 2004 Net Net [[Image Removed]] Continuing [[Image Removed]] Discontinued [[Image Removed]] earnings [[Image Removed]] Continuing [[Image Removed]] Discontinued [[Image Removed]] earnings Operations Operations (loss) Operations Operations (loss) [[Image Removed]] (in $ millions, except for share and per share data) Net earnings (loss) [[Image Removed]] 45 [[Image Removed]] [[Image Removed]] 45 [[Image Removed]] (71 ) [[Image Removed]] [[Image Removed]] (71 ) Less: cumulative undeclared and declared preferred stock dividends [[Image Removed]] (3 ) [[Image Removed]] [[Image Removed]] (3 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) available to common stockholders [[Image Removed]] 42 [[Image Removed]] [[Image Removed]] 42 [[Image Removed]] (71 ) [[Image Removed]] [[Image Removed]] (71 ) Basic earnings (loss) per common share [[Image Removed]] 0.26 [[Image Removed]] [[Image Removed]] 0.26 [[Image Removed]] (0.71 ) [[Image Removed]] [[Image Removed]] (0.71 ) Diluted earnings (loss) per common share [[Image Removed]] 0.26 [[Image Removed]] [[Image Removed]] 0.26 [[Image Removed]] (0.71 ) [[Image Removed]] [[Image Removed]] (0.71 ) Weighted-average shares basic [[Image Removed]] 158,546,594 [[Image Removed]] [[Image Removed]] 158,546,594 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 Dilutive stock options [[Image Removed]] 1,377,185 [[Image Removed]] [[Image Removed]] 1,377,185 [[Image Removed]] [[Image Removed]] [[Image Removed]] Assumed conversion of preferred stock [[Image Removed]] 12,006,491 [[Image Removed]] [[Image Removed]] 12,006,491 [[Image Removed]] [[Image Removed]] [[Image Removed]] Weighted-average shares diluted [[Image Removed]] 171,930,270 [[Image Removed]] [[Image Removed]] 171,930,270 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Nine Months Ended September 30, 2005 [[Image Removed]] Six Months Ended September 30, 2004 Net [[Image Removed]] Continuing [[Image Removed]] Discontinued [[Image Removed]] earnings [[Image Removed]] Continuing [[Image Removed]] Discontinued [[Image Removed]] Net Operations Operations (loss) Operations Operations earnings (loss) [[Image Removed]] (in $ millions, except for share and per share data) Net earnings (loss) [[Image Removed]] 102 [[Image Removed]] [[Image Removed]] 102 [[Image Removed]] (195 ) [[Image Removed]] (1 ) [[Image Removed]] (196 ) Less: cumulative undeclared and declared preferred stock dividends [[Image Removed]] (7 ) [[Image Removed]] [[Image Removed]] (7 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) available to common shareholders [[Image Removed]] 95 [[Image Removed]] [[Image Removed]] 95 [[Image Removed]] (195 ) [[Image Removed]] (1 ) [[Image Removed]] (196 ) Basic earnings (loss) per common share [[Image Removed]] 0.62 [[Image Removed]] [[Image Removed]] 0.62 [[Image Removed]] (1.96 ) [[Image Removed]] (0.01 ) [[Image Removed]] (1.97 ) Diluted earnings (loss) per common share [[Image Removed]] 0.62 [[Image Removed]] [[Image Removed]] 0.62 [[Image Removed]] (1.96 ) [[Image Removed]] (0.01 ) [[Image Removed]] (1.97 ) Weighted-average shares basic [[Image Removed]] 153,001,360 [[Image Removed]] [[Image Removed]] 153,001,360 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 Dilutive stock options [[Image Removed]] 535,442 [[Image Removed]] [[Image Removed]] 535,442 [[Image Removed]] [[Image Removed]] [[Image Removed]] Assumed conversion of preferred stock [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Weighted-average shares diluted [[Image Removed]] 153,536,802 [[Image Removed]] [[Image Removed]] 153,536,802 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 [[Image Removed]] 99,377,884 [[Image Removed]] 51 -------------------------------------------------------------------------------- [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Predecessor [[Image Removed]] Three Months Ended March 31, 2004 [[Image Removed]] Continuing [[Image Removed]] Discontinued [[Image Removed]] Net earnings Operations Operations (loss) [[Image Removed]] (in $ millions, except for share and per share data) Net earnings (loss) [[Image Removed]] 55 [[Image Removed]] 23 [[Image Removed]] 78 Less: cumulative undeclared and declared preferred stock dividends [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) available to common shareholders [[Image Removed]] 55 [[Image Removed]] 23 [[Image Removed]] 78 Basic earnings (loss) per common share [[Image Removed]] 1.12 [[Image Removed]] 0.46 [[Image Removed]] 1.58 Diluted earnings (loss) per common share [[Image Removed]] 1.11 [[Image Removed]] 0.46 [[Image Removed]] 1.57 Weighted-average shares basic [[Image Removed]] 49,321,468 [[Image Removed]] 49,321,468 [[Image Removed]] 49,321,468 Dilutive stock options [[Image Removed]] 390,953 [[Image Removed]] 390,953 [[Image Removed]] 390,953 Weighted-average shares diluted [[Image Removed]] 49,712,421 [[Image Removed]] 49,712,421 [[Image Removed]] 49,712,421 [[Image Removed]] Basic earnings (loss) per common share is based on the net earnings available to common shareholders divided by the weighted average number of common shares outstanding during the period. Diluted earnings per common share is based on the net earnings available to common shareholders divided by the weighted average number of common shares outstanding during the period adjusted to give effect to common stock equivalents, if dilutive. The following securities were not included in the computation of diluted net earnings per share as their effect would have been anti-dilutive: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Three Months Nine Months [[Image Removed]] Ended [[Image Removed]] Ended September 30, September 30, 2005 2005 Options to purchase common stock [[Image Removed]] [[Image Removed]] 911,000 Convertible preferred stock [[Image Removed]] [[Image Removed]] 10,863,016 [[Image Removed]] [[Image Removed]] 11,774,016 [[Image Removed]] Prior to the completion of the initial public offering of Celanese Corporation Series A common stock in January 2005, the Company effected a 152.772947 for 1 stock split of outstanding shares of common stock (see Note 11). Accordingly, basic and diluted shares for the three months ended March 31, 2005 have been calculated based on the weighted average shares outstanding, adjusted for the stock split. Earnings per common share for the Predecessor periods has been calculated by dividing net earnings available to common shareholders by the historical weighted average shares outstanding of the Predecessor. As the capital structure of the Predecessor and Successor are different, the reported earnings (loss) per common share are not comparable. 52 -------------------------------------------------------------------------------- 20. Subsequent Events On October 5, 2005, the Company announced that it has signed a letter of intent to divest its COC business to a venture between Daicel Chemical Industries Ltd. and the Company's Polyplastics Co. Ltd. venture. On October 5, 2005, the Company declared a cash dividend on its 4.25% convertible perpetual preferred stock amounting to $3 million and a cash dividend of $0.04 per share on its Series A common stock amounting to $6 million. Both cash dividends are for the period August 1, 2005 to October 31, 2005 and were paid on November 1, 2005 to holders of record as of October 15, 2005. On October 7, 2005, the Company announced the sale of its Acetate manufacturing facility in Rock Hill, South Carolina to Greens of Rock Hill LLC. Production at the facility was phased out earlier in 2005 as part of its previously announced plans to consolidate its acetate flake manufacturing operations. The Company is assessing the accounting impact of the transaction. 53 -------------------------------------------------------------------------------- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations You should read the following discussion and analysis of the financial condition and the results of operations of Celanese Corporation and its subsidiaries (collectively, the Company or the Successor) together with the Unaudited Interim Consolidated Financial Statements and the notes to those financial statements, which were prepared in accordance with U.S. GAAP and with the Celanese Corporation and its subsidiaries consolidated financial statements for the nine months ended December 31, 2004, as filed with the Securities Exchange Commission on Form 10-K. The following discussion and analysis of financial condition and results of operations cover periods prior and subsequent to the acquisition of Celanese AG and its subsidiaries (collectively CAG or the Predecessor). Accordingly, the discussion and analysis of historical periods prior to the acquisition do not reflect the significant impact that the acquisition of CAG has had and will have on the Successor, including increased leverage and liquidity requirements as well as purchase accounting adjustments. In addition, investors are cautioned that the forward-looking statements contained in this section involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See Forward-Looking Information located at the end of this section. Reconciliation of Non-U.S. GAAP Measures: Management believes that using non-U.S. GAAP financial measures to supplement U.S. GAAP results is useful to investors because such use provides a more complete understanding of the factors and trends affecting the business other than disclosing U.S. GAAP results alone. In this regard, we disclose net debt, which is a non-U.S. GAAP financial measure. Net debt is defined as total debt less cash and cash equivalents. Management uses net debt to evaluate the Companys capital structure. Net debt is not a substitute for any U.S. GAAP financial measure. In addition, the calculation of net debt contained in this report may not be consistent with that of other companies. The most directly comparable financial measure presented in accordance with U.S. GAAP in our financial statements for net debt is total debt. For a reconciliation of net debt and total debt, see Financial Highlights below. Basis of Presentation Impact of the Acquisition of Celanese AG On April 6, 2004, Celanese Europe Holding GmbH & Co. KG (the Purchaser), an indirect wholly owned subsidiary of the Successor, acquired approximately 84% of the Celanese AG ordinary shares, excluding treasury shares (CAG Shares) pursuant to a voluntary tender offer commenced in February 2004. The CAG Shares were acquired at a price of 32.50 per share or an aggregate purchase price of $1,693 million, including direct acquisition costs of approximately $69 million. During the nine months ended September 30, 2005 and December 31, 2004, the Purchaser acquired additional CAG Shares for a purchase price of $397 million and $33 million, respectively. As of September 30, 2005 and December 31, 2004, the Purchaser's ownership percentage was approximately 96% and 84%, respectively. The additional CAG Shares were acquired pursuant to either i) the mandatory offer commenced in September 2004 that will expire on December 1, 2005, unless further extended or ii) the recent purchase of CAG shares as described below. Recent Purchases of CAG Shares In August 2005, the Company acquired approximately 5.9 million, or approximately 12%, of the outstanding CAG Shares from two shareholders of CAG for the aggregate consideration of approximately 302 million ($369 million). In addition, the Company also paid to such shareholders an additional purchase price of approximately 12 million ($15 million) in consideration for the settlement of certain claims and for such shareholders agreeing to, among other things, (1) accept the shareholders' resolutions passed at the extraordinary general meeting of CAG held on July 30 and 31, 2004 and the annual general meeting of CAG held on May 19 and 20, 2005, (2) acknowledge the legal effectiveness of the domination and profit and loss transfer agreement, (3) irrevocably withdraw and 54 -------------------------------------------------------------------------------- abandon all actions, applications and appeals each brought or joined in legal proceedings related to, among other things, challenging the effectiveness of the Domination Agreement and amount of fair cash compensation offered by Purchaser in the mandatory offer required by Section 305(1) of the German Stock Corporation Act, (4) refrain from acquiring any CAG Shares or any other investment in CAG, and (5) refrain from taking any future legal action with respect to shareholder resolutions or corporate actions of CAG. The Company paid the aggregate consideration of 314 million ($384 million) for the additional CAG Shares that were acquired from such shareholders and for the agreements described above using available cash. The Company also announced that it would increase its offer to purchase any remaining outstanding CAG Shares to 51 per share (plus interest on 41.92 per share) for all minority shareholders that would accept the increased offer on or prior to September 29, 2005 and waive their rights to participate in an increase of the offer consideration as a result of the pending award proceedings. In addition, all shareholders who tendered their shares pursuant to the mandatory offer of 41.92 per share commenced in September 2004 and continuing as of the date of this filing, were entitled to claim the difference between the increased offer of 51 per share and the mandatory offer of 41.92 per share. Any shareholder who accepted the increased offer of 51 per share, or claimed the difference between the mandatory offer and the increased offer, was obligated to agree to waive its rights to participate in any possible future increase of the offer consideration as a result of the pending award proceedings. For minority shareholders who did not accept the increased offer on or prior to the September 29, 2005 expiration date, the terms of the original 41.92 per share mandatory offer will continue to apply. The mandatory offer will expire on December 1, 2005, unless further extended. As of November 2, 2005, the Company increased its ownership interest in CAG to approximately 98% as a result of additional shares tendered under the mandatory offer. We accounted for the initial acquisition of CAG using the purchase method of accounting and, accordingly, this resulted in a new basis of accounting. The purchase price was allocated based on the fair value of the underlying assets acquired and liabilities assumed. The assets acquired and liabilities assumed are reflected at fair value for the approximately 84% portion acquired and at CAG historical basis for the remaining approximate 16%. The excess of the total purchase price over the fair value of the net assets acquired at closing was allocated to goodwill, and this indefinite lived asset is subject to an annual impairment review. During the three months ended March 31, 2005, the Company finalized its purchase accounting adjustments for the original acquisition of CAG. (See Notes 2 and 8 to the Unaudited Interim Consolidated Financial Statements). In the nine months ended September 30, 2005, the Company increased goodwill by $15 million as a result of purchase accounting adjustments related to the original acquisition of CAG Shares and to the acquisition of additional CAG shares. Included in this adjustment is a $23 million increase to goodwill, and a corresponding increase to the Company's minority interest liability primarily associated with the organizational restructuring that occurred in October 2004 (see Note 2 to the Unaudited Interim Consolidated Financial Statements). The Company is in the process of determining the fair value of all assets acquired and liabilities assumed for the additional CAG shares acquired. The Company expects to finalize the purchase accounting for this transaction by June 30, 2006. (See Notes 2 and 8 to the Unaudited Interim Consolidated Financial Statements). Impact of the Acquisitions of Vinamul and Acetex In February 2005, the Company acquired Vinamul, the North American and European emulsion polymer business of Imperial Chemical Industries PLC (ICI) for $208 million. The Vinamul product line includes vinyl acetate-ethylene copolymers, vinyl acetate homopolymers and copolymers, and acrylic and vinyl acrylic emulsions. Vinamul operates manufacturing facilities in the United States, Canada, the United Kingdom, and The Netherlands. As part of the agreement, ICI will continue to supply Vinamul with starch, dextrin and other specialty ingredients following the acquisition. The Company will supply ICI with vinyl acetate monomer and polyvinyl alcohols. The supply agreements are for 15 years, and the pricing is based on market and other negotiated terms. The Company 55 -------------------------------------------------------------------------------- primarily financed this acquisition through borrowings of $200 million under the amended and restated senior credit facilities (See Notes 6, 8 and 9 to the Unaudited Interim Consolidated Financial Statements). In September 2005, in connection with the Vinamul transaction, the Company sold its emulsion powders business to ICI for approximately $25 million. The transaction includes a supply agreement whereby the Company will supply product to ICI for a period of up to fifteen years. Net sales and pre-tax earnings for the emulsions powders business for the nine months ended September 30, 2005 were approximately $30 million and $1 million, respectively. In July 2005, the Company acquired Acetex Corporation (Acetex) for $270 million and assumed Acetexs $247 million of net debt, which is net of cash acquired of $54 million. Acetexs operations include an acetyls business with plants in Europe and a North-American specialty polymers and film business. The Company acquired Acetex using primarily existing cash. The Company caused Acetex to exercise its option to redeem its 10 7/8% senior notes due 2009 totaling $265 million. The redemption was funded primarily with cash on hand and occurred on August 19, 2005. The redemption price was $280 million, which represents 105.438% of the outstanding principal amount, plus accrued and unpaid interest to August 19, 2005. On August 25, 2005, the Company repaid the remaining $36 million of assumed debt with available cash. In connection with the acquisitions of Vinamul and Acetex, the Company has preliminarily allocated the purchase price to assets acquired and liabilities assumed primarily based on the historical cost of the business acquired. Included in the liabilities assumed are certain obligations related to the acquired pension and postretirement benefit plans. The excess of the purchase price over the amounts allocated to assets and liabilities for Vinamul and Acetex is included in goodwill, and as of September 30, 2005 is preliminarily estimated to be approximately $27 million and $244 million, respectively. The Company expects to finalize the purchase accounting for Vinamul and Acetex by December 31, 2005 and June 30, 2006, respectively. As of the acquisition dates of Vinamul and Acetex, the Company began formulating plans to exit or restructure certain activities. The Company has not completed these analyses, and as of September 30, 2005, has not recorded any liabilities associated with these activities. As the Company finalizes any plans to exit or restructure activities, it may record additional liabilities for, among other things, severance and severance related costs, and such amounts could be material. Successor Successor Represents the Company's unaudited consolidated financial position as of September 30, 2005 and December 31, 2004 and its unaudited consolidated results of operations for the three months ended September 30, 2005, June 30, 2005, March 31, 2005, September 30, 2004, and June 30, 2004 and for the nine months ended September 30, 2005 and cash flows for the nine months ended September 30, 2005 and for the six months ended September 30, 2004. These consolidated financial statements reflect the application of purchase accounting, described above, relating to the original acquisition of CAG and preliminary purchase price accounting adjustments relating to the acquisitions of Vinamul, Acetex and additional CAG shares acquired during the nine months ended September 30, 2005. Predecessor Predecessor Represents CAG's consolidated results of operations and cash flows for the three months ended March 31, 2004. These consolidated financial statements relate to periods prior to the original acquisition of CAG and present CAG's historical basis of accounting without the application of purchase accounting. The results of the Successor are not comparable to the results of the Predecessor due to the difference in the basis of presentation of purchase accounting as compared to historical cost. Initial Public Offering and Concurrent Financings In January 2005, the Company completed an initial public offering of 50,000,000 shares of Series A common stock and received net proceeds of $752 million after deducting underwriters' discounts 56 -------------------------------------------------------------------------------- and offering expenses of $48 million. Concurrently, the Company received net proceeds of $233 million from the offering of 9,600,000 shares of convertible perpetual preferred stock after deducting underwriters discounts and offering expenses of $7 million. A portion of the proceeds of the share offerings were used to redeem $188 million of senior discount notes and $521 million of senior subordinated notes, excluding early redemption premiums of $19 million and $51 million, respectively. Subsequent to the closing of the initial public offering, the Company borrowed an additional $1,135 million under the amended and restated senior credit facilities, a portion of which was used to repay a $350 million floating rate term loan, which excludes a $4 million early redemption premium, and $200 million of which was used as the primary financing for the February 2005 acquisition of the Vinamul emulsions business. Additionally, the amended and restated senior credit facilities include a $242 million delayed draw term loan. The delayed draw term loan expired unutilized in July 2005. On April 7, 2005, the Company used the remaining proceeds of the initial public offering and concurrent financings to pay a special cash dividend to holders of the Company's Series B common stock of $804 million, which was declared on March 8, 2005. In addition, on March 9, 2005, the Company issued a 7,500,000 Series A common stock dividend to the holders of its Series B common stock which was declared on March 8, 2005. Upon payment of the $804 million dividend, all of the outstanding shares of Series B common stock converted automatically into shares of Series A common stock. Recent Highlights: [[Image Removed]] [[Image Removed]] Increased our ownership of CAG to approximately 98% as of November 2, 2005 following an agreement with major shareholders and ongoing tender offers. In November 2005, the Company's Board of Directors approved commencement of the process for effecting a squeeze-out of remaining shareholders. [[Image Removed]] [[Image Removed]] Appointment of John J. Gallagher III as executive vice president and chief financial officer. [[Image Removed]] [[Image Removed]] Completed the sale of Rock Hill cellulose acetate manufacturing site in October 2005 as part of the restructuring of the Acetate business. [[Image Removed]] [[Image Removed]] Completed the acquisition of Acetex Corporation and redemption of Acetex's outstanding 10 7/8% senior notes primarily with available cash. [[Image Removed]] [[Image Removed]] Completed the transition to purchase the Company's full requirement of Gulf Coast methanol from Southern Chemical Corporation, a Trinidad-based supplier, in an arrangement that is expected to yield significant savings. [[Image Removed]] [[Image Removed]] Discontinued production of certain acetate flake and relocated the Acetate Products headquarters to Dallas. [[Image Removed]] [[Image Removed]] Announced the closure and relocation of our Bedminster, N.J. corporate office to Dallas by mid-2006. [[Image Removed]] [[Image Removed]] Announced intention to build a state-of-the-art vinyl acetate ethylene and conventional emulsion polymer facility in China. Startup is targeted for the first half of 2007. [[Image Removed]] [[Image Removed]] Announced plans to construct a world-scale plant for the manufacture of GUR ultra high molecular weight polyethylene in Asia. Production is expected to begin in the second half of 2007. [[Image Removed]] [[Image Removed]] Continued to focus the product portfolio by exiting non-strategic businesses, such as the high performance polymer polybenzamidazole (PBI), vectran polymer and emulsion powders. [[Image Removed]] [[Image Removed]] Signed a letter of intent to divest the non-core cyclo-olefin copolymer business (COC) to a venture between Daicel Chemical Industries Ltd. and our Polyplastics equity investment. [[Image Removed]] [[Image Removed]] Adopted a policy and began to pay common shareholders in August 2005 dividends of $0.16 per share annually, or 1%, based on the initial public offering price of $16 per share. Overview Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 In the three months ended September 30, 2005, net sales rose 21% to $1,536 million compared to $1,265 million in the same period last year primarily due to higher pricing, mainly in the Chemical 57 -------------------------------------------------------------------------------- Products segment, and the net sales from the recently acquired Vinamul and Acetex businesses. Operating profit more than tripled to $92 million compared to $25 million in the same period last year principally driven by higher pricing, productivity improvements and a decrease in special charges of $35 million. These effects more than offset higher raw material and energy costs, mainly for ethylene and natural gas. Operating profit for the three months ended September 30, 2005 included a $15 million charge to cost of sales for a non-cash inventory-related purchase accounting adjustment. For the three months ended September 30, 2005, Acetex (including AT Plastics) and Vinamul, had operating losses of $1 million and $3 million, respectively, primarily related to inventory purchase accounting adjustments and integration costs in connection with the acquisitions. The Company recorded net earnings of $45 million compared to a net loss of $71 million. This increase is primarily due to higher operating profit and lower interest expense, compared to the prior period in 2004, which included deferred financing costs of $18 million and prepayment premium of $21 million associated with the refinancing of the mandatorily redeemable preferred stock. This increase was partially offset by a $13 million increase in 2005 in interest expense due to higher debt levels and higher interest rates. In September 2005, the Company announced a controlled shutdown of its plants in Clear Lake, Pasadena, Bay City and Bishop, Texas in preparation for Hurricane Rita. The Company subsequently announced that these plants sustained minimal damage from this hurricane. Production has resumed at these plants. The Company believes the hurricane will have an aggregate negative impact on earnings of approximately $15 million in the third and fourth quarters of 2005. Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 In the three months ended June 30, 2005, net sales rose 23% to $1,517 million compared to $1,229 million in the same period last year primarily on higher pricing, mainly in Chemical Products, and the sales of the recently acquired Vinamul emulsions business, which closed in the first quarter of 2005. Operating profit rose significantly to $152 million versus $25 million last year on margin expansion principally driven by higher pricing and productivity improvements. These effects more than offset higher raw material and energy costs, mainly for ethylene and natural gas, and higher special charges. Operating profit in 2004 included a $49 million charge for a non-cash inventory-related purchase accounting adjustment. The Company recorded net earnings of $67 million compared to a net loss of $125 million, which included $71 million of deferred financing costs for the prepayment of the senior subordinated bridge loan facilities. The second quarter of 2005 benefited from higher operating profit and a $40 million favorable change in our net foreign currency gain (loss) resulting from exchange rate movements and a change from a net asset to a net liability foreign currency position. Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 In the three months ended March 31, 2005, net sales rose 21% to $1,509 million compared to $1,243 million, in the same period last year, primarily on significant higher pricing. Higher volumes, favorable currency movements and composition changes, of which $66 million was related to the Vinamul emulsions acquisition, increased net sales. The Company recorded a net loss of $10 million compared to earnings of $78 million for CAG largely due to higher interest expense, which included $102 million in refinancing related costs (comprising early redemption premiums and accelerated amortization of deferred financing costs of $74 million and $28 million, respectively), and higher special charges, mainly due to $35 million in expenses for the termination of sponsor monitoring services. The three months ended March 31, 2005 benefited from higher pricing mainly in Chemical Products, driven by strong demand and higher industry capacity utilization. The Company also benefited from cost savings resulting from restructuring and productivity improvement programs as well as lower depreciation and amortization. These benefits were partially offset by higher raw materials and energy costs. 58 -------------------------------------------------------------------------------- Financial Highlights [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Predecessor Three Three Nine Six Three Months Months Months Months Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended September 30, September 30, September 30, September 30, March 31, 2005 2004 2005 2004 2004 [[Image Removed]] (in $ millions) Statement of Operations Data: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net sales [[Image Removed]] 1,536 [[Image Removed]] 1,265 [[Image Removed]] 4,562 [[Image Removed]] 2,494 [[Image Removed]] 1,243 Special charges [[Image Removed]] (24 ) [[Image Removed]] (59 ) [[Image Removed]] (89 ) [[Image Removed]] (58 ) [[Image Removed]] (28 ) Operating profit [[Image Removed]] 92 [[Image Removed]] 25 [[Image Removed]] 410 [[Image Removed]] 50 [[Image Removed]] 52 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 74 (31 ) 220 (135 ) 72 Earnings (loss) from continuing operations [[Image Removed]] 45 [[Image Removed]] (71 ) [[Image Removed]] 102 [[Image Removed]] (195 ) [[Image Removed]] 55 Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] 23 Net earnings (loss) [[Image Removed]] 45 [[Image Removed]] (71 ) [[Image Removed]] 102 [[Image Removed]] (196 ) [[Image Removed]] 78 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor As of As of [[Image Removed]] September 30, [[Image Removed]] December 31, 2005 2004 [[Image Removed]] (in $ millions) Balance Sheet Data: [[Image Removed]] [[Image Removed]] Short-term borrowings and current installments of [[Image Removed]] [[Image Removed]] long-term debt third party and affiliates 181 144 Plus: Long-term debt [[Image Removed]] 3,315 [[Image Removed]] 3,243 Total debt [[Image Removed]] 3,496 [[Image Removed]] 3,387 Less: Cash and cash equivalents [[Image Removed]] 401 [[Image Removed]] 838 Net debt [[Image Removed]] 3,095 [[Image Removed]] 2,549 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Predecessor Three Three Nine Six Three Months Months Months Months Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended September 30, September 30, September 30, September 30, March 31, 2005 2004 2005 2004 2004 [[Image Removed]] (in $ millions) Other Data: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Depreciation and amortization [[Image Removed]] 70 [[Image Removed]] 79 [[Image Removed]] 200 [[Image Removed]] 150 [[Image Removed]] 72 Operating margin(1) [[Image Removed]] 6.0 % [[Image Removed]] 2.0 % [[Image Removed]] 9.0 % [[Image Removed]] 2.0 % [[Image Removed]] 4.2 % Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests as a percentage of net sales 4.8 % (2.5 )% 4.8 % (5.4 )% 5.8 % [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (1) Defined as operating profit divided by net sales. 59 -------------------------------------------------------------------------------- Celanese Corporation and Subsidiaries Unaudited Consolidated Statements of Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] [[Image Removed]] Nine Months Three Months Ended Ended [[Image Removed]] September 30, [[Image Removed]] June 30, [[Image Removed]] March 31, [[Image Removed]] September 30, 2005 2005 2005 2005 [[Image Removed]] (in $ millions) Net sales [[Image Removed]] 1,536 [[Image Removed]] 1,517 [[Image Removed]] 1,509 [[Image Removed]] 4,562 Cost of sales [[Image Removed]] (1,253 ) [[Image Removed]] (1,175 ) [[Image Removed]] (1,125 ) [[Image Removed]] (3,553 ) Selling, general and administrative expenses [[Image Removed]] (144 ) [[Image Removed]] (136 ) [[Image Removed]] (161 ) [[Image Removed]] (441 ) Research and development expenses [[Image Removed]] (22 ) [[Image Removed]] (23 ) [[Image Removed]] (23 ) [[Image Removed]] (68 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] 4 [[Image Removed]] [[Image Removed]] 4 Restructuring, impairment and other special charges [[Image Removed]] (24 ) [[Image Removed]] (31 ) [[Image Removed]] (38 ) [[Image Removed]] (93 ) Foreign exchange gain (loss), net [[Image Removed]] (2 ) [[Image Removed]] (1 ) [[Image Removed]] 3 [[Image Removed]] Gain (loss) on disposition of assets, net [[Image Removed]] 1 [[Image Removed]] (3 ) [[Image Removed]] 1 [[Image Removed]] (1 ) Operating profit [[Image Removed]] 92 [[Image Removed]] 152 [[Image Removed]] 166 [[Image Removed]] 410 Equity in net earnings of affiliates [[Image Removed]] 21 [[Image Removed]] 12 [[Image Removed]] 15 [[Image Removed]] 48 Interest expense [[Image Removed]] (72 ) [[Image Removed]] (68 ) [[Image Removed]] (176 ) [[Image Removed]] (316 ) Interest income [[Image Removed]] 7 [[Image Removed]] 9 [[Image Removed]] 15 [[Image Removed]] 31 Other income (expense), net [[Image Removed]] 26 [[Image Removed]] 18 [[Image Removed]] 3 [[Image Removed]] 47 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 74 123 23 220 Income tax provision [[Image Removed]] (26 ) [[Image Removed]] (43 ) [[Image Removed]] (8 ) [[Image Removed]] (77 ) Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 48 80 15 143 Minority interests [[Image Removed]] (3 ) [[Image Removed]] (13 ) [[Image Removed]] (25 ) [[Image Removed]] (41 ) Earnings (loss) from continuing operations [[Image Removed]] 45 [[Image Removed]] 67 [[Image Removed]] (10 ) [[Image Removed]] 102 Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Net earnings (loss) [[Image Removed]] 45 [[Image Removed]] 67 [[Image Removed]] (10 ) [[Image Removed]] 102 [[Image Removed]] 60 -------------------------------------------------------------------------------- Celanese Corporation and Subsidiaries Unaudited Consolidated Statements of Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] [[Image Removed]] Three Months Three Months Ended Ended [[Image Removed]] September 30, [[Image Removed]] June 30, [[Image Removed]] March 31, 2004 2004 2004 [[Image Removed]] (in $ millions) Net sales [[Image Removed]] 1,265 [[Image Removed]] 1,229 [[Image Removed]] 1,243 Cost of sales [[Image Removed]] (1,005 ) [[Image Removed]] (1,058 ) [[Image Removed]] (1,002 ) Selling, general and administrative expenses [[Image Removed]] (153 ) [[Image Removed]] (125 ) [[Image Removed]] (137 ) Research and development expenses [[Image Removed]] (23 ) [[Image Removed]] (22 ) [[Image Removed]] (23 ) Special charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] (1 ) [[Image Removed]] 2 [[Image Removed]] Restructuring, impairment and other special charges [[Image Removed]] (58 ) [[Image Removed]] (1 ) [[Image Removed]] (28 ) Foreign exchange gain (loss), net [[Image Removed]] (2 ) [[Image Removed]] [[Image Removed]] Gain (loss) on disposition of assets, net [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] (1 ) Operating profit [[Image Removed]] 25 [[Image Removed]] 25 [[Image Removed]] 52 Equity in net earnings of affiliates [[Image Removed]] 17 [[Image Removed]] 18 [[Image Removed]] 12 Interest expense [[Image Removed]] (98 ) [[Image Removed]] (130 ) [[Image Removed]] (6 ) Interest income [[Image Removed]] 8 [[Image Removed]] 7 [[Image Removed]] 5 Other income (expense), net [[Image Removed]] 17 [[Image Removed]] (24 ) [[Image Removed]] 9 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests (31 ) (104 ) 72 Income tax provision [[Image Removed]] (48 ) [[Image Removed]] (10 ) [[Image Removed]] (17 ) Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests (79 ) (114 ) 55 Minority interests [[Image Removed]] 8 [[Image Removed]] (10 ) [[Image Removed]] Earnings (loss) from continuing operations [[Image Removed]] (71 ) [[Image Removed]] (124 ) [[Image Removed]] 55 Earnings (loss) from discontinued operations: [[Image Removed]] [[Image Removed]] [[Image Removed]] Loss from operation of discontinued operations [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] (5 ) Gain on disposal of discontinued operations [[Image Removed]] [[Image Removed]] [[Image Removed]] 14 Income tax benefit [[Image Removed]] [[Image Removed]] [[Image Removed]] 14 Earnings (loss) from discontinued operations [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] 23 Net earnings (loss) [[Image Removed]] (71 ) [[Image Removed]] (125 ) [[Image Removed]] 78 [[Image Removed]] 61 -------------------------------------------------------------------------------- Selected Data by Business Segment Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Three Months Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] September 30, September 30, Change in 2005 2004 $ [[Image Removed]] (in $ millions) Net Sales [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 1,100 [[Image Removed]] 840 [[Image Removed]] 260 Technical Polymers Ticona [[Image Removed]] 212 [[Image Removed]] 213 [[Image Removed]] (1 ) Acetate Products [[Image Removed]] 163 [[Image Removed]] 176 [[Image Removed]] (13 ) Performance Products [[Image Removed]] 46 [[Image Removed]] 47 [[Image Removed]] (1 ) Segment Total [[Image Removed]] 1,521 [[Image Removed]] 1,276 [[Image Removed]] 245 Other Activities [[Image Removed]] 55 [[Image Removed]] 20 [[Image Removed]] 35 Intersegment Eliminations [[Image Removed]] (40 ) [[Image Removed]] (31 ) [[Image Removed]] (9 ) Total Net Sales [[Image Removed]] 1,536 [[Image Removed]] 1,265 [[Image Removed]] 271 Special Charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 12 [[Image Removed]] 3 [[Image Removed]] 9 Technical Polymers Ticona [[Image Removed]] 1 [[Image Removed]] 6 [[Image Removed]] (5 ) Acetate Products [[Image Removed]] 9 [[Image Removed]] 50 [[Image Removed]] (41 ) Performance Products [[Image Removed]] [[Image Removed]] [[Image Removed]] Segment Total [[Image Removed]] 22 [[Image Removed]] 59 [[Image Removed]] (37 ) Other Activities [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 2 Total Special Charges [[Image Removed]] 24 [[Image Removed]] 59 [[Image Removed]] (35 ) Operating Profit (Loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 98 [[Image Removed]] 83 [[Image Removed]] 15 Technical Polymers Ticona [[Image Removed]] 18 [[Image Removed]] 15 [[Image Removed]] 3 Acetate Products [[Image Removed]] 4 [[Image Removed]] (39 ) [[Image Removed]] 43 Performance Products [[Image Removed]] 13 [[Image Removed]] 12 [[Image Removed]] 1 Segment Total [[Image Removed]] 133 [[Image Removed]] 71 [[Image Removed]] 62 Other Activities [[Image Removed]] (41 ) [[Image Removed]] (46 ) [[Image Removed]] 5 Total Operating Profit [[Image Removed]] 92 [[Image Removed]] 25 [[Image Removed]] 67 Earnings (Loss) from Continuing Operations Before Tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and Minority Interests Chemical Products [[Image Removed]] 134 [[Image Removed]] 100 [[Image Removed]] 34 Technical Polymers Ticona [[Image Removed]] 34 [[Image Removed]] 29 [[Image Removed]] 5 Acetate Products [[Image Removed]] 4 [[Image Removed]] (39 ) [[Image Removed]] 43 Performance Products [[Image Removed]] 10 [[Image Removed]] 11 [[Image Removed]] (1 ) Segment Total [[Image Removed]] 182 [[Image Removed]] 101 [[Image Removed]] 81 Other Activities [[Image Removed]] (108 ) [[Image Removed]] (132 ) [[Image Removed]] 24 Total Earnings (Loss) from Continuing Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] Before Tax and Minority Interests 74 (31 ) 105 [[Image Removed]] 62 -------------------------------------------------------------------------------- Selected Data by Business Segment Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Three Months Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] September 30, September 30, Change in 2005 2004 $ [[Image Removed]] (in $ millions) Depreciation & Amortization [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 45 [[Image Removed]] 39 [[Image Removed]] 6 Technical Polymers Ticona [[Image Removed]] 13 [[Image Removed]] 19 [[Image Removed]] (6 ) Acetate Products [[Image Removed]] 3 [[Image Removed]] 16 [[Image Removed]] (13 ) Performance Products [[Image Removed]] 4 [[Image Removed]] 3 [[Image Removed]] 1 Segment Total [[Image Removed]] 65 [[Image Removed]] 77 [[Image Removed]] (12 ) Other Activities [[Image Removed]] 5 [[Image Removed]] 2 [[Image Removed]] 3 Total Depreciation & Amortization [[Image Removed]] 70 [[Image Removed]] 79 [[Image Removed]] (9 ) [[Image Removed]] Factors Affecting Third Quarter 2005 Segment Net Sales Compared to Third Quarter 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] in percent [[Image Removed]] Volume [[Image Removed]] Price [[Image Removed]] Currency [[Image Removed]] Other* [[Image Removed]] Total Chemical Products [[Image Removed]] 2 % [[Image Removed]] 12 % [[Image Removed]] 1 % [[Image Removed]] 16 % [[Image Removed]] 31 % Technical Polymers Ticona [[Image Removed]] (5 ) [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] [[Image Removed]] Acetate Products [[Image Removed]] (12 ) [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] [[Image Removed]] (7 ) Performance Products [[Image Removed]] 2 [[Image Removed]] (4 ) [[Image Removed]] [[Image Removed]] [[Image Removed]] (2 ) Segment Total [[Image Removed]] (1 )% [[Image Removed]] 9 % [[Image Removed]] % [[Image Removed]] 11 % [[Image Removed]] 19 % [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] * Primarily represents net sales of the recently acquired Vinamul and Acetex businesses, excluding AT Plastics which is included in other activities. 63 -------------------------------------------------------------------------------- Summary by Business SegmentThree Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Chemical Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended [[Image Removed]] Change in $ millions (except for percentages) September 30, 2005 September 30, 2004 in $ Net sales [[Image Removed]] 1,100 [[Image Removed]] 840 [[Image Removed]] 260 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 2 % [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 12 % [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 1 % [[Image Removed]] [[Image Removed]] Other [[Image Removed]] 16 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 98 [[Image Removed]] 83 [[Image Removed]] 15 Operating margin [[Image Removed]] 8.9 % [[Image Removed]] 9.9 % [[Image Removed]] Special charges [[Image Removed]] 12 [[Image Removed]] 3 [[Image Removed]] 9 Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 134 100 34 Depreciation and amortization [[Image Removed]] 45 [[Image Removed]] 39 [[Image Removed]] 6 [[Image Removed]] Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Chemical Products' net sales increased 31% to $1,100 million compared to the same period last year primarily due to the recent acquisitions of Vinamul and Acetex, as well as higher pricing. Pricing increased in all products, primarily in acetic acid, vinyl acetate and acetyl derivatives. The price increase was driven by continued strong demand, high industry utilization in base products and higher raw material costs, particularly for ethylene and natural gas. For the three months ended September 30, 2005, the Chemical Products segment recorded special charges of $12 million compared to $3 million in the same period last year. The increase in special charges primarily relates to charges for a change in the environmental remediation strategy related to the closure of the Edmonton methanol plant, as well as severance related to same closure. Earnings from continuing operations before tax and minority interests increased 34% to $134 million compared to the same period last year benefiting from increased operating profit and dividends from the Ibn Sina cost investment. Dividends more than doubled to $33 million for the three months ended September 30, 2005 from $15 million in the same period last year, primarily due to higher methanol pricing. Higher selling prices for base products more than offset higher raw material costs, such as ethylene and natural gas. However, downstream products, such as emulsions and polyvinyl alcohol experienced margin compression, as raw material costs rose faster than pricing. The increase in earnings was partially offset by higher energy costs, increased special charges, a $7 million charge to cost of sales for non-cash inventory-related purchase accounting adjustments and integration costs in connection with the Vinamul and Acetex acquisitions. For the three months ended September 30, 2005, Vinamul and Acetex (excluding AT Plastics) had losses of $4 million and $2 million, respectively. 64 -------------------------------------------------------------------------------- Technical Polymers Ticona [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended [[Image Removed]] Change in $ millions (except for percentages) September 30, 2005 September 30, 2004 in $ Net sales [[Image Removed]] 212 [[Image Removed]] 213 [[Image Removed]] (1 ) Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] (5 )% [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 5 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 18 [[Image Removed]] 15 [[Image Removed]] 3 Operating margin [[Image Removed]] 8.5 % [[Image Removed]] 7.0 % [[Image Removed]] Special charges [[Image Removed]] 1 [[Image Removed]] 6 [[Image Removed]] (5 ) Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 34 29 5 Depreciation and amortization [[Image Removed]] 13 [[Image Removed]] 19 [[Image Removed]] (6 ) [[Image Removed]] Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Ticonas net sales declined by $1 million to $212 million from the same period last year. The Company was successful in its pricing initiatives, which nearly offset lower volumes, mainly for polyacetal ("POM") due to the weak European automotive market and reduced sales to lower end applications. Earnings from continuing operations before tax and minority interests increased 17% to $34 million from the same period last year primarily due to progress in cost savings from an organization redesign and restructuring initiatives, higher pricing and lower depreciation and amortization expense due to changes in the useful life of certain property, plant and equipment. These factors were partially offset by lower volumes, higher raw material costs and lower inventory compared to the same period last year when there was a build for a planned maintenance turnaround. 65 -------------------------------------------------------------------------------- Acetate Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended [[Image Removed]] Change In $ millions (except for percentages) September 30, 2005 September 30, 2004 in $ Net sales [[Image Removed]] 163 [[Image Removed]] 176 [[Image Removed]] (13 ) Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] (12 )% [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 5 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 4 [[Image Removed]] (39 ) [[Image Removed]] 43 Operating margin [[Image Removed]] 2.5 % [[Image Removed]] (22.2 )% [[Image Removed]] Special charges [[Image Removed]] 9 [[Image Removed]] 50 [[Image Removed]] (41 ) Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] tax and minority interests 4 (39 ) 43 Depreciation and amortization [[Image Removed]] 3 [[Image Removed]] 16 [[Image Removed]] (13 ) [[Image Removed]] Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Net sales for Acetate Products decreased 7% to $163 million from the same period last year as higher pricing for tow and flake and increased flake volumes did not offset lower volumes for filament and tow. The lower volumes are attributed to the Companys anticipated exit from the filament business and the shutdown of a Canadian tow plant. The increase in pricing is primarily to cover increases in raw material costs. For the three months ended September 30, 2005, the Acetate Products segment recorded special charges of $9 million compared to $50 million in the same period last year. Special charges in the three months ended September 30, 2005 primarily related to charges for a change in the environmental remediation strategy related to the closure of the Edmonton methanol plant, while the special charges reflected in the same period last year primarily represented asset impairments associated with a major restructuring of the business. Earnings from continuing operations before tax and minority interests increased to $4 million compared a loss of $39 million in the same period last year, largely due to a decrease in special charges related to restructuring. The three months ended September 30, 2005 also included a decrease in depreciation and amortization expenses, primarily resulting from $8 million of charges for asset retirement obligations recorded in 2004 associated with a major restructuring of the business. Higher pricing and savings from restructuring and productivity improvements were more than offset by increased raw material and energy costs, along with temporarily higher manufacturing costs resulting from a realignment of inventory levels as part of the restructuring strategy. 66 -------------------------------------------------------------------------------- Performance Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended [[Image Removed]] Change (in $ millions (except for percentages)) September 30, 2005 September 30, 2004 in $ Net sales [[Image Removed]] 46 [[Image Removed]] 47 [[Image Removed]] (1 ) Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 2 % [[Image Removed]] [[Image Removed]] Price [[Image Removed]] (4 )% [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 13 [[Image Removed]] 12 [[Image Removed]] 1 Operating margin [[Image Removed]] 28.3 % [[Image Removed]] 25.5 % [[Image Removed]] Special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 10 11 (1 ) Depreciation and amortization [[Image Removed]] 4 [[Image Removed]] 3 [[Image Removed]] 1 [[Image Removed]] Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Net sales for Performance Products decreased by $1 million to $46 million compared to the same period last year as higher volumes, primarily for Sunett sweetener, were more than offset by lower pricing for the sweetener. The decline in pricing for Sunett sweetener continued to be consistent with the Company's positioning strategy for the product. Earnings from continuing operations before tax and minority interests decreased by $1 million to $10 million compared to the same period last year as cost savings initiatives were offset by lower selling prices and impairment of cost investments. Other Activities Other Activities primarily consists of corporate center costs, including financing and administrative activities, and certain other operating entities, including the captive insurance companies and the AT Plastics business, which was acquired in connection with the acquisition of Acetex in July 2005. Three Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Net sales for Other Activities increased to $55 million from $20 million in the same period last year primarily due to the addition of $49 million in net sales from the AT Plastics business, which was partially offset by lower third party sales from the captive insurance companies of $9 million and $5 million related to the divestitures of the performance polymer polybenzamidazole and vectran polymer fiber businesses in the second quarter of 2005. Loss from continuing operations before tax and minority interests improved to a loss of $108 million from a loss of $132 million in the same period last year. This decrease is primarily due to a decrease in interest expense of $26 million which included the effect of the absence of the 2004 expensing of deferred financing costs of $18 million and a prepayment premium of $21 million associated with the refinancing of the mandatorily redeemable preferred stock. This decrease was partially offset by increased interest expense of $13 million due to higher debt levels and interest rates in addition to a $5 million charge to cost of sales for non-cash inventory-related purchase accounting adjustments recorded in the AT Plastics business. 67 -------------------------------------------------------------------------------- Summary of Consolidated ResultsThree Months Ended September 30, 2005 Compared with Three Months Ended September 30, 2004 Net Sales Net sales rose 21% to $1,536 million in the third quarter of 2005 from $1,265 million in the same period last year primarily due to a 9% increase related to higher pricing, mainly in the Chemical Products segment, and an 11% increase in net sales from the recently acquired Vinamul and Acetex businesses. These increases were partially offset by (1)% lower volumes primarily from the Acetate Products segment resulting from the planned exit from the filament business and the shutdown of a Canadian tow plant. Gross Profit Margin Gross profit margin increased to $283 million or 18% of net sales in the three months ended September 30, 2005 from $260 million or 21% of net sales in the comparable period last year. The $23 million or 9% increase reflects significantly higher pricing primarily in Chemical Products and productivity improvements. For the three months ended September 30, 2005, Vinamul and Acetex had a gross profit of $14 million and $6 million, respectively, which included inventory purchase accounting adjustments and integration costs in connection with the acquisitions. Downstream products, such as emulsions and polyvinyl alcohol, however, experienced margin compression, as raw material costs rose faster than pricing. The increase is partially offset by a $15 million charge to cost of sales in the three months ended September 30, 2005 for non-cash inventory-related purchase accounting adjustments. Selling, General and Administrative Expenses Selling, general and administrative expenses of $144 million in the three months ended September 30, 2005 decreased $9 million from the same period last year. This decrease was due to ongoing cost savings initiatives, organizational redesign of the Ticona segment and other restructuring initiatives in addition to decreases in legal, audit and general expenses associated with the acquisition of CAG. These decreases are partially offset by the addition of costs associated with Vinamul and Acetex. Special Charges The components of special charges for the three months ended September 30, 2005 and 2004 were as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended September 30, 2005 September 30, 2004 [[Image Removed]] (in $ millions) Employee termination benefits [[Image Removed]] (9 ) [[Image Removed]] (6 ) Plant/office closures [[Image Removed]] (1 ) [[Image Removed]] (52 ) Restructuring adjustments [[Image Removed]] [[Image Removed]] 1 Total Restructuring [[Image Removed]] (10 ) [[Image Removed]] (57 ) Environmental related plant closures [[Image Removed]] (12 ) [[Image Removed]] Asset impairments [[Image Removed]] (1 ) [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] [[Image Removed]] (1 ) Other [[Image Removed]] (1 ) [[Image Removed]] (1 ) Total Special Charges [[Image Removed]] (24 ) [[Image Removed]] (59 ) [[Image Removed]] Special charges decreased to $24 million compared to $59 million for the same period last year. The decrease is primarily due to impairment charges associated with the Acetate Products segment restructuring recorded in the third quarter of 2004. The third quarter of 2005 includes charges for a change in the environmental remediation strategy related to the closure of the Edmonton methanol plant, severance associated with the same closure and severance related to the relocation of corporate offices of $12 million, $6 million and $3 million, respectively. 68 -------------------------------------------------------------------------------- Operating Profit Operating profit more than tripled to $92 million compared to $25 million in the same period last year principally driven by higher pricing, productivity improvements and $35 million in lower special charges. These effects more than offset higher raw material and energy costs, mainly for ethylene and natural gas. For the three months ended September 30, 2005, Acetex (including AT Plastics) and Vinamul, had operating losses of $1 million and $3 million, respectively, primarily related to inventory purchase accounting adjustments and integration costs in connection with the acquisitions. Operating profit in 2004 included $59 million in special charges largely for non-cash asset impairments associated with the restructuring of the Acetate Products segment. Operating profit in 2005 included $24 million in special charges and $15 million in inventory purchase accounting adjustments. Equity in Net Earnings of Affiliates Equity in net earnings of affiliates increased by $4 million to $21 million for the three months ended September 30, 2005, compared to the same period last year primarily due to increased performance in the Company's Asian investments. Cash distributions received from equity affiliates of $14 million for the three months ended September 30, 2005 remained flat compared to the same period last year. Interest Expense Interest expense decreased $26 million to $72 million for the three months ended September 30, 2005 from $98 million in the same period last year mainly due to the expensing of deferred financing costs of $18 million and a prepayment premium of $21 million associated with the refinancing of the mandatorily redeemable preferred stock, both of which occurred during the three months ended September 30, 2004. This decrease was partially offset by a $13 million increase in 2005 in interest expense due to higher debt levels and interest rates. Other Income (Expense), Net Other income (expense), net increased to $26 million of income for the three months ended September 30, 2005, compared to income of $17 million for the comparable period last year. This increase was primarily due to an increase in dividend income of $16 million which was partially offset by expenses associated with the anticipated guaranteed payment to CAG minority shareholders of $5 million, net of tax. Dividend income accounted for under the cost method increased to $33 million for the three months ended September 30, 2005, compared to $17 million in the same period last year mainly due to higher methanol pricing from the Companys methanol cost investment. Income Taxes Income taxes for the three months ended September 30, 2005 and 2004 are recorded based on the estimated annual effective tax rate. As of September 30, 2005, the estimated annualized tax rate for 2005 is 35%, which is slightly less than the combination of the statutory rate and state income tax rates in the U.S. The estimated annual effective tax rate for 2005 reflects earnings in low tax jurisdictions, a valuation allowance for the tax benefit associated with projected U.S. losses (which includes expenses associated with the early redemption of debt), and tax expense in certain non-U.S. jurisdictions. For the three months ended September 30, 2005, the Company recorded tax expenses of $26 million. For the three months ended September 30, 2004, a tax expense of $48 million was recorded which resulted in a tax rate of negative 155%. This effective tax rate was significantly affected by the non-recognition of tax benefits associated with acquisition related expenses. Net Earnings (Loss) As a result of the factors mentioned above, the Company's net earnings was $45 million in the three months ended September 30, 2005, compared to a net loss of $71 million in the same period in 2004. 69 -------------------------------------------------------------------------------- Selected Data by Business SegmentThree Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] June 30, June 30, Change in 2005 2004 $ [[Image Removed]] (in $ millions) Net Sales [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 1,085 [[Image Removed]] 808 [[Image Removed]] 277 Technical Polymers Ticona [[Image Removed]] 223 [[Image Removed]] 220 [[Image Removed]] 3 Acetate Products [[Image Removed]] 183 [[Image Removed]] 173 [[Image Removed]] 10 Performance Products [[Image Removed]] 47 [[Image Removed]] 45 [[Image Removed]] 2 Segment Total [[Image Removed]] 1,538 [[Image Removed]] 1,246 [[Image Removed]] 292 Other Activities [[Image Removed]] 8 [[Image Removed]] 11 [[Image Removed]] (3 ) Intersegment Eliminations [[Image Removed]] (29 ) [[Image Removed]] (28 ) [[Image Removed]] (1 ) Total Net Sales [[Image Removed]] 1,517 [[Image Removed]] 1,229 [[Image Removed]] 288 Special Charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] (3 ) [[Image Removed]] (1 ) [[Image Removed]] (2 ) Technical Polymers Ticona [[Image Removed]] (20 ) [[Image Removed]] 2 [[Image Removed]] (22 ) Acetate Products [[Image Removed]] [[Image Removed]] [[Image Removed]] Performance Products [[Image Removed]] [[Image Removed]] [[Image Removed]] Segment Total [[Image Removed]] (23 ) [[Image Removed]] 1 [[Image Removed]] (24 ) Other Activities [[Image Removed]] (4 ) [[Image Removed]] [[Image Removed]] (4 ) Total Special Charges [[Image Removed]] (27 ) [[Image Removed]] 1 [[Image Removed]] (28 ) Operating Profit (Loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 155 [[Image Removed]] 36 [[Image Removed]] 119 Technical Polymers Ticona [[Image Removed]] 5 [[Image Removed]] 11 [[Image Removed]] (6 ) Acetate Products [[Image Removed]] 10 [[Image Removed]] 10 [[Image Removed]] Performance Products [[Image Removed]] 15 [[Image Removed]] 2 [[Image Removed]] 13 Segment Total [[Image Removed]] 185 [[Image Removed]] 59 [[Image Removed]] 126 Other Activities [[Image Removed]] (33 ) [[Image Removed]] (34 ) [[Image Removed]] 1 Total Operating Profit [[Image Removed]] 152 [[Image Removed]] 25 [[Image Removed]] 127 Earnings (Loss) from Continuing Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] Before Tax and Minority Interests Chemical Products [[Image Removed]] 149 [[Image Removed]] 34 [[Image Removed]] 115 Technical Polymers Ticona [[Image Removed]] 22 [[Image Removed]] 26 [[Image Removed]] (4 ) Acetate Products [[Image Removed]] 12 [[Image Removed]] 14 [[Image Removed]] (2 ) Performance Products [[Image Removed]] 14 [[Image Removed]] 1 [[Image Removed]] 13 Segment Total [[Image Removed]] 197 [[Image Removed]] 75 [[Image Removed]] 122 Other Activities [[Image Removed]] (74 ) [[Image Removed]] (179 ) [[Image Removed]] 105 Total Earnings (Loss) from Continuing Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] Before Tax and Minority Interests 123 (104 ) 227 [[Image Removed]] 70 -------------------------------------------------------------------------------- [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] June 30, June 30, Change in 2005 2004 $ [[Image Removed]] (in $ millions) Depreciation & Amortization [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 39 [[Image Removed]] 38 [[Image Removed]] 1 Technical Polymers Ticona [[Image Removed]] 14 [[Image Removed]] 15 [[Image Removed]] (1 ) Acetate Products [[Image Removed]] 9 [[Image Removed]] 14 [[Image Removed]] (5 ) Performance Products [[Image Removed]] 3 [[Image Removed]] 2 [[Image Removed]] 1 Segment Total [[Image Removed]] 65 [[Image Removed]] 69 [[Image Removed]] (4 ) Other Activities [[Image Removed]] 2 [[Image Removed]] 2 [[Image Removed]] Total Depreciation & Amortization [[Image Removed]] 67 [[Image Removed]] 71 [[Image Removed]] (4 ) [[Image Removed]] Factors Affecting Second Quarter 2005 Segment Net Sales Compared to Second Quarter 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] in percent [[Image Removed]] Volume [[Image Removed]] Price [[Image Removed]] Currency [[Image Removed]] Other* [[Image Removed]] Total Chemical Products [[Image Removed]] (1 )% [[Image Removed]] 21 % [[Image Removed]] 2 % [[Image Removed]] 12 % [[Image Removed]] 34 % Technical Polymers Ticona [[Image Removed]] (5 ) [[Image Removed]] 4 [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 1 Acetate Products [[Image Removed]] 1 [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] [[Image Removed]] 6 Performance Products [[Image Removed]] 2 [[Image Removed]] (3 ) [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 4 Segment Total [[Image Removed]] (2 )% [[Image Removed]] 15 % [[Image Removed]] 2 % [[Image Removed]] 8 % [[Image Removed]] 23 % [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] * Primarily represents net sales of the recently acquired Vinamul emulsions business 71 -------------------------------------------------------------------------------- Summary by Business Segment Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Chemical Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended June 30, [[Image Removed]] Ended June 30, [[Image Removed]] Change in in $ millions (except for percentages) 2005 2004 $ Net sales [[Image Removed]] 1,085 [[Image Removed]] 808 [[Image Removed]] 277 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] (1 )% [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 21 % [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 2 % [[Image Removed]] [[Image Removed]] Other [[Image Removed]] 12 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 155 [[Image Removed]] 36 [[Image Removed]] 119 Operating margin [[Image Removed]] 14.3 % [[Image Removed]] 4.5 % [[Image Removed]] Special charges [[Image Removed]] (3 ) [[Image Removed]] (1 ) [[Image Removed]] (2 ) Earnings (loss) from continuing operations before tax and [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 149 34 115 Depreciation and amortization [[Image Removed]] 39 [[Image Removed]] 38 [[Image Removed]] 1 [[Image Removed]] Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Chemical Products' net sales increased 34% to $1,085 million compared to the same period last year on significantly higher pricing, sales of the newly acquired Vinamul business and favorable currency movements. Major business lines continued to operate at high utilization rates while volumes declined for non-core derivative products. Pricing increased for most chemical products, particularly vinyl acetate, acetic acid and acetate esters, driven by continued strong demand, high utilization rates across the industry and higher raw material costs, mainly for ethylene and natural gas. Earnings from continuing operations before tax and minority interests increased to $149 million from $34 million on higher pricing and productivity improvements, which were partly offset by higher raw material costs. Earnings in 2004 included a $15 million charge for a non-cash inventory-related purchase accounting adjustment. 72 -------------------------------------------------------------------------------- Technical Polymers Ticona [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended June 30, [[Image Removed]] Ended June 30, [[Image Removed]] Change in (in $ millions (except for percentages)) 2005 2004 $ Net sales [[Image Removed]] 223 [[Image Removed]] 220 [[Image Removed]] 3 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] (5 )% [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 4 % [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 2 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 5 [[Image Removed]] 11 [[Image Removed]] (6 ) Operating margin [[Image Removed]] 2.2 % [[Image Removed]] 5.0 % [[Image Removed]] Special charges [[Image Removed]] (20 ) [[Image Removed]] 2 [[Image Removed]] (22 ) Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 22 26 (4 ) Depreciation and amortization [[Image Removed]] 14 [[Image Removed]] 15 [[Image Removed]] (1 ) [[Image Removed]] Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Ticona's net sales increased 1% to $223 million compared to the same period last year on higher pricing and favorable currency movements. Pricing rose as previously announced price increases took effect. Volumes declined largely for polyacetal (POM) due to weakness in the automotive sector, primarily in Europe, and on reduced sales for lower-end applications. Earnings from continuing operations before tax and minority interests decreased to $22 million from $26 million as higher pricing, cost savings and dividend income from cost investments did not fully offset $20 million in special charges, primarily for the impairment of the COC business, lower volumes and higher raw material costs. Equity in net earnings of affiliates remained relatively flat compared to last year. Earnings in 2004 included an $18 million charge for a non-cash inventory-related purchase accounting adjustment. 73 -------------------------------------------------------------------------------- Acetate Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended June 30, [[Image Removed]] Ended June 30, [[Image Removed]] Change in (in $ millions (except for percentages)) 2005 2004 $ Net sales [[Image Removed]] 183 [[Image Removed]] 173 [[Image Removed]] 10 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 1 % [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 5 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 10 [[Image Removed]] 10 [[Image Removed]] Operating margin [[Image Removed]] 5.5 % [[Image Removed]] 5.8 % [[Image Removed]] Special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] tax and minority interests 12 14 (2 ) Depreciation and amortization [[Image Removed]] 9 [[Image Removed]] 14 [[Image Removed]] (5 ) [[Image Removed]] Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Net sales for Acetate Products increased by 6% to $183 million compared to the same period last year on higher pricing and volumes. Pricing increased for all business lines while volumes increased mainly on higher flake sales to the Company's recently expanded China tow ventures. Earnings from continuing operations before tax and minority interests decreased to $12 million compared to $14 million in the same period last year. Higher pricing and savings from restructuring and productivity improvements were more than offset by increased raw material and energy costs as well as temporarily higher manufacturing costs, resulting from a realignment of production and inventory levels as part of the acetate restructuring strategy. 74 -------------------------------------------------------------------------------- Performance Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended June 30, [[Image Removed]] Ended June 30, [[Image Removed]] Change in (in $ millions (except for percentages)) 2005 2004 $ Net sales [[Image Removed]] 47 [[Image Removed]] 45 [[Image Removed]] 2 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 2 % [[Image Removed]] [[Image Removed]] Price [[Image Removed]] (3 )% [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 5 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 15 [[Image Removed]] 2 [[Image Removed]] 13 Operating margin [[Image Removed]] 31.9 % [[Image Removed]] 4.4 % [[Image Removed]] Special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before tax and [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 14 1 13 Depreciation and amortization [[Image Removed]] 3 [[Image Removed]] 2 [[Image Removed]] 1 [[Image Removed]] Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Net sales for Performance Products increased by 4% to $47 million compared to the same period last year mainly as the result of favorable currency effects and modest volume increases. Pricing for Sunett sweetener declined, consistent with the Company's positioning strategy for the product while pricing for sorbates continued to improve. Earnings from continuing operations before tax and minority interests increased to $14 million from $1 million last year, which included a $12 million charge for a non-cash inventory-related purchase accounting adjustment. The increase in earnings resulted from favorable currency movements, improved sorbates performance and productivity improvements. Other Activities Other Activities primarily consists of corporate center costs, including financing and administrative activities, and certain other operating entities, including the captive insurance companies. Three Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Net sales for Other Activities decreased to $8 million from $11 million in the same quarter last year primarily due to the sale of PBI and the Vectran product lines in the second quarter of 2005. Loss from continuing operations before tax and minority interests improved to a loss of $74 million from a loss of $179 million in the same period last year. This was primarily due to the expensing in 2004 of $71 million in deferred financing costs for the prepayment of the senior subordinated bridge loan facilities. Also contributing to this decrease was a $40 million favorable change in our net foreign currency gain (loss) resulting from exchange rate movements and a change from a net asset to a net liability foreign currency position. Summary of Consolidated ResultsThree Months Ended June 30, 2005 Compared with Three Months Ended June 30, 2004 Net Sales Net sales rose 23% to $1,517 million in the second quarter compared to the same period last year primarily on higher pricing (15%), mainly in the Chemical Products segment, sales of the recently acquired Vinamul emulsions business in February 2005 (8%), and favorable currency movements (2%). These increases were slightly offset by lower volumes (2%). Gross Profit Margin Gross profit margin increased to $342 million or 23% of sales in the three months ended June 30, 2005 from $171 million or 14% of sales in the comparable period last year. This increase primarily 75 -------------------------------------------------------------------------------- reflects significantly higher pricing and productivity improvements, primarily in Chemical Products, and the absence of a $49 million non-cash charge for the manufacturing profit added to inventory under purchase accounting which was charged to cost of sales. Higher raw material and energy costs partially offset these increases. Selling, General and Administrative Expenses Selling, general and administrative expense increased to $136 million compared to $125 million for the same period last year. This increase is primarily due to higher amortization expense of identifiable intangible assets acquired from CAG of $10 million as well the inclusion of the Vinamul emulsions business acquired in February 2005. These increases were partially offset by cost savings. Special Charges The components of special charges for the three months ended June 30, 2005 and 2004 were as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Successor [[Image Removed]] Three Months Ended [[Image Removed]] Three Months Ended June 30, 2005 June 30, 2004 [[Image Removed]] (in $ millions) Employee termination benefits [[Image Removed]] (7 ) [[Image Removed]] (1 ) Plant/office closures [[Image Removed]] [[Image Removed]] Total Restructuring [[Image Removed]] (7 ) [[Image Removed]] (1 ) Asset impairments [[Image Removed]] (24 ) [[Image Removed]] Insurance recoveries associated with plumbing cases [[Image Removed]] 4 [[Image Removed]] 2 Total Special Charges [[Image Removed]] (27 ) [[Image Removed]] 1 [[Image Removed]] Special charges increased to $27 million compared to income of $1 million for the same period last year. This increase was primarily due an additional impairment charge associated with revised estimates related to the Company's decision to divest its COC business. Operating Profit Operating profit rose significantly to $152 million versus $25 million last year on margin expansion principally driven by higher pricing and productivity improvements. The effects more than offset higher raw material and energy costs, mainly for ethylene and natural gas, and higher special charges. Operating profit in 2004 included a $49 million charge for a non-cash inventory-related purchase accounting adjustment. Equity in Net Earnings of Affiliates Equity in net earnings of affiliates decreased by $6 million to $12 million for the three months ended June 30, 2005, compared to the same period last year. This decrease is primarily due to an impairment charge of $10 million related to the Estech GmbH & Co. KG venture, a producer of neopolyol esters in Oberhausen, Germany. Cash distributions received from equity affiliates increased to $10 million for the three months ended June 30, 2005, compared to $6 million in the same period of 2004. Interest Expense Interest expense decreased to $68 million for the three months ended June 30, 2005 from $130 million in the same period last year as interest expense in 2004 included $71 million of deferred financing costs for the prepayment of the senior subordinated bridge loan facilities. This decrease was slightly offset by increased interest on higher debt levels. Interest Income For the three months ended June 30, 2005, interest income increased by $2 million to $9 million compared to the same period in the prior year. 76 -------------------------------------------------------------------------------- Other Income (Expense), Net Other income (expense), net increased to $18 million of income for the three months ended June 30, 2005, compared to expense of $24 million for the comparable period last year. This increase is primarily due to a favorable change of $40 million in our net foreign currency gain (loss) resulting from exchange rate movements and a change from a net asset to a net liability foreign currency position. This increase was partially offset by expenses associated with the anticipated guaranteed payment to CAG minority shareholders of $7 million. Dividend income accounted for under the cost method remained flat at $7 million for the three months ended June 30, 2005, compared to the same period in 2004. Income Taxes Income taxes for the three months ended June 30, 2005 and 2004, are recorded based on the estimated annual effective tax rate. As of June 30, 2005, the estimated annualized tax rate for 2005 is 35%, which is slightly less than the combination of the statutory rate and state income tax rates in the U.S. The estimated annual effective tax rate for 2005 reflects earnings in low tax jurisdictions, a valuation allowance for the tax benefit associated with projected U.S. losses (which includes expenses associated with the early redemption of debt), and tax expense in certain non-U.S. jurisdictions. For the three months ended June 30, 2004, a tax expense of $10 million was recorded which resulted in a tax rate of negative 10%. This effective tax rate was primarily affected by the non-recognition of tax benefits associated with acquisition related expenses. Earnings (Loss) from Discontinued Operations Earnings from discontinued operations was $0 million for the three months ended June 30, 2005 compared to a loss of $1 million from the comparable period last year. The loss in the three months ended June 30, 2004 reflected a purchase price adjustment related to the sale of the nylon business. Net Earnings (Loss) As a result of the factors mentioned above, the Company had net earnings of $67 million in the three months ended June 30, 2005, compared to a net loss of $125 million in the same period last year. 77 -------------------------------------------------------------------------------- Selected Data by Business Segment Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended March [[Image Removed]] Ended March [[Image Removed]] Change in 31, 2005 31, 2004 $ [[Image Removed]] (in $ millions) Net Sales [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 1,044 [[Image Removed]] 818 [[Image Removed]] 226 Technical Polymers Ticona [[Image Removed]] 239 [[Image Removed]] 227 [[Image Removed]] 12 Acetate Products [[Image Removed]] 196 [[Image Removed]] 172 [[Image Removed]] 24 Performance Products [[Image Removed]] 47 [[Image Removed]] 44 [[Image Removed]] 3 Segment Total [[Image Removed]] 1,526 [[Image Removed]] 1,261 [[Image Removed]] 265 Other Activities [[Image Removed]] 12 [[Image Removed]] 11 [[Image Removed]] 1 Intersegment Eliminations [[Image Removed]] (29 ) [[Image Removed]] (29 ) [[Image Removed]] Total Net Sales [[Image Removed]] 1,509 [[Image Removed]] 1,243 [[Image Removed]] 266 Special Charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] (1 ) [[Image Removed]] (1 ) [[Image Removed]] Technical Polymers Ticona [[Image Removed]] (1 ) [[Image Removed]] (1 ) [[Image Removed]] Acetate Products [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Performance Products [[Image Removed]] [[Image Removed]] [[Image Removed]] Segment Total [[Image Removed]] (3 ) [[Image Removed]] (2 ) [[Image Removed]] (1 ) Other Activities [[Image Removed]] (35 ) [[Image Removed]] (26 ) [[Image Removed]] (9 ) Total Special Charges [[Image Removed]] (38 ) [[Image Removed]] (28 ) [[Image Removed]] (10 ) Operating Profit (Loss) [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 177 [[Image Removed]] 65 [[Image Removed]] 112 Technical Polymers Ticona [[Image Removed]] 39 [[Image Removed]] 31 [[Image Removed]] 8 Acetate Products [[Image Removed]] 20 [[Image Removed]] 9 [[Image Removed]] 11 Performance Products [[Image Removed]] 13 [[Image Removed]] 11 [[Image Removed]] 2 Segment Total [[Image Removed]] 249 [[Image Removed]] 116 [[Image Removed]] 133 Other Activities [[Image Removed]] (83 ) [[Image Removed]] (64 ) [[Image Removed]] (19 ) Total Operating Profit [[Image Removed]] 166 [[Image Removed]] 52 [[Image Removed]] 114 Earnings (Loss) from Continuing Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] Before Tax and Minority Interests Chemical Products [[Image Removed]] 193 [[Image Removed]] 64 [[Image Removed]] 129 Technical Polymers Ticona [[Image Removed]] 51 [[Image Removed]] 45 [[Image Removed]] 6 Acetate Products [[Image Removed]] 20 [[Image Removed]] 9 [[Image Removed]] 11 Performance Products [[Image Removed]] 12 [[Image Removed]] 11 [[Image Removed]] 1 Segment Total [[Image Removed]] 276 [[Image Removed]] 129 [[Image Removed]] 147 Other Activities [[Image Removed]] (253 ) [[Image Removed]] (57 ) [[Image Removed]] (196 ) Total Earnings from Continuing Operations [[Image Removed]] [[Image Removed]] [[Image Removed]] Before Tax and Minority Interests 23 72 (49 ) [[Image Removed]] 78 -------------------------------------------------------------------------------- Selected Data by Business Segment Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 (Continued) [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended March [[Image Removed]] Ended March [[Image Removed]] Change in 31, 2005 31, 2004 $ [[Image Removed]] (in $ millions) Depreciation & Amortization [[Image Removed]] [[Image Removed]] [[Image Removed]] Chemical Products [[Image Removed]] 34 [[Image Removed]] 39 [[Image Removed]] (5 ) Technical Polymers Ticona [[Image Removed]] 15 [[Image Removed]] 16 [[Image Removed]] (1 ) Acetate Products [[Image Removed]] 9 [[Image Removed]] 13 [[Image Removed]] (4 ) Performance Products [[Image Removed]] 3 [[Image Removed]] 2 [[Image Removed]] 1 Segment Total [[Image Removed]] 61 [[Image Removed]] 70 [[Image Removed]] (9 ) Other Activities [[Image Removed]] 2 [[Image Removed]] 2 [[Image Removed]] Total Depreciation & Amortization [[Image Removed]] 63 [[Image Removed]] 72 [[Image Removed]] (9 ) [[Image Removed]] Factors Affecting First Quarter 2005 Segment Net Sales Compared to First Quarter 2004 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] in percent [[Image Removed]] Volume [[Image Removed]] Price [[Image Removed]] Currency [[Image Removed]] Other* [[Image Removed]] Total Chemical Products [[Image Removed]] (1 )% [[Image Removed]] 22 % [[Image Removed]] 3 % [[Image Removed]] 4 % [[Image Removed]] 28 % Technical Polymers Ticona [[Image Removed]] 2 [[Image Removed]] [[Image Removed]] 3 [[Image Removed]] [[Image Removed]] 5 Acetate Products [[Image Removed]] 11 [[Image Removed]] 3 [[Image Removed]] [[Image Removed]] [[Image Removed]] 14 Performance Products [[Image Removed]] 9 [[Image Removed]] (7 ) [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 7 Segment Total [[Image Removed]] 2 % [[Image Removed]] 15 % [[Image Removed]] 2 % [[Image Removed]] 2 % [[Image Removed]] 21 % [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] * Primarily represents net sales of the recently acquired Vinamul emulsions business 79 -------------------------------------------------------------------------------- Summary by Business Segment Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Chemical Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended March 31, [[Image Removed]] Ended March 31, [[Image Removed]] Change in in $ millions (except for percentages) 2005 2004 $ Net sales [[Image Removed]] 1,044 [[Image Removed]] 818 [[Image Removed]] 226 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] (1 )% [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 22 % [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 3 % [[Image Removed]] [[Image Removed]] Other [[Image Removed]] 4 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 177 [[Image Removed]] 65 [[Image Removed]] 112 Operating margin [[Image Removed]] 17.0 % [[Image Removed]] 7.9 % [[Image Removed]] Special charges [[Image Removed]] (1 ) [[Image Removed]] (1 ) [[Image Removed]] Earnings (loss) from continuing operations before tax and [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 193 64 129 Depreciation and amortization [[Image Removed]] 34 [[Image Removed]] 39 [[Image Removed]] (5 ) [[Image Removed]] Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Chemical Products' net sales increased 28% to $1,044 million compared to the same period last year mainly on higher pricing, segment composition changes, of which $66 million was related to the Vinamul emulsions acquisition, and favorable currency effects. Pricing increased for most products, driven by continued strong demand and high utilization rates across the chemical industry. Earnings from continuing operations before tax and minority interests increased to $193 million from $64 million in the same period last year as higher pricing was partially offset by higher raw material costs. Earnings also benefited from an increase of $9 million in dividends from our methanol cost investment, which totaled $12 million in the quarter. 80 -------------------------------------------------------------------------------- Technical Polymers Ticona [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended March 31, [[Image Removed]] Ended March 31, [[Image Removed]] Change in in $ millions (except for percentages) 2005 2004 $ Net sales [[Image Removed]] 239 [[Image Removed]] 227 [[Image Removed]] 12 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 2 % [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 3 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 39 [[Image Removed]] 31 [[Image Removed]] 8 Operating margin [[Image Removed]] 16.3 % [[Image Removed]] 13.7 % [[Image Removed]] Special charges [[Image Removed]] (1 ) [[Image Removed]] (1 ) [[Image Removed]] Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interests 51 45 6 Depreciation and amortization [[Image Removed]] 15 [[Image Removed]] 16 [[Image Removed]] (1 ) [[Image Removed]] Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Net sales for Ticona increased by 5% to $239 million compared to the same period last year due to favorable currency effects and slightly higher volumes. Volumes increased for most product lines due to the successful introduction of new applications, which outweighed declines in polyacetal volumes resulting from the Company's focus on high-end business and decreased sales to European automotive customers. Overall pricing remained flat quarter over quarter as successfully implemented price increases were offset by lower average pricing for certain products due to the commercialization of lower cost grades for new applications. Earnings from continuing operations before tax and minority interests increased 13% to $51 million as the result of cost savings from a recent restructuring, the favorable effects of a planned maintenance turnaround as well as slightly higher volumes. These increases were partially offset by higher raw material and energy costs. 81 -------------------------------------------------------------------------------- Acetate Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended March 31, [[Image Removed]] Ended March 31, [[Image Removed]] Change in in $ millions (except for percentages) 2005 2004 $ Net sales [[Image Removed]] 196 [[Image Removed]] 172 [[Image Removed]] 24 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 11 % [[Image Removed]] [[Image Removed]] Price [[Image Removed]] 3 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 20 [[Image Removed]] 9 [[Image Removed]] 11 Operating margin [[Image Removed]] 10.2 % [[Image Removed]] 5.2 % [[Image Removed]] Special charges [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Earnings (loss) from continuing operations before [[Image Removed]] [[Image Removed]] [[Image Removed]] tax and minority interests 20 9 11 Depreciation and amortization [[Image Removed]] 9 [[Image Removed]] 13 [[Image Removed]] (4 ) [[Image Removed]] Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Net sales for Acetate Products increased by 14% to $196 million compared to the same quarter last year on higher volumes and pricing. Flake volumes increased mainly as a result of demand from Company ventures in China that recently completed tow capacity expansions. Filament volumes rose in anticipation of the Company's plans to exit this business by the end of the second quarter. Pricing increased for all business lines to cover higher raw material costs. Earnings from continuing operations before tax and minority interests more than doubled from $9 million in first quarter last year to $20 million this year due to increased volumes, pricing and productivity improvements, which more than offset higher raw material and energy costs. Earnings also benefited from $4 million in lower depreciation and amortization expense largely as a result of previous impairments related to a major restructuring, which was partly offset by $3 million of expense for an asset retirement obligation. 82 -------------------------------------------------------------------------------- Performance Products [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months [[Image Removed]] Three Months Ended March 31, [[Image Removed]] Ended March 31, [[Image Removed]] Change in in $ millions (except for percentages) 2005 2004 $ Net sales [[Image Removed]] 47 [[Image Removed]] 44 [[Image Removed]] 3 Net sales variance: [[Image Removed]] [[Image Removed]] [[Image Removed]] Volume [[Image Removed]] 9 % [[Image Removed]] [[Image Removed]] Price [[Image Removed]] (7 )% [[Image Removed]] [[Image Removed]] Currency [[Image Removed]] 5 % [[Image Removed]] [[Image Removed]] Operating profit [[Image Removed]] 13 [[Image Removed]] 11 [[Image Removed]] 2 Operating margin [[Image Removed]] 27.7 % [[Image Removed]] 25.0 % [[Image Removed]] Special charges [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before tax and [[Image Removed]] [[Image Removed]] [[Image Removed]] minority interests 12 11 1 Depreciation and amortization [[Image Removed]] 3 [[Image Removed]] 2 [[Image Removed]] 1 [[Image Removed]] Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Net sales for the Performance Products segment increased by 7% to $47 million compared to the same period last year mainly on higher volumes, which more than offset lower pricing. Favorable currency movements also contributed to the sales increase. Higher volumes for Sunett sweetener reflected strong growth from new and existing applications in the U.S. and European beverage and confectionary markets. Pricing for Sunett declined on lower unit selling prices associated with higher volumes to major customers. Pricing for sorbates continued to recover, although worldwide overcapacity still prevailed in the industry. Earnings from continuing operations before tax and minority interests increased to $12 million from $11 million in the same quarter last year. Strong volumes for Sunett, as well as favorable currency movements and cost savings, more than offset lower pricing for the sweetener. A primary European and U.S. production patent for Sunett expired at the end of March 2005. Other Activities Other Activities primarily consists of corporate center costs, including financing and administrative activities, and certain other operating entities, including the captive insurance companies. Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Net sales for Other Activities increased slightly to $12 million from $11 million in the same quarter last year. Loss from continuing operations before tax and minority interests increased to $253 million from a loss of $57 million in the same period last year, largely due to $169 million of higher interest expense due to refinancing costs, increased debt levels, and higher interest rates. The loss includes $45 million of expenses for sponsor monitoring and related cancellation fees compared to special charges of $25 million in the same period last year for advisory services related to the tender offer of CAG. Summary of Consolidated Results Three Months Ended March 31, 2005 Compared with Three Months Ended March 31, 2004 Net Sales Net sales rose 21% to $1,509 million in the first quarter compared to the same period last year primarily on higher pricing of 15%, mainly in the Chemical Products segment. Favorable currency movements, higher volumes, and a composition change in the Chemical Products segment each increased net sales by 2%. 83 -------------------------------------------------------------------------------- The segment composition changes consisted of the acquisition of the Vinamul emulsions business in February 2005, which was partly offset by the effects of a contract manufacturing arrangement under which certain acrylates products are now being sold. Only the margin realized under the contract manufacturing arrangement is included in net sales. Gross Profit Margin Gross profit margin increased to $384 million or 25% of sales in the three months ended March 31, 2005 from $241 million or 19% of sales in the comparable period last year. This increase primarily reflects significantly higher pricing, primarily in Chemical Products, lower depreciation expense and productivity improvements. Higher raw material and energy costs partially offset these increases. Selling, General and Administrative Expenses Selling, general and administrative expense increased to $161 million compared to $137 million for the same period last year. This increase is primarily due to expenses for sponsor monitoring services of $10 million, higher amortization expense of identifiable intangible assets acquired of $10 million as well as higher professional costs primarily related to compliance with Section 404 of the Sarbanes-Oxley Act of 2002. Special Charges The components of special charges for the three months ended March 31, 2005 and 2004 were as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor [[Image Removed]] Three Months Three Months [[Image Removed]] Ended March 31, [[Image Removed]] Ended March 31, [[Image Removed]] Change in 2005 2004 $ [[Image Removed]] (in $ millions) Employee termination benefits [[Image Removed]] (2 ) [[Image Removed]] (2 ) [[Image Removed]] Plant/office closures [[Image Removed]] (1 ) [[Image Removed]] [[Image Removed]] (1 ) Total restructuring [[Image Removed]] (3 ) [[Image Removed]] (2 ) [[Image Removed]] (1 ) Termination of advisor monitoring services [[Image Removed]] (35 ) [[Image Removed]] [[Image Removed]] (35 ) Advisory services [[Image Removed]] [[Image Removed]] (25 ) [[Image Removed]] 25 Other [[Image Removed]] [[Image Removed]] (1 ) [[Image Removed]] 1 Total special charges [[Image Removed]] (38 ) [[Image Removed]] (28 ) [[Image Removed]] (10 ) [[Image Removed]] Operating Profit Operating profit increased to $166 million in the quarter compared to $52 million in the same period last year on gross margin expansion of $143 million, as significantly higher pricing, primarily in Chemical Products, lower depreciation expense and productivity improvements more than offset higher raw material and energy costs. Operating profit also benefited from increased volumes in Acetate Products, Performance Products and Ticona. Depreciation and amortization expense declined by $9 million as decreases in depreciation resulting from purchase accounting adjustments, more than offset increased amortization expense for acquired intangible assets. Equity in Net Earnings of Affiliates Equity in net earnings of affiliates rose by $3 million to $15 million for the three months ended March 31, 2005, compared to the same period last year. Cash distributions received from equity affiliates increased to $36 million for the three months ended March 31, 2005, compared to $16 million in the same period of 2004. The increase in cash distributions is mainly due to strong business conditions in 2004 for Ticona's high performance product ventures and Chemical Products' methanol venture and the timing of dividend payments. Interest Expense Interest expense increased to $176 million for the three months ended March 31, 2005 from $6 million in the same period last year, primarily due to expenses of $102 million including early 84 -------------------------------------------------------------------------------- redemption premiums and deferred financing costs associated with the refinancing that occurred in the first quarter of 2005. Higher debt levels resulting primarily from the acquisition of CAG and higher interest rates also increased interest expense. Interest Income For the three months ended March 31, 2005, interest income increased by $10 million to $15 million compared to the same period in the prior year, primarily due to higher average cash levels. Other Income (Expense), Net Other income (expense), net decreased to $3 million of income for the three months ended March 31, 2005, compared to $9 million for the comparable period last year. This decrease is primarily due to expenses associated with the anticipated guaranteed payment to CAG minority shareholders and the ineffective portion of a net investment hedge. These decreases were partially offset by higher dividends from cost investments. Dividend income accounted for under the cost method increased by $8 million to $14 million for the three months ended March 31, 2005, compared to the same period in 2004. The increase in the first quarter of 2005 primarily resulted from the timing of receipt of dividends. Income Taxes Income taxes for the three months ended March 31, 2005 and 2004, are recorded based on the estimated annual effective tax rate. As of March 31, 2005, the estimated annualized tax rate for 2005 is 35%, which is slightly less than the combination of the statutory rate and state income tax rates in the U.S. The estimated annual effective tax rate for 2005 reflects earnings in low tax jurisdictions, a valuation allowance for the tax benefit associated with projected U.S. losses (which includes expenses associated with the early redemption of debt), and tax expense in certain non-U.S. jurisdictions. The Predecessor had an effective tax rate of 24% for the three months ended March 31, 2004, compared to the German statutory rate of 40%, which was primarily affected by earnings in low tax jurisdictions. Earnings from Discontinued Operations Earnings from discontinued operations was $0 million for the three months ended March 31, 2005 compared to $23 million from the comparable period last year. Earnings in 2004 reflected a gain and tax benefit recognized in 2004 associated with the sale of the acrylates business. The tax benefit is mainly attributable to the utilization of a capital loss carryover benefit that had been previously subject to a valuation allowance. For the three months ended March 31, 2004, the Chemical Products segment had net sales of $21 million and an operating loss of $5 million. Net Earnings As a result of the factors mentioned above, net earnings decreased by $88 million to a net loss of $10 million in the three months ended March 31, 2005, compared to the same period last year. 85 -------------------------------------------------------------------------------- Outlook For the fourth quarter of 2005, the Company expects the North American and Asian markets to continue to grow and that pricing may temporarily be impacted as new acetyls capacity comes on stream in the fourth quarter of 2005. For the remainder of the year, the Company expects to incur expenses and cash outlays for the restructuring of its businesses and product portfolio, cost improvement and focused growth in core areas. Liquidity and Capital Resources Cash Flows Net Cash Provided by/(Used in) Operating Activities Cash flow from operating activities increased to a cash inflow of $516 million for the nine months ended September 30, 2005 compared to a cash inflow of $2 million for the same period last year. This increase primarily resulted from the contribution of an increase in operating profit in 2005 of $308 million, the payment of a $95 million obligation to a third party in 2004, the absence of payments associated with stock appreciation rights of $59 million, recoveries from an insurance provider related to the plumbing matters of $44 million in 2005, a decrease in pension contributions of $142 million and an increase in dividends received from cost and equity investments of $48 million. These increases were partially offset by higher interest payments of $31 million, contributions to the non-qualified pension plan's rabbi trusts of $63 million in 2005 and $45 million in monitoring fees paid during the nine months ended September 30, 2005. Unfavorable foreign currency effects on the euro versus the U.S. dollar on cash and cash equivalents was $94 million compared to a $15 million unfavorable effect in the same period last year. Net Cash Provided by/(Used in) Investing Activities Net cash from investing activities improved to a cash outflow of $781 million in the nine months ended September 30, 2005 compared to a cash outflow of $1,628 million for the same period last year. The cash outflow in 2004 primarily resulted from the CAG acquisition. The 2005 cash outflow included the acquisitions of the Vinamul and Acetex businesses, the additional CAG shares acquired and a decrease in net proceeds from disposal of discontinued operations of $64 million. The net proceeds from the disposal of discontinued operations represents cash received in 2005 from an early contractual settlement of receivables of $75 million related to the sale in 2000 of the Predecessor's interest in Vinnolit Kunstoff GmbH and Vintron GmbH while the net proceeds of $139 million in the same period last year represented the net proceeds from the sale of the acrylates business. Capital expenditures on property, plant and equipment decreased to $132 million from $150 million in 2004. Net Cash Provided by/(Used in) Financing Activities Net cash from financing activities decreased to a cash outflow of $78 million for the nine months ended September 30, 2005 compared to a cash inflow of $2,405 million in the same period last year. The cash inflow in 2004 primarily reflected higher net proceeds from borrowings in connection with the acquisition of CAG. Major financing activities for 2005 are as follows: [[Image Removed]] [[Image Removed]] [[Image Removed]] Borrowings under the term loan facility of $1,135 million. [[Image Removed]] [[Image Removed]] [[Image Removed]] Distribution to Series B shareholders of $804 million. [[Image Removed]] [[Image Removed]] [[Image Removed]] Redemption and related premiums of the senior subordinated notes of $572 million and senior discount notes of $207 million. [[Image Removed]] [[Image Removed]] [[Image Removed]] Proceeds from the issuances of common stock, net of $752 million and preferred stock, net of $233 million. [[Image Removed]] [[Image Removed]] [[Image Removed]] Repayment of floating rate term loan, including related premium, of $354 million. [[Image Removed]] [[Image Removed]] [[Image Removed]] Exercise of Acetex's option to redeem its 10 7/8% senior notes for approximately $280 million. 86 -------------------------------------------------------------------------------- Refer to the Liquidity Section for more information. Liquidity Our contractual obligations, commitments and debt service requirements over the next several years are significant and are substantially higher than historical amounts. Our primary source of liquidity will continue to be cash generated from operations as well as existing cash on hand. We believe we will have available resources to meet both our short-term and long-term liquidity requirements, including debt service. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be forced to use other means available to us such as to increase our borrowings under our lines of credit, reduce or delay capital expenditures, seek additional capital or seek to restructure or refinance our indebtedness. In January 2005, we completed an initial public offering of Series A common stock and received net proceeds of approximately $752 million after deducting underwriters discounts and offering expenses of $48 million. Concurrently, the Company received net proceeds of $233 million from the offering of its convertible preferred stock and borrowed an additional $1,135 million under the amended and restated senior credit facilities. A portion of the proceeds of the share offerings were used to redeem $188 million of senior discount notes and $521 million of senior subordinated notes, which excludes early redemption premiums of $19 million and $51 million, respectively. We also used a portion of the proceeds from additional borrowings under our senior credit facilities to repay our $350 million floating rate term loan, which excludes a $4 million early redemption premium, and used $200 million of the proceeds as the primary financing for the acquisition of the Vinamul emulsion business. On April 7, 2005, we used the remaining proceeds to pay a special cash dividend to holders of the Company's Series B common stock of $804 million. Upon payment of the $804 million dividend, all of the outstanding shares of Celanese Series B common stock converted automatically to shares of Celanese Series A common stock. In addition, we may use the available sources of liquidity to purchase the remaining outstanding shares of Celanese AG. As a result of the offerings in January 2005, we now have $240 million aggregate liquidation preference of outstanding preferred stock. Holders of the preferred stock are entitled to receive, when, as and if, declared by our board of directors, out of funds legally available therefor, cash dividends at the rate of 4.25% per annum (or $1.06 per share) of liquidation preference, payable quarterly in arrears, which commenced on May 1, 2005. Dividends on the preferred stock are cumulative from the date of initial issuance. This dividend is expected to result in an annual dividend payment of $10 million. Accumulated but unpaid dividends accumulate at an annual rate of 4.25%. The preferred stock is convertible, at the option of the holder, at any time into shares of our Series A common stock at a conversion rate of approximately 1.25 shares, subject to adjustments, of our Series A common stock per $25.00 liquidation preference of the preferred stock. As of November 1, 2005 the Company will have paid $8 million in aggregate dividends on its preferred stock. During July 2005, our board of directors adopted a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of our Series A common stock at an annual rate initially equal to approximately 1% of the $16.00 initial public offering price per share of our Series A common stock (or $0.16 per share) unless our board of directors in its sole discretion determines otherwise. As of November 1, 2005, the Company has paid $13 million in aggregate dividends on its Series A common stock. Based upon the number of outstanding shares as of September 30, 2005, the anticipated annual cash dividend payment is approximately $25 million. However, there is no assurance that sufficient cash or surplus will be available to pay such dividend. In July 2005, the Company acquired Acetex Corporation (Acetex) for $270 million and assumed Acetexs $247 million of net debt, which is net of cash acquired of $54 million. Acetexs operations include an acetyls business with plants in Europe and a North-American specialty polymers and film business. The Company acquired Acetex using existing cash. The Company caused Acetex to exercise its option to redeem its 10 7/8% senior notes due 2009 totaling approximately $265 million. The redemption was funded primarily with cash on hand and occurred on August 19, 2005. The 87 -------------------------------------------------------------------------------- redemption price was approximately $280 million, which represented 105.438% of the outstanding principal amount, plus accrued and unpaid interest to August 19, 2005. On August 25, 2005, the Company repaid the remaining $36 million of assumed debt with available cash. As of September 30, 2005, the Company had total debt of $3,496 million and cash and cash equivalents of $401 million. Net debt (total debt less cash and cash equivalents) increased to $3,095 million from $2,549 million as of December 31, 2004 primarily due to a decrease in cash and cash equivalents of $437 million. The Company largely used available cash to finance the Acetex acquisition, the redemption of Acetex senior notes and the purchase of the CAG Shares from two minority shareholders. Domination Agreement. At the CAG annual shareholders' meeting on June 15, 2004, CAG shareholders approved payment of a dividend on the CAG Shares for the fiscal year ended December 31, 2003 of 0.12 per share. For the nine month fiscal year ended on September 30, 2004, Celanese will not be able to pay a dividend to the CAG shareholders due to losses incurred in the CAG statutory accounts. Accordingly, in the near term, the Issuer, Crystal LLC and BCP Crystal, will use existing cash and borrowings from their subsidiaries, subject to various restrictions, including restrictions imposed by the amended and restated senior credit facilities and indentures and by relevant provisions of German and other applicable laws, to make interest payments. If the Domination Agreement ceases to be operative, the ability of the Issuer, Crystal LLC and BCP Crystal to meet their obligations will be materially and adversely affected. The Domination Agreement was approved at the CAG's extraordinary shareholders' meeting on July 31, 2004. The Domination Agreement between CAG and the Purchaser became effective on October 1, 2004. When the Domination Agreement became effective, the Purchaser was obligated to offer to acquire all outstanding CAG Shares from the minority shareholders of CAG in return for payment of fair cash compensation. This offer will continue until two months following the date on which the decision on the last motion in award proceedings (Spruchverfahren), as described in "BusinessLegal ProceedingsShareholder Litigation", has been disposed of and has been published. These award proceedings were dismissed in 2005; however, the dismissal is still subject to appeal. The amount of this fair cash compensation has been determined to be 41.92 per share, plus interest, in accordance with applicable German law. Simultaneously with our acquisition of additional CAG Shares in August 2005, we also announced that we would increase our offer to purchase any remaining outstanding CAG Shares to 51 per share (plus interest on 41.92 per share) for all minority shareholders that would accept the increased offer on or prior to September 29, 2005 and waive their rights to participate in an increase of the offer consideration as a result of the pending award proceedings. In addition, all shareholders who tendered their shares pursuant to the mandatory offer of 41.92 per share commenced in September 2004 and continuing as of the date of this prospectus, were entitled to claim the difference between the increased offer of 51 per share and the mandatory offer of 41.92 per share. Any shareholder who accepted the increased offer of 51 per share, or claimed the difference between the mandatory offer and the increased offer, was obligated to agree to waive its rights to participate in any possible future increase of the offer consideration as a result of the pending award proceedings. For minority shareholders who did not accept the increased offer on or prior to the September 29, 2005 expiration date, the terms of the original 41.92 per share mandatory offer will continue to apply. The mandatory offer will expire on December 1, 2005, unless further extended. As a result of the award proceedings, the amount of the fair cash consideration and the guaranteed fixed annual payment offered under the Domination Agreement could be increased by the court so that all minority shareholders, including those who have already tendered their shares into the mandatory offer and have received the fair cash compensation, could claim higher amounts. Any minority shareholder who elects not to sell their shares to the Purchaser will be entitled to remain a shareholder of CAG and to receive from the Purchaser a gross guaranteed fixed annual payment on their shares of 3.27 per CAG Share less certain corporate taxes in lieu of any future dividend. Taking into account the circumstances and the tax rates at the time of entering into the Domination Agreement, the net guaranteed fixed annual payment is 2.89 per CAG share for a full fiscal year. Based upon the number of CAG Shares held by the minority shareholders, as of September 30, 2005, a net guaranteed fixed annual payment of 6 million is expected. The net 88 -------------------------------------------------------------------------------- guaranteed fixed annual payment may, depending on applicable corporate tax rates, in the future be higher, lower, or the same as 2.89 per CAG share. As of November 2, 2005 the Purchaser owned approximately 98% of the outstanding CAG Shares. If the Purchaser acquires all the remaining CAG Shares outstanding as of November 2, 2005, the total amount of funds necessary to purchase such outstanding shares under the current offer of 41.92 per share would be approximately 40 million plus accrued interest on 41.92 per share from October 2, 2004. While the Domination Agreement is operative, the Purchaser is required to compensate CAG for any statutory annual loss incurred by CAG, the dominated entity, at the end of its fiscal year when the loss was incurred. If the Purchaser were obligated to make cash payments to CAG to cover an annual loss, the Purchaser may not have sufficient funds to pay interest when due and, unless the Purchaser is able to obtain funds from a source other than annual profits of CAG, the Purchaser may not be able to satisfy its obligation to fund such shortfall. The Domination Agreement cannot be terminated by the Purchaser in the ordinary course until September 30, 2009. Our subsidiaries, BCP Caylux Holdings Luxembourg S.C.A. and BCP Crystal, have each agreed to provide the Purchaser with financing to strengthen the Purchaser's ability to fulfill its obligations under, or in connection with, the Domination Agreement and to ensure that the Purchaser will perform all of its obligations under, or in connection with, the Domination Agreement when such obligations become due, including, without limitation, the obligations to make a guaranteed fixed annual payment to the outstanding minority shareholders, to offer to acquire all outstanding CAG Shares from the minority shareholders in return for payment of fair cash consideration and to compensate CAG for any statutory annual loss incurred by CAG during the term of the Domination Agreement. In addition, the Issuer expects to guarantee all obligations of the Purchaser under, or in connection with, the Domination Agreement, including the repayment of all existing and future intercompany indebtedness of the Issuer's subsidiaries to CAG. Further, under the terms of the Issuer's guarantee, in certain limited circumstances CAG may be entitled to require the immediate repayment of some or all of the intercompany indebtedness owed by the Issuer's subsidiaries to CAG. If the Issuer, BCP Caylux and/or BCP Crystal are obligated to make payments under such guarantees to the Purchaser, CAG and/or the minority shareholders, as the case may be, or if the intercompany indebtedness owed to CAG is accelerated, we may not have sufficient funds for payments on our indebtedness when due or to make funds available to the Issuer. The Company was in compliance with all of the financial covenants related to its debt agreements as of September 30, 2005. Contractual Obligations.The following table sets forth our fixed contractual debt obligations as of September 30, 2005: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 2010 [[Image Removed]] [[Image Removed]] [[Image Removed]] 2006- [[Image Removed]] 2008- [[Image Removed]] and Fixed Contractual Debt Obligations Total Remaining 2005 2007 2009 thereafter [[Image Removed]] (in $ millions) Senior Credit Facilities Term Loans Facility [[Image Removed]] 1,719 [[Image Removed]] 4 [[Image Removed]] 34 [[Image Removed]] 33 [[Image Removed]] 1,648 Senior Credit Facilities Revolving Credit Facility [[Image Removed]] 35 [[Image Removed]] [[Image Removed]] [[Image Removed]] 35 [[Image Removed]] Senior Subordinated Notes(1) [[Image Removed]] 953 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 953 Senior Discount Notes(2) [[Image Removed]] 554 [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] 554 Other Debt(3) [[Image Removed]] 419 [[Image Removed]] 136 [[Image Removed]] 42 [[Image Removed]] 27 [[Image Removed]] 214 Total Fixed Contractual Debt Obligations [[Image Removed]] 3,680 [[Image Removed]] 140 [[Image Removed]] 76 [[Image Removed]] 95 [[Image Removed]] 3,369 [[Image Removed]] [[Image Removed]] [[Image Removed]][[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] (1) Does not include $4 million of premium on the $225 million of the senior subordinated notes issued July 1, 2004. [[Image Removed]] [[Image Removed]] (2) Reflects the accreted value of the notes at maturity. [[Image Removed]] [[Image Removed]] (3) Does not include $2 million purchase accounting adjustment resulting from acquisition of CAG. Senior Credit Facilities.As of September 30, 2005, the senior credit facilities of $2,547 million consist of a term loan facility, a revolving credit facility, and a credit-linked revolving facility. 89 -------------------------------------------------------------------------------- Subsequent to the consummation of the initial public offering in January 2005, we entered into amended and restated senior credit facilities which increased the term facility. The terms of the amended and restated senior credit facilities are substantially similar to the terms of our immediately previous senior credit facilities. As of September 30, 2005, the term loan facility had a balance of $1,719 million (including approximately 275 million), which matures in 2011. In addition, there was a $242 million delayed draw facility, which expired unutilized in July 2005. The revolving credit facility, through a syndication of banks, provides for borrowings of up to $600 million, including the availability of letters of credit in U.S. dollars and euros and for borrowings on same-day notice. In the first quarter of 2005, the revolving credit facility was increased from $380 million to $600 million under the amended and restated senior credit facilities. As of September 30, 2005, $507 million remained available for borrowing under the revolving credit facility, taking into account letters of credit issued under the revolving credit facility. As of September 30, 2005, there was $35 million borrowed under the revolving credit facility and $58 million of letters of credit had been issued under the revolving credit facility. In addition, the Company has a $228 million credit-linked revolving facility, which matures in 2009. The credit-linked revolving facility includes borrowing capacity available for letters of credit. As of September 30, 2005, there were $226 million of letters of credit issued under the credit-linked revolving facility and an additional $2 million was available for borrowing. Senior Subordinated Notes.In February 2005, we used approximately $521 million of the net proceeds of the offering of our Series A common stock to redeem a portion of the senior subordinated notes and $51 million to pay the premium associated with the early redemption. As of September 30, 2005, the senior subordinated notes, excluding $4 million of premiums, consist of $796 million of 9 5/8% Senior Subordinated Notes due 2014 and 130 million of 10 3/8% Senior Subordinated Notes due 2014. All of BCP Crystal's U.S. domestic, wholly owned subsidiaries that guarantee BCP Crystal's obligations under the senior credit facilities guarantee the senior subordinated notes on an unsecured senior subordinated basis. Senior Discount Notes.In September 2004, Crystal LLC and Crystal US Sub 3 Corp., a subsidiary of Crystal LLC, issued $853 million aggregate principal amount at maturity of their senior discount notes due 2014 consisting of $163 million principal amount at maturity of their 10% Series A senior discount notes due 2014 and $690 million principal amount at maturity of their 1012;% Series B Senior Discount Notes due 2014 (collectively, the senior discount notes). The gross proceeds of the offering were $513 million. Approximately $500 million of the proceeds were distributed to the Company's Original Shareholders, with the remaining proceeds used to pay fees associated with the refinancing. Until October 1, 2009, interest on the senior discount notes will accrue in the form of an increase in the accreted value of such notes. Cash interest on the senior discount notes will accrue commencing on October 1, 2009 and be payable semiannually in arrears on April 1 and October 1. In February 2005, we used approximately $37 million of the net proceeds of the offering of our Series A common stock to redeem a portion of the Series A senior discount notes and $151 million to redeem a portion of the Series B senior discount notes and $19 million to pay the premium associated with the early redemption. As of September 30, 2005, there were $554 million aggregate principal amount at maturity outstanding, consisting of $106 million principal amount at maturity of their 10% Series A senior discount notes due 2014 and $448 million principal amount at maturity of their 1012;% Series B Senior Discount Notes due 2014. Other Debt.Other debt of $419 million, which does not include a $2 million reduction under purchase accounting, is primarily made up of fixed rate pollution control and industrial revenue bonds, short-term borrowings from affiliated companies and capital lease obligations. Off-Balance Sheet Arrangements We have not entered into any material off-balance sheet arrangements. 90 -------------------------------------------------------------------------------- Recent Accounting Pronouncements See Note 5 to the Unaudited Interim Consolidated Financial Statements included in this Form 10-Q for discussion of recent accounting pronouncements. Critical Accounting Policies and Estimates The preparation of the Company's consolidated financial statements requires management to apply accounting principles generally accepted in the United States of America to the Company's specific circumstances and make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. There have been no material revisions to the critical accounting policies as filed in the Company's Annual Report on Form 10-K for the nine months ended December 31, 2004 with the Securities and Exchange Commission on March 31, 2005. During the nine months ended September 30, 2005, the Company recorded asset impairments of $25 million primarily consisting of revised estimates related to the Companys decision to divest its COC business. The Company also increased goodwill by $15 million associated with purchase accounting adjustments related to the acquisition of CAG, including the additional CAG shares acquired. The goodwill adjustment is preliminary and is expected to be finalized by June 30, 2006. Forward-Looking Statements May Prove Inaccurate This Quarterly Report contains certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. These statements include, but are not limited to, statements about our strategies, plans, objectives, expectations, intentions, expenditures, and assumptions and other statements contained in this prospectus that are not historical facts. When used in this document, words such as anticipate, believe, estimate, expect, intend, plan and project and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views with respect to future events, are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. These factors include, among other things: [[Image Removed]] [[Image Removed]] [[Image Removed]] changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; [[Image Removed]] [[Image Removed]] [[Image Removed]] the length and depth of product and industry business cycles particularly in the automotive, electrical, electronics and construction industries; [[Image Removed]] [[Image Removed]] [[Image Removed]] changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of fuel oil, natural gas, coal, electricity and petrochemicals such as ethylene, propylene and butane, including changes in production quotas in OPEC countries and the deregulation of the natural gas transmission industry in Europe; [[Image Removed]] [[Image Removed]] [[Image Removed]] the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; [[Image Removed]] [[Image Removed]] [[Image Removed]] the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; [[Image Removed]] [[Image Removed]] [[Image Removed]] the ability to reduce production costs and improve productivity by implementing technological improvements to existing plants; 91 -------------------------------------------------------------------------------- [[Image Removed]] [[Image Removed]] [[Image Removed]] the existence of temporary industry surplus production capacity resulting from the integration and start-up of new world-scale plants; [[Image Removed]] [[Image Removed]] [[Image Removed]] increased price competition and the introduction of competing products by other companies; [[Image Removed]] [[Image Removed]] [[Image Removed]] the ability to develop, introduce and market innovative products, product grades and applications, particularly in the Ticona and Performance Products segments of our business; [[Image Removed]] [[Image Removed]] [[Image Removed]] changes in the degree of patent and other legal protection afforded to our products; [[Image Removed]] [[Image Removed]] [[Image Removed]] compliance costs and potential disruption or interruption of production due to accidents or other unforeseen events or delays in construction of facilities; [[Image Removed]] [[Image Removed]] [[Image Removed]] potential liability for remedial actions under existing or future environmental regulations; [[Image Removed]] [[Image Removed]] [[Image Removed]] potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; [[Image Removed]] [[Image Removed]] [[Image Removed]] changes in currency exchange rates and interest rates; [[Image Removed]] [[Image Removed]] [[Image Removed]] changes in the composition or restructuring of us or our subsidiaries and the successful completion of acquisitions, divestitures and venture activities; [[Image Removed]] [[Image Removed]] [[Image Removed]] inability to successfully integrate current and future acquisitions; [[Image Removed]] [[Image Removed]] [[Image Removed]] pending or future challenges to the Domination Agreement; and [[Image Removed]] [[Image Removed]] [[Image Removed]] various other factors, both referenced and not referenced in this document. Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates. Item 3. Quantitative and Qualitative Disclosures about Market Risk Market risk for our Company has not changed significantly from the foreign exchange, interest rate, and commodity risks disclosed in Item 7A of our Annual Report on Form 10-K for the nine months ended December 31, 2004, with the exception of the following: The Company entered into an interest rate swap with a notional amount of $300 million to reduce its exposure to fluctuations in interest rates associated with a portion of the term loans borrowed under our senior credit facilities. This interest rate swap was designated as a cash flow hedge. The fair value of the swap as of September 30, 2005 was a liability of $2 million. Item 4. Controls and Procedures In connection with the audit of our financial statements as of and for the nine months ended December 31, 2004, the Company identified a material weakness in its internal controls for the same period. On March 30, 2005, the Company received a letter from KPMG LLP (KPMG), its independent auditors, who also identified the same material weakness and a second material weakness in the course of their audit. The additional material weakness identified by KPMG related to several deficiencies in the assessment of hedge effectiveness and documentation. The required adjustments were made in the proper accounting period, except for one immaterial hedging transaction adjusted during the quarter ended June 30, 2005. The material weakness identified by KPMG and the Company related to conditions preventing its ability to adequately research, document, review and draw conclusions on accounting and reporting matters, which had previously resulted in adjustments that had to be recorded to prevent the Companys financial statements from being materially misleading. The conditions largely related to significant increases in the frequency of, and the limited 92 -------------------------------------------------------------------------------- number of personnel available to address, complex accounting matters and transactions and as a result of the consummation of simultaneous debt and equity offerings during the year-end closing process. The Company does not believe that the adjustments made in connection with these material weaknesses had any material impact on previously reported financial information. In response to the letter from KMPG with respect to the first material weakness indentified above, the Company organized a team responsible for the identification and documentation of potential derivative accounting transactions and commenced formal training for team members specifically related to derivative accounting. With respect to the second material weakness identified above, the Company hired certain accounting personnel and is in the process of hiring additional personnel which should ensure that adequate personnel is available to adequately research, document, review and conclude on accounting and reporting matters and will increase accounting resources. In addition, the Company hired additional personnel responsible for the development and implementation of additional internal reporting and accounting procedures, including derivative accounting procedures. Both material weaknesses were identified during the Companys year-end closing process for the year ended December 31, 2004 and still exist as of September 30, 2005. The Company expects to remediate these material weaknesses by the end of the fiscal year ending December 31, 2005. In addition, in September 2005 we identified a significant deficiency in internal controls relating to sales to countries and other parties that are or have previously been subject to sanctions and embargoes imposed by the U.S. government. This significant deficiency was identified as a result of an internal investigation that was initiated in connection with the SEC review of a registration statement. The Company has taken immediate corrective actions which include a directive to senior business leaders stating that they are prohibited from selling products into certain countries subject to these trade restrictions, as well as making accounting systems modifications that prevents the initiation of purchase orders and shipment of products to these countries. Also, we plan to enhance the business conduct policy training in the area of export control. As a result, we believe that we have taken remediation measures that, once fully implemented, will be effective in eliminating this deficiency. Celanese, under the supervision and with the participation of Celanese's management, including the chief executive officer (CEO) and chief financial officer (CFO), performed an evaluation of the effectiveness of Celanese's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the 34 Act)) as of September 30, 2005. Disclosure controls and procedures are defined as controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the 34 Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (SEC). Based on this evaluation, and as a result of the material weaknesses that were identified and continued during the period covered by this Quarterly Report, Celanese's CEO and CFO concluded that, as of September 30, 2005, the end of the period covered by this Quarterly Report, Celanese's disclosure controls and procedures were not effective for gathering, analyzing and disclosing the material information Celanese is required to disclose in the reports it files under the 34 Act, within the time periods specified in the rules and forms of the SEC. Except as discussed above, there have been no changes in Celanese's internal controls over financial reporting (as defined in Rule 13a-15(f) under the 34 Act) during the period covered by this Quarterly Report that have materially affected or are reasonably likely to materially affect, internal controls over financial reporting. We are in the process of implementing changes to strengthen our internal controls. In addition, while we have taken actions to address these deficiencies and weaknesses, additional measures may be necessary and these measures along with other measures we expect to take to improve our internal controls may not be sufficient to address the issues identified by us or ensure that our internal controls are effective. If we are unable to correct existing or future deficiencies or weaknesses in internal controls in a timely manner, our ability to record, process, summarize and report financial information within the time periods specified in the rules and forms of the SEC will be adversely affected. This failure could materially and adversely impact our business, our financial condition and the market value of our securities. In addition, there could be a negative reaction in the financial markets due to a loss of confidence in reliability of future financial statements and SEC filings. We expect to incur expenses of approximately $2 million per year associated with the strengthening of our disclosure controls and procedures and internal controls over financial reporting. 93 -------------------------------------------------------------------------------- PART II OTHER INFORMATION Item 1. Legal Proceedings We are involved in a number of legal proceedings, lawsuits and claims incidental to the normal conduct of our business, relating to such matters as product liability, antitrust, past waste disposal practices and release of chemicals into the environment. While it is impossible at this time to determine with certainty the ultimate outcome of these proceedings, lawsuits and claims, management believes that adequate provisions have been made and that the ultimate outcomes will not have a material adverse effect on our financial position, but may have a material adverse effect on the results of operations or cash flows in any given accounting period. See also Note 12 to the Unaudited Interim Consolidated Financial Statements. Plumbing Actions No material developments regarding this matter, previously reported in the Annual Report on Form 10-K for the year ended December 31, 2004, and in the Quarterly Report on Form 10-Q for the three months ended March 31, 2005, occurred during the third quarter of 2005. For a summary of the history and current status of these matters, see Note 12 to the Unaudited Interim Consolidated Financial Statements. Sorbates Antitrust Actions No material developments regarding this matter, previously reported in the Annual Report on Form 10-K for the year ended December 31, 2004, and in the Quarterly Report on form 10-Q for the six months ended June 30, 2005, occurred during the third quarter of 2005, except as set forth below. For a summary of the history and current status of these matters, see Note 12 to the Unaudited Interim Consolidated Financial Statements. Kerr v. Eastman Chemical Co. et al., previously pending in the Superior Court of New Jersey, Law Division, Gloucester County, was dismissed for failure to prosecute.The only other private antitrust action by Sorbates customers still pending, Freeman v. Daicel et al., had been dismissed. The plaintiffs lost their appeal to the Supreme Court of Tennessee in August 2005 and have since filed a motion for leave. The action by the New York Attorney General, New York v. Daicel Chemical Industries Ltd. et al., which was pending in the New York State Supreme Court, New York County, was dismissed in August 2005; however, it is still subject to appeal. Acetic Acid Patent Infringement Matters On August 31, 2005 a Taiwanese Court held that the China Petrochemical Development Corporation (CPDC) infringed Celanese International Corporations acetic acid patent and awarded Celanese International Corporation approximately $28 million for the period of 1995 through 1999. The judgment has been appealed. The Company will not record income associated with this favorable judgment until cash is received. Shareholder Litigation No material developments regarding this matter previously reported in the Annual Report on Form 10-K for the year ended December 31, 2004, in the Quarterly Report on Form 10-Q for the three months ended March 31, 2005 and in the Quarterly Report on Form 10-Q for the six months ended June 30, 2005, occurred during the third quarter of 2005, except as set forth below. For a summary and history of these matters, see Note 12 to the Unaudited Interim Consolidated Financial Statements. Twenty-seven CAG minority shareholders filed lawsuits in May and June of 2005 in the Frankfurt District Court (Landgericht) contesting the shareholder resolutions passed at the CAG annual general meeting held May 19-20, 2005, which confirmed the resolutions passed at the July 30-31, 2004 94 -------------------------------------------------------------------------------- extraordinary general meeting. In conjunction with the acquisition of 5.9 million CAG shares from two shareholders in August 2005, two of those lawsuits were withdrawn in August 2005. In May and September 2005, Celanese AG was served in three actions filed in the Frankfurt District Court (Landgericht), requesting that the court declare some or all of the shareholder resolutions passed at the extraordinary general meeting on July 30 and 31, 2004 null and void (Nichtigkeitsklage), based on allegations that certain formal requirements necessary in connection with the invitation to the extraordinary general meeting had been violated. The Frankfurt District Court (Landgericht) has suspended the proceedings regarding the resolutions passed at the July 30-31, 2004 extraordinary general meeting described above as long as the lawsuits contesting the confirmatory resolutions are pending. Based upon the information available, the outcome of the foregoing proceedings cannot be predicted with certainty. Other Matters As of September 30, 2005, Celanese Ltd. and/or CNA Holdings, Inc., both our U.S. subsidiaries, are defendants in approximately 650 asbestos cases. Because many of these cases involve numerous plaintiffs, we are subject to claims significantly in excess of the number of actual cases. We have reserves for defense costs related to claims arising from these matters. We believe we do not have any significant exposure in these matters. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds During the period covered by this Quarterly Report, we sold 17,360 shares of our Series A common stock for $124,992 to one of our key employees under our Stock Incentive Plan. We issued such shares of Series A common stock to the recipient pursuant to a written subscription agreement in accordance with Rule 701 under the Securities Act. Item 3. Defaults Upon Senior Securities None. Item 4. Submission of Matters to a Vote of Security Holders None. Item 5. Other Information None. Item 6. Exhibits [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Exhibit Number [[Image Removed]] Description 3.1 Second Amended and Restated Certificate of Incorporation of Registrant (incorporated by [[Image Removed]] reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K (File No. 001-32410) filed with the SEC on January 28, 2005) 3.2 Amended and Restated By-laws of Registrant [[Image Removed]] (incorporated by reference to Exhibit 3.2 to the Registrant's Registration Statement on Form S-4 (File No. 333 - ) filed with the SEC on April 13, 2005). 3.3 Certificate of Designations of Convertible Perpetual Preferred Stock (incorporated by reference to Exhibit [[Image Removed]] 3.2 to the Registrant's Current Report on Form 8-K (File No. 001-32410) filed with the SEC on January 28, 2005) [[Image Removed]] 95 -------------------------------------------------------------------------------- [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Exhibit Number [[Image Removed]] Description 4.1 Form of certificate of Series A common stock (incorporated by reference to Exhibit 4.1 to [[Image Removed]] Amendment No. 6 to the Registrant's Registration Statement on Form S-1 (File No. 333-120187) (the Form S-1) filed with the SEC on January 19, 2005) 4.2 Form of certificate of Convertible Perpetual [[Image Removed]] Preferred Stock (incorporated by reference to Exhibit 4.2 to Amendment No. 5 to the Form S-1 filed with the SEC on January 13, 2005) 4.3 Third Amended and Restated Shareholders' Agreement, dated as of October 31, 2005, among Celanese Corporation, Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone Capital Partners (Cayman) Ltd. 2, [[Image Removed]] Blackstone Capital Partners (Cayman) Ltd. 3 and BA Capital Investors Sidecar Fund, L.P. (incorporated by reference to Exhibit 4.3 to the Registrant's Registration Statement filed on Form S-1 (File No. 333-127902) filed with the SEC on November 1, 2005) 4.4 Amended and Restated Registration Rights Agreement, dated as of January 26, 2005, among Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone Capital [[Image Removed]] Partners (Cayman) Ltd. 2, Blackstone Capital Partners (Cayman) Ltd. 3, BA Capital Investors Sidecar Fund, L.P. and Celanese Corporation (incorporated by reference to Exhibit 10.2 to the Form 8-K (File No. 001-32410) filed with the SEC on January 28, 2005) 10.1 Share Purchase and Transfer Agreement and Settlement Agreement, dated August 19, 2005, between Celanese Europe Holding GmbH & Co. KG, as the purchaser and Paulson & Co. Inc. and Arnold and S. Bleichroeder [[Image Removed]] Advisers, LLC, each on behalf of its own and with respect to shares owned by the investment funds and separate accounts managed by it, as the sellers (incorporated by reference to Exhibit 10.1 to the Form 8-K (File No. 001-32410) filed with the SEC on August 19, 2005) 10.2 Employment Agreement, dated as of August 31, 2005 by and between Celanese Corporation and John J. [[Image Removed]] Gallagher III (incorporated by reference to Exhibit 10.1 to the Form 8-K File No. 001-32410) filed with the SEC on August 31, 2005 10.3 Offer Letter from Celanese Corporation dated August 30, 2005, executed by John J. Gallagher III on August [[Image Removed]] 30, 2005 (incorporated by reference to Exhibit 10.2 to the Form 8-K (File No. 001-32410) filed with the SEC on August 31, 2005 12 [[Image Removed]] Computation of ratio of earnings to fixed charges (filed herewith) 31.1 Certification of Chief Executive Officer pursuant to [[Image Removed]] Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith) 31.2 Certification of Chief Financial Officer pursuant to [[Image Removed]] Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith) 32.1 Certification of Chief Executive Officer pursuant to [[Image Removed]] Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith) 32.2 Certification of Chief Financial Officer pursuant to [[Image Removed]] Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith) [[Image Removed]] PLEASE NOTE: It is inappropriate for readers to assume the accuracy of, or rely upon any covenants, representations or warranties that may be contained in agreements or other documents filed as Exhibits to, or incorporated by reference in, this Quarterly Report. Any such covenants, representations or warranties may have been qualified or superseded by disclosures contained in separate schedules or exhibits not filed with or incorporated by reference in this Quarterly Report, may reflect the parties' negotiated risk allocation in the particular transaction, may be qualified by materiality standards that differ from those applicable for securities law purposes, and may not be true as of the date of this Quarterly Report or any other date and may be subject to waivers by any or all 96 -------------------------------------------------------------------------------- of the parties. Where exhibits and schedules to agreements filed or incorporated by reference as Exhibits hereto are not included in these exhibits, such exhibits and schedules to agreements are not included or incorporated by reference herein. 97 -------------------------------------------------------------------------------- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] CELANESE CORPORATION [[Image Removed]] By: [[Image Removed]] /s/ David N. Weidman Name: David N. Weidman [[Image Removed]] [[Image Removed]] Title: President and Chief Executive Officer Date: November 10, 2005 [[Image Removed]] By: [[Image Removed]] /s/ John J. Gallagher III Name: John J. Gallagher III Title: Executive Vice President and Chief [[Image Removed]] [[Image Removed]] Financial Officer (Principal Financial Officer) Date: November 10, 2005 [[Image Removed]] 98 -------------------------------------------------------------------------------- EX-12 5 file002.htm COMPUTATION OF RATIO OF EARNINGS Exhibit 12 CELANESE CORPORATION COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Successor [[Image Removed]] Predecessor Three Months Three Months Nine Months Six Months Three Months [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended [[Image Removed]] Ended September 30, September 30, September 30, September 30, March 31, 2005 2004 2005 2004 2004 Earnings: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Earnings (loss) from continuing operations before tax [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] and minority interest 74 (31 ) 220 (135 ) 72 Less: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Equity in net earnings of affiliates [[Image Removed]] (21 ) [[Image Removed]] (17 ) [[Image Removed]] (48 ) [[Image Removed]] (35 ) [[Image Removed]] (12 ) Plus: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Income distributions from equity investments [[Image Removed]] 14 [[Image Removed]] 15 [[Image Removed]] 60 [[Image Removed]] 21 [[Image Removed]] 15 Amortization of capitalized interest [[Image Removed]] [[Image Removed]] 2 [[Image Removed]] 3 [[Image Removed]] 4 [[Image Removed]] 2 Total fixed charges [[Image Removed]] 85 [[Image Removed]] 106 [[Image Removed]] 363 [[Image Removed]] 243 [[Image Removed]] 16 Total earnings as defined before combined fixed [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] charges 152 75 598 98 93 Fixed charges: [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] Interest expense [[Image Removed]] 72 [[Image Removed]] 98 [[Image Removed]] 316 [[Image Removed]] 228 [[Image Removed]] 6 Capitalized interest [[Image Removed]] [[Image Removed]] 1 [[Image Removed]] 3 [[Image Removed]] 2 [[Image Removed]] 3 Estimated interest portion of rent expense [[Image Removed]] 5 [[Image Removed]] 7 [[Image Removed]] 17 [[Image Removed]] 13 [[Image Removed]] 7 Cumulative undeclared and declared preferred stock [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] [[Image Removed]] dividends 3 7 Guaranteed payment to minority shareholders [[Image Removed]] 5 [[Image Removed]] [[Image Removed]] 20 [[Image Removed]] [[Image Removed]] Total combined fixed charges [[Image Removed]] 85 [[Image Removed]] 106 [[Image Removed]] 363 [[Image Removed]] 243 [[Image Removed]] 16 Ratio of earnings to combined fixed charges(1) [[Image Removed]] 1.8 [[Image Removed]] [[Image Removed]] 1.6 [[Image Removed]] [[Image Removed]] 5.8 [[Image Removed]] [[Image Removed]] [[Image Removed]] (1) Earnings were insufficient to cover combined fixed charges by $31 million and $145 million for the three months and six months ended September 30, 2004, respectively. -------------------------------------------------------------------------------- EX-31.1 6 file003.htm CERTIFICATION PURSUANT TO SECTION 302 Exhibit 31.1 CERTIFICATION PURSUANT TO 17 CFR 240.13a-14 PROMULGATED UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, David N. Weidman, certify that: [[Image Removed]] [[Image Removed]] 1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation; [[Image Removed]] [[Image Removed]] 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; [[Image Removed]] [[Image Removed]] 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; [[Image Removed]] [[Image Removed]] 4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have: [[Image Removed]] [[Image Removed]] [[Image Removed]] (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; [[Image Removed]] [[Image Removed]] [[Image Removed]] (b) [Reserved] [[Image Removed]] [[Image Removed]] [[Image Removed]] (c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and [[Image Removed]] [[Image Removed]] [[Image Removed]] (d) disclosed in this report any change in the registrant's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and [[Image Removed]] [[Image Removed]] 5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): [[Image Removed]] [[Image Removed]] [[Image Removed]] (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and [[Image Removed]] [[Image Removed]] [[Image Removed]] (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: November 10, 2005 /s/ David N. Weidman David N. Weidman President and Chief Executive Officer -------------------------------------------------------------------------------- EX-31.2 7 file004.htm CERTIFICATION PURSUANT TO SECTION 302 Exhibit 31.2 CERTIFICATION PURSUANT TO 17 CFR 240.13a-14 PROMULGATED UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, John J. Gallagher III, certify that: [[Image Removed]] [[Image Removed]] 1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation; [[Image Removed]] [[Image Removed]] 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; [[Image Removed]] [[Image Removed]] 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; [[Image Removed]] [[Image Removed]] 4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have: [[Image Removed]] [[Image Removed]] [[Image Removed]] (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; [[Image Removed]] [[Image Removed]] [[Image Removed]] (b) [Reserved] [[Image Removed]] [[Image Removed]] [[Image Removed]] (c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and [[Image Removed]] [[Image Removed]] [[Image Removed]] (d) disclosed in this report any change in the registrant's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and [[Image Removed]] [[Image Removed]] 5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): [[Image Removed]] [[Image Removed]] [[Image Removed]] (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and [[Image Removed]] [[Image Removed]] [[Image Removed]] (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: November 10, 2005 /s/ John J. Gallagher III John J. Gallagher III Chief Financial Officer -------------------------------------------------------------------------------- EX-32.1 8 file005.htm CERTIFICATION PURSUANT TO SECTION 906 Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Celanese Corporation (the Company) on Form 10-Q for the period ending September 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, David N. Weidman, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: [[Image Removed]] [[Image Removed]] 1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and [[Image Removed]] [[Image Removed]] 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: November 10, 2005 /s/ David N. Weidman David N. Weidman President and Chief Executive Officer -------------------------------------------------------------------------------- EX-32.2 9 file006.htm CERTIFICATION PURSUANT TO SECTION 906 Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Celanese Corporation (the Company) on Form 10-Q for the period ending September 30, 2005 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, John J. Gallagher III, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: [[Image Removed]] [[Image Removed]] 1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and [[Image Removed]] [[Image Removed]] 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: November 10, 2005 /s/ John J. Gallagher III John J. Gallagher III Executive Vice President and Chief Financial Officer --------------------------------------------------------------------------------